Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,A1BG,Alpha-1B-glycoprotein,24294,101,1.64 [0.55-4.91],0.3775821193573454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AAMDC,Mth938 domain-containing protein,23579,96,1.12 [0.78-1.61],0.5299037195460379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AARSD1,Alanyl-tRNA editing protein Aarsd1,27803,121,1.20 [0.91-1.59],0.1965115226808934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ABCA2,ATP-binding cassette sub-family A member 2,23482,98,1.06 [0.62-1.80],0.8420499238881376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ABHD14B,Protein ABHD14B,27640,119,1.30 [0.99-1.70],0.0589023135350546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ABL1,Tyrosine-protein kinase ABL1,27803,121,1.24 [0.99-1.54],0.0561364046194162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ABO,Histo-blood group ABO system transferase,24282,100,1.01 [0.89-1.15],0.8716828026284166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ABRAXAS2,BRISC complex subunit Abraxas 2,23482,98,1.20 [0.91-1.59],0.1995141371311848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",27238,115,0.99 [0.81-1.21],0.9384831756853864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",23811,95,0.97 [0.73-1.29],0.829800329135447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24257,99,1.06 [0.86-1.30],0.6121338802957734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ACAN,Aggrecan core protein,27677,121,1.51 [0.86-2.65],0.1535729648410101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ACE,Angiotensin-converting enzyme,24282,100,1.80 [0.86-3.76],0.1189091682462005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ACE2,Angiotensin-converting enzyme 2,27425,119,1.33 [1.01-1.76],0.044168850058883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ACHE,Acetylcholinesterase,23715,97,0.92 [0.51-1.67],0.7931961034435171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ACOT13,Acyl-coenzyme A thioesterase 13,24167,101,1.15 [0.98-1.36],0.089476247354902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,27929,121,1.03 [0.75-1.41],0.852329180941218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ACP1,Low molecular weight phosphotyrosine protein phosphatase,23569,96,1.00 [0.65-1.54],0.998774926947428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ACP5,Tartrate-resistant acid phosphatase type 5,28030,121,1.67 [1.06-2.64],0.0281708620618857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ACP6,Lysophosphatidic acid phosphatase type 6,28142,121,1.10 [0.85-1.42],0.4551954058924256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ACRBP,Acrosin-binding protein,24145,101,1.46 [0.96-2.24],0.079860212807385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ACRV1,Acrosomal protein SP-10,23569,96,1.05 [0.79-1.38],0.7394013563037414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ACSL1,Long-chain-fatty-acid--CoA ligase 1,23482,98,1.25 [0.79-1.99],0.333530814445248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ACTA2,"Actin, aortic smooth muscle",27425,119,1.55 [1.19-2.02],0.0012178507032954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ACTN2,Alpha-actinin-2,23482,98,0.97 [0.69-1.34],0.8342571674216617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ACTN4,Alpha-actinin-4,27408,119,1.54 [1.08-2.18],0.0172149278406533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ACVRL1,Serine/threonine-protein kinase receptor R3,27690,120,3.15 [1.72-5.75],0.0001927309750568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ACY1,Aminoacylase-1,27929,121,0.94 [0.73-1.20],0.6097849628718578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,23482,98,0.95 [0.68-1.33],0.7767877282764358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ACYP1,Acylphosphatase-1,23624,97,1.16 [0.87-1.55],0.2984225328180889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADA,Adenosine deaminase,28265,122,0.91 [0.58-1.44],0.6955524832380016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADA2,Adenosine deaminase 2,27745,119,1.43 [0.99-2.08],0.0590216591719876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,23569,96,1.54 [1.13-2.09],0.0058484895710699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,27425,119,1.07 [0.63-1.82],0.8069461161408122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,27738,120,1.40 [0.89-2.20],0.1498395402663453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,28265,122,0.86 [0.56-1.33],0.4998617068488271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,28150,122,1.74 [1.03-2.95],0.0397769637578485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24167,101,1.72 [0.97-3.06],0.0628866080111768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,23569,96,1.66 [1.07-2.57],0.0239372368255512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,28272,122,0.83 [0.42-1.63],0.5790971798394673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,27803,121,1.29 [0.88-1.89],0.1850154987531091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,27425,119,1.42 [1.01-1.99],0.0448731974619307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,23569,96,0.98 [0.57-1.68],0.9433081423559224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,27992,119,0.95 [0.67-1.35],0.7663466622724856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADAMTSL2,ADAMTS-like protein 2,24251,100,1.24 [0.70-2.18],0.4589844037310491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADAMTSL4,ADAMTS-like protein 4,23579,96,1.09 [0.49-2.44],0.8245547293161541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADAMTSL5,ADAMTS-like protein 5,24257,99,0.81 [0.50-1.32],0.4037624183192573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,27238,115,1.06 [0.67-1.67],0.8056281223414606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADD1,Alpha-adducin,23715,97,1.08 [0.82-1.43],0.5744236695591924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADGRB3,Adhesion G protein-coupled receptor B3,27690,120,1.07 [0.66-1.75],0.7736898462280495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADGRD1,Adhesion G-protein coupled receptor D1,23715,97,1.08 [0.66-1.76],0.756336707166458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADGRE1,Adhesion G protein-coupled receptor E1,24167,101,1.26 [0.90-1.75],0.1813123543430752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADGRE2,Adhesion G protein-coupled receptor E2,28050,121,1.41 [0.81-2.45],0.2259534102407492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADGRE5,Adhesion G protein-coupled receptor E5,28120,121,1.12 [0.66-1.90],0.6828312923755231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADGRF5,Adhesion G protein-coupled receptor F5,24257,99,1.76 [0.91-3.40],0.0906339105133225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADGRG1,Adhesion G-protein coupled receptor G1,27803,121,1.14 [0.90-1.45],0.2887875918559594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADGRG2,Adhesion G-protein coupled receptor G2,27929,121,0.88 [0.49-1.56],0.6597750289031685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADGRV1,Adhesion G-protein coupled receptor V1,23483,97,0.97 [0.73-1.29],0.8203734832756968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADH1B,All-trans-retinol dehydrogenase,23715,97,0.90 [0.70-1.16],0.4213841246041229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,27425,119,1.00 [0.83-1.21],0.994200956416809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADIPOQ,Adiponectin,24294,101,1.17 [0.89-1.55],0.2565074856816858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADM,Pro-adrenomedullin,28179,121,3.86 [2.13-6.97],7.839878298709504e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ADRA2A,Alpha-2A adrenergic receptor,23482,98,1.14 [0.90-1.44],0.2645920622242242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AFAP1,Actin filament-associated protein 1,23715,97,1.06 [0.84-1.32],0.6405318691503473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AFM,Afamin,24294,101,1.23 [0.47-3.24],0.676082073799591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AFP,Alpha-fetoprotein,27650,120,1.27 [1.00-1.60],0.0484669139813174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AGBL2,Cytosolic carboxypeptidase 2,23483,97,1.05 [0.84-1.30],0.6856532464195126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AGER,Advanced glycosylation end product-specific receptor,27858,120,1.24 [0.84-1.82],0.2833874423944459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AGR2,Anterior gradient protein 2 homolog,27047,112,1.20 [1.02-1.42],0.0264147467303198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AGR3,Anterior gradient protein 3,27201,115,1.16 [0.89-1.51],0.2698649197894351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AGRN,Agrin,28050,121,2.20 [1.49-3.25],7.74495238723292e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AGRP,Agouti-related protein,28265,122,1.52 [1.13-2.06],0.0062741241835413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AGT,Angiotensinogen,24282,100,1.24 [0.56-2.72],0.595909750892292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AGXT,Serine--pyruvate aminotransferase,27929,121,0.96 [0.78-1.18],0.688602647911011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AHCY,Adenosylhomocysteinase,27929,121,1.11 [0.88-1.40],0.3772377422463514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AHNAK,Neuroblast differentiation-associated protein AHNAK,23579,96,1.23 [0.69-2.18],0.4883810574757544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AHNAK2,Protein AHNAK2,23579,96,1.33 [0.72-2.49],0.3632326401621092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24145,101,1.11 [0.87-1.43],0.400273826021243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AHSG,Alpha-2-HS-glycoprotein,24282,100,1.19 [0.59-2.40],0.6325623769299893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AHSP,Alpha-hemoglobin-stabilizing protein,27878,121,1.13 [0.95-1.35],0.1793591468621512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AIDA,"Axin interactor, dorsalization-associated protein",23584,95,1.13 [0.92-1.38],0.2573291551140726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AIF1,Allograft inflammatory factor 1,27238,115,1.26 [0.93-1.71],0.1385995324222428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AIF1L,Allograft inflammatory factor 1-like,23579,96,0.75 [0.49-1.14],0.1754083055235171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",27752,121,1.08 [0.93-1.25],0.3117870709632491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AK1,Adenylate kinase isoenzyme 1,27929,121,1.20 [0.94-1.53],0.1352037128826587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AK2,"Adenylate kinase 2, mitochondrial",24190,99,1.14 [0.95-1.36],0.1571518340824004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AKAP12,A-kinase anchor protein 12,23715,97,1.45 [0.70-2.99],0.3172963869548608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AKR1B1,Aldo-keto reductase family 1 member B1,27238,115,1.05 [0.85-1.30],0.6350203758200956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AKR1B10,Aldo-keto reductase family 1 member B10,23584,95,1.19 [0.90-1.58],0.2153842516145886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AKR1C4,Aldo-keto reductase family 1 member C4,27425,119,0.95 [0.69-1.30],0.7454557325027185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AKR7L,Aflatoxin B1 aldehyde reductase member 4,23569,96,1.03 [0.78-1.34],0.848118222464643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AKT1S1,Proline-rich AKT1 substrate 1,27266,115,1.28 [1.00-1.63],0.0521928101954998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AKT2,RAC-beta serine/threonine-protein kinase,24223,100,1.09 [0.94-1.27],0.2423100316690275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AKT3,RAC-gamma serine/threonine-protein kinase,27097,114,1.24 [0.94-1.64],0.1318709092272606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ALCAM,CD166 antigen,28272,122,1.20 [0.54-2.69],0.6575179369551442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ALDH1A1,Retinal dehydrogenase 1,27919,121,1.07 [0.80-1.42],0.6489895303340497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24145,101,1.10 [0.78-1.55],0.5971207705301786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",27876,119,1.21 [0.98-1.49],0.0736495916950489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24223,100,1.31 [0.92-1.88],0.1383200370786249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ALMS1,Alstrom syndrome protein 1,23811,95,1.09 [0.73-1.64],0.6724120036698213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ALPI,Intestinal-type alkaline phosphatase,23569,96,1.00 [0.85-1.18],0.9772637388324666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ALPP,"Alkaline phosphatase, placental type",27803,121,1.07 [0.93-1.24],0.3481548697600247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AMBN,Ameloblastin,27408,119,1.45 [0.96-2.21],0.0780084094946241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AMBP,Protein AMBP,28142,120,5.21 [2.43-11.17],2.150445505142465e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24251,100,1.48 [0.73-3.00],0.279233000594471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AMFR,E3 ubiquitin-protein ligase AMFR,27266,115,1.09 [0.86-1.38],0.4940321156345173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AMIGO1,Amphoterin-induced protein 1,23584,95,0.81 [0.52-1.25],0.3400832797854578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AMIGO2,Amphoterin-induced protein 2,27803,121,1.74 [0.87-3.48],0.1190057709271774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AMN,Protein amnionless,27408,119,1.04 [0.74-1.45],0.8229000765954292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AMOT,Angiomotin,23715,97,1.89 [1.25-2.88],0.0028238235336179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AMOTL2,Angiomotin-like protein 2,24066,101,1.30 [0.93-1.81],0.124331683798837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AMPD3,AMP deaminase 3,24190,99,1.15 [0.89-1.49],0.2874061948790419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,22762,93,1.25 [0.88-1.80],0.217161660520073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AMY2A,Pancreatic alpha-amylase,26881,118,1.30 [0.92-1.83],0.1357874203343746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AMY2B,Alpha-amylase 2B,26039,115,1.26 [0.90-1.78],0.1815179832588181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ANG,Angiogenin,27826,119,1.12 [0.71-1.79],0.6236275808731477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ANGPT1,Angiopoietin-1,27844,120,1.00 [0.83-1.20],0.959189941436585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ANGPT2,Angiopoietin-2,28179,121,1.78 [1.21-2.63],0.0036939460226199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ANGPTL1,Angiopoietin-related protein 1,27509,118,1.96 [1.14-3.36],0.0147976811130185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ANGPTL2,Angiopoietin-related protein 2,27959,121,1.31 [0.88-1.94],0.1855890185061921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ANGPTL3,Angiopoietin-related protein 3,27925,119,1.21 [0.77-1.91],0.401357349329393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ANGPTL4,Angiopoietin-related protein 4,28007,121,1.56 [1.11-2.20],0.0104824638185849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ANGPTL7,Angiopoietin-related protein 7,28179,121,1.12 [0.74-1.68],0.6026524841934264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ANK2,Ankyrin-2,23482,98,0.89 [0.66-1.21],0.4615537459929474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,23569,96,1.09 [0.86-1.39],0.4854666652253158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ANKRA2,Ankyrin repeat family A protein 2,23402,100,1.04 [0.74-1.46],0.8148444560798014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ANKRD54,Ankyrin repeat domain-containing protein 54,27238,115,1.26 [0.99-1.61],0.0566021082994382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,23579,96,0.78 [0.44-1.39],0.398193630952716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ANPEP,Aminopeptidase N,27957,119,1.38 [0.79-2.41],0.2557216000122114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ANXA1,Annexin A1,23579,97,1.35 [0.97-1.88],0.0711673008794264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ANXA10,Annexin A10,27266,115,1.11 [0.91-1.35],0.3011997429610587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ANXA11,Annexin A11,27867,119,1.00 [0.78-1.27],0.9875682645036092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ANXA2,Annexin A2,23238,95,1.26 [0.99-1.61],0.0571283543488245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ANXA3,Annexin A3,28150,122,1.07 [0.86-1.34],0.5477354871593381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ANXA4,Annexin A4,27785,121,1.03 [0.83-1.28],0.7865921518255998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ANXA5,Annexin A5,27171,115,1.50 [0.90-2.51],0.1203636712758548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AOC1,Amiloride-sensitive amine oxidase [copper-containing],27408,119,1.24 [0.99-1.56],0.0616821919179288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AOC3,Membrane primary amine oxidase,28004,119,1.03 [0.61-1.74],0.9074927608449428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AP1G2,AP-1 complex subunit gamma-like 2,24145,101,1.21 [0.97-1.51],0.0936477933227254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AP2B1,AP-2 complex subunit beta,23584,95,1.21 [0.84-1.74],0.3028700739975519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AP3B1,AP-3 complex subunit beta-1,24167,101,1.29 [1.02-1.63],0.0366451271987005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AP3S2,AP-3 complex subunit sigma-2,24190,99,1.39 [0.97-2.00],0.0758435477725575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,27803,121,1.30 [0.97-1.75],0.0836491349157182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,APCS,Serum amyloid P-component,24090,100,0.95 [0.55-1.65],0.86499507190919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,28102,121,1.22 [0.94-1.58],0.1259290515802625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,APLP1,Amyloid-like protein 1,27929,121,1.01 [0.74-1.37],0.9572534019989464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,APOA1,Apolipoprotein A-I,24294,101,0.86 [0.41-1.79],0.69092985606812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,APOA2,Apolipoprotein A-II,24282,100,1.37 [0.93-2.01],0.115892581723622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,APOA4,Apolipoprotein A-IV,24294,101,1.13 [0.68-1.87],0.6418842068707904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,APOB,Apolipoprotein B-100,24282,100,2.15 [0.90-5.15],0.0861519487286731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,APOBR,Apolipoprotein B receptor,23579,96,0.76 [0.49-1.18],0.2232150829030944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,APOC1,Apolipoprotein C-I,24243,100,1.05 [0.64-1.72],0.8565080199269035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,APOD,Apolipoprotein D,23162,99,0.52 [0.29-0.94],0.0308852937576698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,APOE,Apolipoprotein E,24294,101,1.13 [0.91-1.41],0.2663163288043725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,APOF,Apolipoprotein F,24282,100,1.50 [0.81-2.78],0.1929298440175465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,APOH,Beta-2-glycoprotein 1,27919,121,1.26 [0.82-1.94],0.2897146567408052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,APOL1,Apolipoprotein L1,24282,100,1.07 [0.81-1.41],0.647507699563838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,APOM,Apolipoprotein M,27970,119,0.94 [0.52-1.70],0.8357708771063914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,APP,Amyloid-beta precursor protein,27868,120,1.04 [0.82-1.31],0.7643200762200547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,APPL2,DCC-interacting protein 13-beta,23715,97,1.08 [0.91-1.29],0.3794652535258949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,APRT,Adenine phosphoribosyltransferase,27705,120,1.08 [0.77-1.51],0.6481612849285902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ARAF,Serine/threonine-protein kinase A-Raf,23811,95,1.13 [0.86-1.49],0.3634360263483185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AREG,Amphiregulin,27803,121,1.64 [1.24-2.17],0.0006113589967128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ARF6,ADP-ribosylation factor 6,24167,101,1.11 [0.93-1.33],0.2489247180116318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ARFIP1,Arfaptin-1,24223,100,1.23 [0.95-1.61],0.1179956531658174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ARG1,Arginase-1,27787,120,1.31 [0.97-1.76],0.0748494820957013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ARG2,"Arginase-2, mitochondrial",24145,101,1.63 [1.21-2.18],0.0012072442985827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ARHGAP1,Rho GTPase-activating protein 1,27238,115,1.07 [0.76-1.52],0.6953967783411465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ARHGAP25,Rho GTPase-activating protein 25,27238,115,1.28 [1.01-1.64],0.0436811342300336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ARHGAP30,Rho GTPase-activating protein 30,23811,95,1.14 [0.72-1.81],0.5632882249495628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ARHGAP45,Rho GTPase-activating protein 45,23715,97,1.21 [0.96-1.52],0.1127908514021813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ARHGAP5,Rho GTPase-activating protein 5,23402,100,1.21 [0.97-1.51],0.0984897494439392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ARHGEF1,Rho guanine nucleotide exchange factor 1,24190,99,1.14 [0.92-1.41],0.2296931107902838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ARHGEF10,Rho guanine nucleotide exchange factor 10,24223,100,1.19 [0.98-1.45],0.0839031399150227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ARHGEF12,Rho guanine nucleotide exchange factor 12,27914,119,1.11 [0.95-1.30],0.186620903312882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ARHGEF5,Rho guanine nucleotide exchange factor 5,23483,97,1.06 [0.82-1.36],0.6568317107734656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ARID3A,AT-rich interactive domain-containing protein 3A,23483,97,1.27 [0.81-1.98],0.2968847944617232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ARID4B,AT-rich interactive domain-containing protein 4B,27266,115,1.11 [0.78-1.59],0.5524625340368627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ARL13B,ADP-ribosylation factor-like protein 13B,23482,98,1.06 [0.82-1.39],0.6437141122542405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,23482,98,1.22 [0.77-1.95],0.3928497256820136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ARMCX2,Armadillo repeat-containing X-linked protein 2,23483,97,0.86 [0.60-1.24],0.423204518944153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ARNT,Aryl hydrocarbon receptor nuclear translocator,27408,119,1.22 [0.83-1.78],0.3093542749454521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,23482,98,1.04 [0.73-1.50],0.8187532466469172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ARSA,Arylsulfatase A,27919,121,0.96 [0.68-1.34],0.7922395668662032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ARSB,Arylsulfatase B,27803,121,1.05 [0.79-1.39],0.72141893336645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ART3,Ecto-ADP-ribosyltransferase 3,28004,119,1.20 [0.75-1.93],0.4550357052092201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ART5,Ecto-ADP-ribosyltransferase 5,23483,97,0.95 [0.68-1.32],0.7468359732287055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ARTN,Artemin,27408,119,1.12 [0.82-1.53],0.4857417450030893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ASAH1,Acid ceramidase,24048,99,1.12 [0.76-1.65],0.5539307478971689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ASAH2,Neutral ceramidase,27738,120,1.19 [0.87-1.64],0.2756907931541127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ASGR1,Asialoglycoprotein receptor 1,27738,120,2.55 [1.60-4.06],7.994966094210891e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ASGR2,Asialoglycoprotein receptor 2,24282,100,2.33 [1.16-4.69],0.0171753192699745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ASPN,Asporin,24257,99,0.70 [0.34-1.47],0.3488098017798658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ASPSCR1,Tether containing UBX domain for GLUT4,24223,100,1.06 [0.81-1.40],0.6643242978540982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ASRGL1,Isoaspartyl peptidase/L-asparaginase,23579,96,1.04 [0.86-1.26],0.6829586254743183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ASS1,Argininosuccinate synthase,23482,98,0.77 [0.60-0.99],0.0414588560498635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ATF2,Cyclic AMP-dependent transcription factor ATF-2,27266,115,1.09 [0.88-1.34],0.4380955416933787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ATF4,Cyclic AMP-dependent transcription factor ATF-4,23402,100,1.05 [0.60-1.85],0.8619675385130336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ATG16L1,Autophagy-related protein 16-1,24167,101,1.24 [1.00-1.54],0.0489754262088879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ATG4A,Cysteine protease ATG4A,27238,115,1.11 [0.85-1.45],0.4397426504482169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ATOX1,Copper transport protein ATOX1,27992,119,1.19 [0.95-1.49],0.1326493029378277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,23482,98,1.09 [0.76-1.57],0.6368735883341866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,23482,98,1.27 [0.74-2.18],0.3773468105540669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,23482,98,1.00 [0.62-1.63],0.9849610236508246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ATP1B4,Protein ATP1B4,23402,100,1.29 [0.85-1.94],0.2298526459544712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ATP2B4,Plasma membrane calcium-transporting ATPase 4,23482,98,1.08 [0.81-1.44],0.5972409626768125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ATP5F1D,"ATP synthase subunit delta, mitochondrial",23482,98,0.87 [0.56-1.33],0.5074396335154115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ATP5IF1,"ATPase inhibitor, mitochondrial",28050,121,1.10 [0.95-1.28],0.1865267399851459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ATP5PO,"ATP synthase subunit O, mitochondrial",27266,115,1.41 [1.09-1.83],0.0089765703908386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ATP6AP2,Renin receptor,27238,115,0.93 [0.62-1.42],0.7474968474020409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ATP6V1D,V-type proton ATPase subunit D,27803,121,1.34 [0.79-2.29],0.2787385301010555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ATP6V1F,V-type proton ATPase subunit F,27217,114,1.14 [0.90-1.44],0.2689385155865932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ATP6V1G1,V-type proton ATPase subunit G 1,23579,96,1.00 [0.77-1.31],0.9912818416363284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ATP6V1G2,V-type proton ATPase subunit G 2,23482,98,0.98 [0.80-1.21],0.8712880825900845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ATRAID,All-trans retinoic acid-induced differentiation factor,24167,101,1.48 [1.07-2.04],0.0180102202153489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ATRN,"Attractin, Isoform 2",24294,101,1.42 [0.46-4.41],0.5456730412141011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ATXN10,Ataxin-10,27266,115,1.17 [0.93-1.47],0.1908617473984792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ATXN2,Ataxin-2,23483,97,1.00 [0.84-1.20],0.9753946614270648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ATXN2L,Ataxin-2-like protein,24223,100,1.31 [0.94-1.81],0.1080910294602529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ATXN3,Ataxin-3,24190,99,1.23 [0.92-1.65],0.1690849026305853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AXIN1,Axin-1,27914,119,1.10 [0.92-1.30],0.2905245036813004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AXL,Tyrosine-protein kinase receptor UFO,28004,119,1.34 [0.75-2.40],0.3251847648862438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AZI2,5-azacytidine-induced protein 2,24223,100,1.24 [0.90-1.70],0.1907854316376241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,AZU1,Azurocidin,27093,119,1.18 [0.99-1.42],0.0709328229522831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,B2M,Beta-2-microglobulin,24294,101,1.43 [1.02-2.01],0.037074922083509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,23482,98,0.90 [0.34-2.36],0.8272556365073209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",23579,96,1.16 [0.69-1.97],0.571200130608911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,B4GALT1,"Beta-1,4-galactosyltransferase 1",28050,121,2.92 [1.74-4.89],4.641540482314225e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,B4GAT1,"Beta-1,4-glucuronyltransferase 1",27919,121,0.95 [0.49-1.83],0.8786779547489162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BABAM1,BRISC and BRCA1-A complex member 1,23569,96,1.63 [0.96-2.75],0.06851874782176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BACH1,Transcription regulator protein BACH1,27914,119,1.18 [0.96-1.46],0.1232873954872928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BAG3,BAG family molecular chaperone regulator 3,27690,120,1.04 [0.69-1.55],0.86135737429975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BAG4,BAG family molecular chaperone regulator 4,23569,96,1.41 [1.02-1.97],0.0400540550337173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BAG6,Large proline-rich protein BAG6,27425,119,1.65 [1.09-2.50],0.0182870374842602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,27238,115,1.20 [0.94-1.53],0.1491313921894238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BAMBI,BMP and activin membrane-bound inhibitor homolog,27238,115,1.55 [0.95-2.51],0.0782264565155727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BANK1,B-cell scaffold protein with ankyrin repeats,27914,119,1.11 [0.95-1.30],0.1928492475717781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BAP18,Chromatin complexes subunit BAP18,24190,99,1.13 [0.89-1.45],0.3198607887538733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BATF,Basic leucine zipper transcriptional factor ATF-like,23584,95,0.86 [0.65-1.13],0.2845807213330222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BAX,Apoptosis regulator BAX,27216,115,1.20 [1.01-1.43],0.0416829161352779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BCAM,Basal cell adhesion molecule,27919,121,1.45 [0.76-2.78],0.2627953984012141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BCAN,Brevican core protein,27738,120,0.72 [0.45-1.15],0.1659441172774837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24257,99,1.46 [0.84-2.55],0.1838685810907459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",23483,97,1.00 [0.69-1.44],0.998237868777845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BCHE,Cholinesterase,23824,98,1.03 [0.51-2.04],0.9436356722964008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BCL2,Apoptosis regulator Bcl-2,24167,101,1.33 [1.01-1.74],0.0435066466725141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BCL2L1,Bcl-2-like protein 1,24190,99,1.16 [0.96-1.40],0.1291773444847024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",27914,119,0.99 [0.69-1.42],0.9676853598988364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BCL2L15,Bcl-2-like protein 15,23569,96,1.43 [1.12-1.83],0.0047366421508894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BCL7A,B-cell CLL/lymphoma 7 protein family member A,23402,100,0.80 [0.57-1.13],0.2000002941921266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24145,101,1.31 [0.94-1.85],0.1145241028681702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BCR,Breakpoint cluster region protein,27914,119,1.18 [0.99-1.41],0.0589930330296198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BDNF,Brain-derived neurotrophic factor,24251,100,0.92 [0.74-1.15],0.4863884406360902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BECN1,Beclin-1,23579,96,1.24 [0.91-1.67],0.1678460105521834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BEX3,Protein BEX3,23402,100,1.19 [0.84-1.69],0.3236784087278825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BGLAP,Osteocalcin,24251,100,1.25 [1.01-1.53],0.0374362387561103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BGN,Biglycan,27199,114,0.95 [0.83-1.09],0.4699546174039883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BHLHE40,Class E basic helix-loop-helix protein 40,23483,97,1.00 [0.76-1.32],0.9818317729203412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,23482,98,1.65 [0.79-3.44],0.1823735519268523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BID,BH3-interacting domain death agonist,27914,119,1.01 [0.80-1.28],0.9286055371425752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BIN2,Bridging integrator 2,27919,121,1.08 [0.91-1.29],0.379722873305383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BIRC2,Baculoviral IAP repeat-containing protein 2,27238,115,1.29 [1.01-1.65],0.0450855253649845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BLMH,Bleomycin hydrolase,28272,122,1.02 [0.62-1.66],0.948292659068262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BLNK,B-cell linker protein,23569,96,1.40 [0.93-2.13],0.1093243964503992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,23483,97,1.04 [0.80-1.34],0.7813926650375937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24190,99,1.29 [0.84-1.99],0.2420082817239801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BLVRB,Flavin reductase,27919,121,1.18 [0.94-1.48],0.1423454848854876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BMP10,Bone morphogenetic protein 10,23715,97,3.75 [1.84-7.63],0.0002611877547992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BMP4,Bone morphogenetic protein 4,27690,120,1.01 [0.72-1.42],0.9437905750668276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BMP6,Bone morphogenetic protein 6,27375,119,0.89 [0.61-1.30],0.5354399032519479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BMPER,BMP-binding endothelial regulator protein,23715,97,1.88 [0.94-3.79],0.0754082671270944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24257,99,1.15 [0.67-1.97],0.6038305916929626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,23569,96,1.44 [0.99-2.10],0.055279491558453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BOC,Brother of CDO,27425,119,1.51 [0.76-2.99],0.2379294705017058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BOLA1,BolA-like protein 1,23483,97,1.08 [0.76-1.52],0.6721144716555982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BOLA2_BOLA2B,BolA-like protein 2,23579,96,0.94 [0.66-1.34],0.7429309978569427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BPIFA2,BPI fold-containing family A member 2,22734,91,1.06 [0.89-1.27],0.5070334779307469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BPIFB1,BPI fold-containing family B member 1,27875,121,0.99 [0.77-1.26],0.9302658154579234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BPIFB2,BPI fold-containing family B member 2,24217,99,1.04 [0.78-1.39],0.7904519629731677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BRAP,BRCA1-associated protein,23936,99,1.21 [1.01-1.45],0.0391379925199147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BRD1,Bromodomain-containing protein 1,23811,95,1.26 [0.70-2.27],0.4386830148753057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BRD2,Bromodomain-containing protein 2,23483,97,1.74 [1.14-2.65],0.0098560779576064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BRD3,Bromodomain-containing protein 3,23482,98,1.04 [0.70-1.54],0.8414553342473335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BRDT,Bromodomain testis-specific protein,23482,98,1.32 [0.80-2.19],0.2736361484651587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BRK1,Protein BRICK1,27266,115,1.38 [0.96-1.97],0.0786910020475955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BRME1,Break repair meiotic recombinase recruitment factor 1,23483,97,1.14 [0.76-1.73],0.5299890527946776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BRSK2,Serine/threonine-protein kinase BRSK2,24223,100,1.28 [0.82-2.00],0.2726370637157955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BSG,Basigin,28217,122,1.79 [0.80-4.00],0.1554780156510349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BSND,Barttin,23402,100,0.80 [0.43-1.49],0.4841060437448384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,28192,122,0.85 [0.62-1.15],0.2799592501882659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BST2,Bone marrow stromal antigen 2,28192,122,1.30 [1.01-1.68],0.0401379832821146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BTC,Probetacellulin,27238,115,1.10 [0.89-1.36],0.3605915732502964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BTD,Biotinidase,24294,101,0.96 [0.39-2.36],0.9248817519757592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BTLA,B- and T-lymphocyte attenuator,23402,100,0.88 [0.68-1.15],0.3458122156550447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BTN1A1,Butyrophilin subfamily 1 member A1,24102,101,1.42 [1.02-1.96],0.0373819954245083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BTN2A1,Butyrophilin subfamily 2 member A1,28050,121,1.95 [1.08-3.52],0.0272335080671048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BTN3A2,Butyrophilin subfamily 3 member A2,27914,119,1.82 [1.26-2.63],0.0014031549303869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,BTNL10,Butyrophilin-like protein 10,23402,100,0.96 [0.58-1.60],0.8726930103860351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,C19orf12,Protein C19orf12,27266,115,0.95 [0.74-1.23],0.7222324571188112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,C1GALT1C1,C1GALT1-specific chaperone 1,23482,98,1.50 [0.92-2.44],0.1046284750162891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,C1QA,Complement C1q subcomponent subunit A,28122,121,2.04 [1.05-4.00],0.036639758006592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24223,100,1.12 [0.87-1.43],0.3880181226906425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,C1QL2,Complement C1q-like protein 2,23569,96,0.74 [0.46-1.19],0.2115543374532192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,28004,119,1.26 [0.88-1.81],0.2101583631100445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,23715,97,1.30 [0.77-2.19],0.3311843326331959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24223,100,1.53 [0.94-2.49],0.0890048567322935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,23675,97,0.75 [0.52-1.08],0.1177721503477691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,C1R,Complement C1r subcomponent,24294,101,1.20 [0.48-2.98],0.6981073911710283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,C1RL,Complement C1r subcomponent-like protein,24255,101,2.50 [0.93-6.69],0.0682989407044095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,C1S,Complement C1s subcomponent,24294,101,1.84 [0.79-4.28],0.1589620889105459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,C2,Complement C2,27970,119,1.05 [0.52-2.12],0.8963567605838878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,C2CD2L,Phospholipid transfer protein C2CD2L,27217,114,1.21 [0.86-1.71],0.2721932265734801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,C2orf69,UPF0565 protein C2orf69,23584,95,1.13 [0.83-1.52],0.4471581695283035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,C3,Complement C3,23060,95,1.02 [0.67-1.55],0.923825366200856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,C4BPB,C4b-binding protein beta chain,27992,119,1.21 [0.81-1.79],0.3531668710458178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,C5,Complement C5,24294,101,1.99 [0.71-5.61],0.1932434989050359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,C7,Complement component C7,23726,98,1.01 [0.55-1.84],0.976979388385148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,C7orf50,Uncharacterized protein C7orf50,24190,99,0.91 [0.40-2.10],0.8312565752543445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,C8B,Complement component C8 beta chain,24294,101,1.14 [0.62-2.10],0.6774108430195265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,C9,Complement component C9,24282,100,0.75 [0.54-1.04],0.0853813452813956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,C9orf40,Uncharacterized protein C9orf40,24167,101,1.17 [0.94-1.47],0.165798210399623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CA1,Carbonic anhydrase 1,27280,118,1.19 [0.91-1.55],0.2022053275445014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CA11,Carbonic anhydrase-related protein 11,27238,115,0.98 [0.58-1.67],0.9453437499286376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CA12,Carbonic anhydrase 12,27803,121,1.87 [1.29-2.73],0.0010498134343487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CA13,Carbonic anhydrase 13,27600,119,1.03 [0.88-1.20],0.7028178176855155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CA14,Carbonic anhydrase 14,28179,121,0.97 [0.62-1.52],0.9069491975973905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CA2,Carbonic anhydrase 2,27839,121,1.09 [0.87-1.36],0.4736537906924833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CA3,Carbonic anhydrase 3,28225,122,1.40 [1.11-1.76],0.0047236972442685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CA4,Carbonic anhydrase 4,28272,122,1.41 [0.73-2.74],0.3108631747787223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CA5A,"Carbonic anhydrase 5A, mitochondrial",27425,119,0.93 [0.78-1.12],0.4391204997800769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CA6,Carbonic anhydrase 6,27827,121,0.89 [0.69-1.14],0.3510281412144576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CA7,Carbonic anhydrase 7,23811,95,1.03 [0.59-1.80],0.9303928169324612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CA8,Carbonic anhydrase-related protein,23569,96,1.02 [0.48-2.17],0.9643906528761113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CA9,Carbonic anhydrase 9,28179,121,1.19 [0.84-1.68],0.3226873632239035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CABP2,Calcium-binding protein 2,23584,95,1.08 [0.80-1.44],0.6160782461714671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,23483,97,1.13 [0.63-2.01],0.6826995296168891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,23482,98,1.00 [0.72-1.40],0.998174473208538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,23483,97,1.27 [0.95-1.68],0.1055014754827363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24223,100,1.16 [0.93-1.44],0.1980094933288467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CACYBP,Calcyclin-binding protein,23663,97,1.16 [0.96-1.41],0.1208178321274322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CADPS,Calcium-dependent secretion activator 1,23584,95,0.76 [0.44-1.30],0.3127093697260188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CALB1,Calbindin,27803,121,1.59 [1.09-2.33],0.0167218008357295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CALB2,Calretinin,27266,115,1.55 [1.00-2.40],0.0521195921018259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CALCA,Calcitonin,27689,119,0.97 [0.75-1.26],0.8239327318054525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CALCB,Calcitonin gene-related peptide 2,24190,99,1.10 [0.68-1.77],0.6963130388556447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,28098,121,1.10 [0.94-1.29],0.2207810705204749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,23579,96,1.19 [0.93-1.52],0.1691004944631913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CALY,Neuron-specific vesicular protein calcyon,23482,98,0.91 [0.52-1.58],0.7345146366289969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,27238,115,1.40 [1.02-1.94],0.0381591578458886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,23584,95,1.14 [0.82-1.59],0.4445473200956696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24223,100,1.11 [0.93-1.32],0.2323242617721671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CANT1,Soluble calcium-activated nucleotidase 1,27856,121,1.82 [0.83-4.00],0.1376357294314902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CAPG,Macrophage-capping protein,27755,120,1.40 [1.10-1.80],0.0069401416471856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CAPN3,Calpain-3,24145,101,1.03 [0.63-1.70],0.8966909207902141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CAPS,Calcyphosin,24190,99,0.95 [0.75-1.21],0.6911171535217546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CARHSP1,Calcium-regulated heat-stable protein 1,27266,115,1.21 [0.89-1.64],0.2199948572036916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CASC3,Protein CASC3,23584,95,1.43 [0.96-2.15],0.0816804751720013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CASP1,Caspase-1,27266,115,0.84 [0.66-1.09],0.1903226189099706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CASP10,Caspase-10,27266,115,1.07 [0.85-1.35],0.5509194088691407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CASP2,Caspase-2,27914,119,1.02 [0.81-1.29],0.867896791835256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CASP3,Caspase-3,28272,122,1.11 [0.92-1.33],0.2666925980452136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CASP4,Caspase-4,23811,95,0.98 [0.87-1.11],0.760921269188832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CASP7,Caspase-7,24190,99,1.14 [0.91-1.43],0.2536952347536348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CASP8,Caspase-8,28105,120,1.22 [0.96-1.54],0.1064540946069369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CASP9,Caspase-9,23569,96,0.99 [0.73-1.35],0.9666300838558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CASQ2,Calsequestrin-2,23482,98,1.22 [0.89-1.68],0.2250968472377915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CAT,Catalase,23916,99,1.04 [0.73-1.46],0.839309809690127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CBLIF,Cobalamin binding intrinsic factor,27897,121,1.23 [0.98-1.55],0.0704294475007347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CBLN1,Cerebellin-1,23483,97,1.03 [0.85-1.25],0.7742853088049026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CBLN4,Cerebellin-4,28179,121,0.83 [0.50-1.37],0.4654127092581943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CBS,Cystathionine beta-synthase,23579,96,1.00 [0.68-1.46],0.9976637632211204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CBX2,Chromobox protein homolog 2,23482,98,1.03 [0.64-1.65],0.9154350794670856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,27738,120,1.29 [1.06-1.58],0.0130384723426123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCAR2,Cell cycle and apoptosis regulator protein 2,24190,99,1.03 [0.74-1.42],0.8753137867257595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCDC134,Coiled-coil domain-containing protein 134,24145,101,1.51 [1.08-2.10],0.0146861987412414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCDC28A,Coiled-coil domain-containing protein 28A,23584,95,1.59 [0.83-3.05],0.1595308581525308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCDC50,Coiled-coil domain-containing protein 50,24223,100,1.08 [0.86-1.36],0.493266310984612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCDC80,Coiled-coil domain-containing protein 80,27929,121,1.57 [0.98-2.50],0.0612372463329414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,23579,96,0.88 [0.64-1.22],0.4507360294821773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCL11,Eotaxin,28265,122,1.36 [0.91-2.05],0.1372489079161805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCL13,C-C motif chemokine 13,28216,122,0.96 [0.77-1.21],0.7353627925549455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCL14,C-C motif chemokine 14,27826,119,1.05 [0.70-1.57],0.8072991911527659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCL15,C-C motif chemokine 15,28272,122,1.44 [1.04-2.00],0.0281489443835366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCL16,C-C motif chemokine 16,28272,122,1.41 [1.05-1.87],0.0203589585211452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCL17,C-C motif chemokine 17,27857,121,1.07 [0.90-1.28],0.4284386823258782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCL18,C-C motif chemokine 18,27530,119,1.10 [0.90-1.35],0.3564024253733225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCL19,C-C motif chemokine 19,28192,122,1.12 [1.00-1.25],0.0411443432886243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCL2,C-C motif chemokine 2,27690,120,1.09 [0.81-1.47],0.5678584436075987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCL20,C-C motif chemokine 20,28265,122,1.13 [0.96-1.34],0.1417290411887791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCL21,C-C motif chemokine 21,28050,121,1.17 [0.82-1.67],0.3734235468976046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCL22,C-C motif chemokine 22,27609,120,1.34 [1.00-1.80],0.0508975824477343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCL23,C-C motif chemokine 23,28050,121,1.50 [1.04-2.15],0.0287985442196194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCL24,C-C motif chemokine 24,28007,121,1.13 [0.93-1.36],0.2147427862075024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCL25,C-C motif chemokine 25,28265,122,1.44 [1.05-1.97],0.0234003548507567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCL26,C-C motif chemokine 26,27914,119,1.04 [0.87-1.23],0.6838620173014209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCL27,C-C motif chemokine 27,27929,121,1.40 [1.09-1.81],0.0096409998450528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCL28,C-C motif chemokine 28,27830,118,1.19 [0.92-1.54],0.1791165285370657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCL3,C-C motif chemokine 3,27914,119,1.11 [0.94-1.31],0.2326113662012581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCL4,C-C motif chemokine 4,27952,121,1.08 [0.86-1.37],0.500138025166002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCL5,C-C motif chemokine 5,28004,119,1.07 [0.91-1.25],0.4051529734844701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCL7,C-C motif chemokine 7,27914,119,1.00 [0.76-1.32],0.993365715729606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCL8,C-C motif chemokine 8,28142,120,1.30 [1.00-1.69],0.0508915008275624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCN1,CCN family member 1,27763,120,1.29 [1.04-1.61],0.0216851768601102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCN2,CCN family member 2,27929,121,1.06 [0.81-1.39],0.6806157582506804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCN3,CCN family member 3,28226,122,1.64 [1.06-2.54],0.0273095012193758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCN4,CCN family member 4,28179,121,1.33 [0.93-1.90],0.1235559487268838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCN5,CCN family member 5,27919,121,2.15 [1.47-3.13],7.033138805369814e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCND2,G1/S-specific cyclin-D2,23811,95,1.09 [0.64-1.85],0.7602113986162902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCNE1,G1/S-specific cyclin-E1,23569,96,0.97 [0.78-1.21],0.7850103455356477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCS,Copper chaperone for superoxide dismutase,27738,120,1.07 [0.77-1.49],0.6906896192079752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CCT5,T-complex protein 1 subunit epsilon,27238,115,1.10 [0.78-1.55],0.5967428054419415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD101,Immunoglobulin superfamily member 2,24167,101,0.88 [0.56-1.38],0.5735252815007403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD109,CD109 antigen,27919,121,1.34 [0.83-2.16],0.2339580394684786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD14,Monocyte differentiation antigen CD14,27305,116,1.53 [1.05-2.24],0.0285655737072894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD160,CD160 antigen,28265,122,1.36 [0.97-1.91],0.0717322271728553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD163,Scavenger receptor cysteine-rich type 1 protein M130,28004,119,1.26 [0.87-1.81],0.2165046080369904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD164,Sialomucin core protein 24,27919,121,1.03 [0.57-1.89],0.9126605245200604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD164L2,CD164 sialomucin-like 2 protein,23584,95,1.28 [0.78-2.10],0.32932906601203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD177,CD177 antigen,27872,121,1.08 [0.94-1.24],0.2676592286064236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD1C,T-cell surface glycoprotein CD1c,27992,119,0.79 [0.41-1.53],0.4899932994551156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD2,T-cell surface antigen CD2,23482,98,1.06 [0.65-1.72],0.8213529351210351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD200,OX-2 membrane glycoprotein,27914,119,1.13 [0.61-2.09],0.6978825532618854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD200R1,Cell surface glycoprotein CD200 receptor 1,27813,119,0.97 [0.61-1.54],0.8836460910628223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD207,C-type lectin domain family 4 member K,27334,121,1.40 [0.93-2.13],0.1108344577075643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD209,CD209 antigen,27985,119,0.86 [0.57-1.29],0.4675518120701651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD22,B-cell receptor CD22,28265,122,1.18 [0.80-1.74],0.4139314044459671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD226,CD226 antigen,23569,96,0.97 [0.61-1.54],0.9026008419664392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD244,Natural killer cell receptor 2B4,28265,122,1.19 [0.66-2.12],0.5670759704658378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD248,Endosialin,24251,100,0.96 [0.60-1.53],0.8542130407959236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD27,CD27 antigen,27992,119,2.01 [1.40-2.88],0.0001432981859693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD274,Programmed cell death 1 ligand 1,27738,120,1.49 [0.97-2.31],0.0711891747440925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD276,CD276 antigen,27905,121,1.76 [1.11-2.78],0.0155134619964382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD28,T-cell-specific surface glycoprotein CD28,27238,115,0.98 [0.62-1.57],0.9488723470101672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD2AP,CD2-associated protein,27929,121,1.37 [1.08-1.73],0.0098739446423406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD300A,CMRF35-like molecule 8,23715,97,1.76 [0.92-3.35],0.0860484457040434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD300C,CMRF35-like molecule 6,28192,122,1.68 [1.09-2.60],0.0197263283211519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD300E,CMRF35-like molecule 2,28090,121,2.10 [1.45-3.03],7.946572921516747e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD300LF,CMRF35-like molecule 1,28179,121,1.45 [1.11-1.90],0.0062392460058783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD300LG,CMRF35-like molecule 9,27919,121,1.75 [1.14-2.68],0.010338649184535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD302,CD302 antigen,27803,121,2.00 [1.25-3.19],0.0036756331786061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD33,Myeloid cell surface antigen CD33,27992,119,0.93 [0.76-1.14],0.4694519198631488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD34,Hematopoietic progenitor cell antigen CD34,28094,121,1.38 [0.71-2.65],0.3400561210758639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD36,Platelet glycoprotein 4,23569,96,0.80 [0.52-1.21],0.2925774445612824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,27803,121,1.85 [1.12-3.05],0.0165615268100234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD3D,T-cell surface glycoprotein CD3 delta chain,23483,97,0.98 [0.57-1.71],0.954428888877784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD3E,T-cell surface glycoprotein CD3 epsilon chain,23811,95,0.87 [0.47-1.61],0.6683924267389225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD3G,T-cell surface glycoprotein CD3 gamma chain,23569,96,1.13 [0.96-1.34],0.1504186345378461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD4,T-cell surface glycoprotein CD4,27868,118,1.59 [1.11-2.29],0.012217541823442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD40,Tumor necrosis factor receptor superfamily member 5,27909,121,1.51 [1.13-2.00],0.0048204287166322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD40LG,CD40 ligand,28265,122,1.02 [0.83-1.25],0.8480679758266573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD46,Membrane cofactor protein,27735,119,1.82 [1.13-2.94],0.01397108606517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD48,CD48 antigen,28007,121,1.74 [1.01-2.99],0.0448450145456202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD5,T-cell surface glycoprotein CD5,28142,120,1.88 [1.21-2.93],0.0052791776675791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD55,Complement decay-accelerating factor,26919,115,1.28 [0.69-2.39],0.4274802160197484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD58,Lymphocyte function-associated antigen 3,27850,121,1.55 [0.63-3.86],0.3427723332193652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD59,CD59 glycoprotein,26885,115,2.46 [1.36-4.47],0.0030406603122994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD5L,CD5 antigen-like,24162,100,1.15 [0.77-1.71],0.5021498282715983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD6,T-cell differentiation antigen CD6,28217,122,1.34 [1.00-1.81],0.0538765643063215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD63,CD63 antigen,27690,120,0.99 [0.72-1.35],0.9447163196888728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD69,Early activation antigen CD69,27776,120,1.13 [0.94-1.36],0.1785784144019593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD7,T-cell antigen CD7,23533,94,1.16 [0.73-1.82],0.5300010817202252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD70,CD70 antigen,27914,119,1.16 [0.79-1.70],0.4418569201836941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD72,B-cell differentiation antigen CD72,23715,97,1.47 [0.93-2.30],0.0972202789367068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD74,HLA class II histocompatibility antigen gamma chain,28192,122,1.85 [1.20-2.85],0.0052543889155995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD79B,B-cell antigen receptor complex-associated protein beta chain,28265,122,1.71 [1.23-2.39],0.001482539633725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD80,T-lymphocyte activation antigen CD80,24257,99,1.17 [0.67-2.02],0.58504712502512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD82,CD82 antigen,23811,95,0.56 [0.30-1.05],0.0705484975050261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD83,CD83 antigen,27914,119,1.21 [0.75-1.96],0.4369246260480119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD84,SLAM family member 5,27914,119,1.08 [0.65-1.79],0.763878781340056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD86,T-lymphocyte activation antigen CD86,24167,101,0.84 [0.46-1.55],0.583305331304492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD8A,T-cell surface glycoprotein CD8 alpha chain,28192,122,1.40 [1.01-1.92],0.0403722126739488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD93,Complement component C1q receptor,26832,114,1.25 [0.73-2.13],0.4170476836158715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD99,CD99 antigen,27919,121,2.16 [0.96-4.87],0.0617682806594733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CD99L2,CD99 antigen-like protein 2,27919,121,2.10 [1.10-4.00],0.0235556102143903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CDA,Cytidine deaminase,24217,99,1.04 [0.70-1.54],0.8396258678869478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CDAN1,Codanin-1,24190,99,1.14 [0.52-2.54],0.7395009375517421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CDC123,Cell division cycle protein 123 homolog,23402,100,1.23 [0.97-1.56],0.0876772285812467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CDC25A,M-phase inducer phosphatase 1,23402,100,1.15 [0.75-1.75],0.5266779569046556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CDC26,Anaphase-promoting complex subunit CDC26,24128,101,1.15 [0.89-1.49],0.2826975191537273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CDC27,Cell division cycle protein 27 homolog,27238,115,1.30 [1.02-1.65],0.03481187624108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CDC37,Hsp90 co-chaperone Cdc37,27992,119,1.17 [0.97-1.41],0.1056857465426123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24167,101,1.18 [0.99-1.40],0.0696933656762108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CDCP1,CUB domain-containing protein 1,27738,120,1.07 [0.79-1.45],0.666079854799102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CDH1,Cadherin-1,26957,111,1.17 [0.80-1.70],0.4229980007370449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CDH15,Cadherin-15,28143,121,1.13 [0.87-1.47],0.3483707097646413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CDH17,Cadherin-17,27929,121,1.19 [0.95-1.49],0.1297471799613578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CDH2,Cadherin-2,27929,121,1.34 [0.86-2.07],0.1917051376004419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CDH22,Cadherin-22,23811,95,0.60 [0.28-1.30],0.1958020742107406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CDH23,Cadherin-23,24190,99,1.81 [1.02-3.22],0.042389410078705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CDH3,Cadherin-3,28192,122,1.34 [0.87-2.07],0.1866983486490377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CDH4,Cadherin-4,23483,97,1.23 [0.86-1.77],0.2593336720018666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CDH5,Cadherin-5,28272,122,0.79 [0.47-1.34],0.3886486041966738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CDH6,Cadherin-6,27929,121,1.17 [0.77-1.77],0.4620658699065129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CDHR1,Cadherin-related family member 1,27266,115,0.91 [0.61-1.37],0.6640748294145744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CDHR2,Cadherin-related family member 2,27803,121,1.05 [0.84-1.30],0.692341202873795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CDHR5,Cadherin-related family member 5,27929,121,2.05 [1.31-3.19],0.001568598569147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CDK1,Cyclin-dependent kinase 1,23402,100,1.13 [0.67-1.90],0.65792809224401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24223,100,1.18 [0.89-1.57],0.2446579185642044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CDKL5,Cyclin-dependent kinase-like 5,23483,97,1.21 [0.88-1.67],0.241351668956884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CDKN1A,Cyclin-dependent kinase inhibitor 1,27803,121,1.14 [0.98-1.32],0.0946174052115307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,27803,121,1.08 [0.91-1.28],0.3780924539085157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CDNF,Cerebral dopamine neurotrophic factor,27803,121,1.50 [0.99-2.29],0.0584834560712971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,27955,121,1.78 [0.98-3.23],0.057082153474886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CDSN,Corneodesmosin,28173,121,1.60 [1.11-2.31],0.0112068196506134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,27951,119,1.46 [0.79-2.70],0.2298578474426281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24167,101,0.98 [0.78-1.23],0.8589760874657624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,23811,95,0.78 [0.54-1.12],0.1773100969356655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24167,101,1.51 [0.96-2.38],0.0771364595332098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,23811,95,1.09 [0.71-1.66],0.7044113458062693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,27914,119,0.94 [0.78-1.14],0.5173481626701676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,27238,115,1.12 [0.81-1.55],0.5091835476342592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,26862,113,1.00 [0.76-1.31],0.9821322268020702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24251,100,0.83 [0.51-1.34],0.4429183057028556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,27425,119,1.41 [1.06-1.88],0.0199314846275729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CEBPA,CCAAT/enhancer-binding protein alpha,23569,96,1.36 [0.96-1.94],0.0842172010910919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CEBPB,CCAAT/enhancer-binding protein beta,27425,119,1.52 [1.06-2.16],0.0210182201799802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CELA2A,Chymotrypsin-like elastase family member 2A,24251,100,0.96 [0.71-1.32],0.8152096164964527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CELA3A,Chymotrypsin-like elastase family member 3A,28223,122,1.32 [1.01-1.72],0.0447945222666813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,23715,97,1.33 [0.67-2.61],0.4129383935134395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CEMIP2,Cell surface hyaluronidase,23569,96,1.31 [0.85-2.03],0.222666393690684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CEND1,Cell cycle exit and neuronal differentiation protein 1,23483,97,1.15 [0.87-1.52],0.3168067612864012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CENPF,Centromere protein F,23811,95,1.13 [0.81-1.58],0.4677974119520778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CENPJ,Centromere protein J,23811,95,1.09 [0.85-1.40],0.5073944359828975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CEP112,Centrosomal protein of 112 kDa,23482,98,1.14 [0.78-1.65],0.5061502659262946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CEP152,Centrosomal protein of 152 kDa,23402,100,1.02 [0.66-1.58],0.92934751473439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CEP164,Centrosomal protein of 164 kDa,27408,119,0.97 [0.74-1.28],0.8434426671669225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CEP170,Centrosomal protein of 170 kDa,23579,96,0.98 [0.77-1.27],0.9032389416323608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CEP20,Centrosomal protein 20,27238,115,1.25 [1.01-1.54],0.0383533552416946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CEP290,Centrosomal protein of 290 kDa,23811,95,0.75 [0.48-1.16],0.1985360978517948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CEP350,Centrosome-associated protein 350,23402,100,0.91 [0.53-1.55],0.7277151433753921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CEP43,Centrosomal protein 43,27207,117,1.30 [1.04-1.62],0.0222785259527748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CEP85,Centrosomal protein of 85 kDa,27238,115,1.18 [0.92-1.51],0.1817065989603057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CERT,Ceramide transfer protein,27266,115,1.09 [0.83-1.42],0.5326781332360406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CES1,Liver carboxylesterase 1,27974,119,1.01 [0.84-1.22],0.9064251818944832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CES2,Cocaine esterase,27803,121,0.87 [0.65-1.18],0.3782928607391821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CES3,Carboxylesterase 3,27803,121,0.97 [0.77-1.22],0.8008705983884989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CETN2,Centrin-2,27266,115,1.24 [0.99-1.56],0.0663340127196087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CETN3,Centrin-3,24167,101,1.24 [0.98-1.56],0.0701053853869912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CFB,Complement factor B,23843,99,1.27 [0.71-2.27],0.4123908052690118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CFC1,Cryptic protein,27238,115,1.04 [0.73-1.47],0.8318060066183455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CFD,Complement factor D,24294,101,1.86 [0.92-3.77],0.0852874466607253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CFH,Complement factor H,22883,96,2.00 [0.89-4.48],0.0926282815267429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CFHR2,Complement factor H-related protein 2,24120,99,1.17 [0.82-1.67],0.3910282625311267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CFHR4,Complement factor H-related protein 4,24246,101,1.08 [0.83-1.41],0.5798466134837118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CFHR5,Complement factor H-related protein 5,23970,98,1.16 [0.73-1.86],0.5212926286973341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CFI,Complement factor I,24294,101,2.20 [0.88-5.49],0.0923658556724764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CFP,Properdin,24294,101,1.03 [0.47-2.27],0.9365872222686804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CGA,Glycoprotein hormones alpha chain,27919,121,1.29 [1.07-1.55],0.0069700141956592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24282,100,1.32 [1.11-1.57],0.0019819130905624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CGN,Cingulin,23584,95,1.64 [1.17-2.29],0.0038435687456729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CGREF1,Cell growth regulator with EF hand domain protein 1,27929,121,1.48 [1.03-2.14],0.0341380376572522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,27238,115,1.17 [0.90-1.52],0.2329686726108827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CHAD,Chondroadherin,23715,97,1.04 [0.71-1.52],0.8380057029008475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24190,99,1.39 [0.91-2.14],0.1309192031019548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CHCHD6,MICOS complex subunit MIC25,24145,101,1.70 [1.09-2.65],0.0183701503107748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CHEK2,Serine/threonine-protein kinase Chk2,27425,119,0.97 [0.59-1.58],0.8954097157033059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CHGA,Chromogranin-A,24251,100,1.30 [1.08-1.57],0.0067106556183945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CHGB,Secretogranin-1,28093,120,1.47 [0.99-2.19],0.056531243039115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CHI3L1,Chitinase-3-like protein 1,27259,115,0.99 [0.80-1.23],0.9426742196581244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CHIT1,Chitotriosidase-1,28037,121,0.95 [0.86-1.04],0.2507281709167619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CHL1,Neural cell adhesion molecule L1-like protein,27959,117,1.16 [0.70-1.93],0.5612049548176139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CHM,Rab proteins geranylgeranyltransferase component A 1,23584,95,1.09 [0.79-1.49],0.6015212830554545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CHMP1A,Charged multivesicular body protein 1a,27738,120,1.21 [0.98-1.48],0.0770291246377909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CHMP6,Charged multivesicular body protein 6,24257,99,1.10 [0.79-1.53],0.5899986314504116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CHP1,Calcineurin B homologous protein 1,23483,97,0.88 [0.66-1.17],0.3676848197825015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CHRDL1,Chordin-like protein 1,28007,121,1.75 [1.05-2.90],0.031091034592069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CHRDL2,Chordin-like protein 2,27929,121,0.99 [0.75-1.31],0.9344219229873592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CHRM1,Muscarinic acetylcholine receptor M1,23584,95,1.11 [0.68-1.83],0.6727952020961616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CIAPIN1,Anamorsin,27992,119,1.25 [0.98-1.61],0.0772717173417225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CILP,Cartilage intermediate layer protein 1,24251,100,1.11 [0.78-1.57],0.5766772169597847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CINP,Cyclin-dependent kinase 2-interacting protein,23811,95,1.30 [0.93-1.84],0.1287816132674481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CIRBP,Cold-inducible RNA-binding protein,24167,101,1.18 [0.97-1.44],0.1044280095106383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CIT,Citron Rho-interacting kinase,23584,95,1.16 [0.78-1.72],0.4536236903797463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CKAP4,Cytoskeleton-associated protein 4,28120,122,2.62 [1.66-4.16],3.9774611388357336e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CKB,Creatine kinase B-type,24251,100,1.40 [1.02-1.91],0.0360014850067903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",27804,121,0.87 [0.70-1.09],0.2245702330892071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLASP1,CLIP-associating protein 1,23402,100,1.12 [0.87-1.43],0.3809143481949183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLC,Galectin-10,27891,121,0.94 [0.74-1.20],0.6355281157266428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLEC10A,C-type lectin domain family 10 member A,27738,120,1.06 [0.69-1.65],0.7812742059809271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLEC11A,C-type lectin domain family 11 member A,27870,120,1.21 [0.86-1.70],0.2644278436893741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLEC12A,C-type lectin domain family 12 member A,23569,96,1.80 [0.80-4.05],0.157225004412514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLEC14A,C-type lectin domain family 14 member A,27919,121,1.93 [1.17-3.19],0.0099540707200255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLEC1A,C-type lectin domain family 1 member A,27425,119,1.16 [0.70-1.93],0.5565009632160391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLEC1B,C-type lectin domain family 1 member B,28192,122,1.05 [0.89-1.23],0.5898121624441566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLEC2L,C-type lectin domain family 2 member L,23584,95,1.11 [0.78-1.59],0.548706038690236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLEC3B,Tetranectin,23730,99,1.08 [0.47-2.50],0.8532120880251157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLEC4A,C-type lectin domain family 4 member A,27914,119,1.08 [0.69-1.71],0.7305345883549949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLEC4C,C-type lectin domain family 4 member C,27914,119,0.89 [0.63-1.26],0.5199028327260431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLEC4D,C-type lectin domain family 4 member D,27914,119,1.41 [1.11-1.81],0.0055500708051674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLEC4G,C-type lectin domain family 4 member G,27914,119,1.12 [0.70-1.81],0.6385106354050745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLEC4M,C-type lectin domain family 4 member M,24211,100,0.79 [0.53-1.16],0.2223703172613819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLEC5A,C-type lectin domain family 5 member A,27830,121,2.02 [1.21-3.37],0.0072212285433119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLEC6A,C-type lectin domain family 6 member A,27238,115,1.16 [0.83-1.62],0.3876493854334593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLEC7A,C-type lectin domain family 7 member A,28265,122,0.93 [0.72-1.20],0.5791956435108498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLGN,Calmegin,23584,95,1.74 [1.22-2.47],0.0021637594986035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLIC5,Chloride intracellular channel protein 5,23584,95,0.83 [0.43-1.60],0.5732648660554415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLINT1,Clathrin interactor 1,23402,100,1.01 [0.68-1.51],0.9597252773839956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLIP2,CAP-Gly domain-containing linker protein 2,27914,119,1.06 [0.92-1.23],0.4067919839987634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLMP,CXADR-like membrane protein,28179,121,2.28 [1.11-4.70],0.0253470370448696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLNS1A,Methylosome subunit pICln,23584,95,1.28 [0.76-2.15],0.3552525396465303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",27689,119,1.18 [1.01-1.39],0.042163765368248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLPS,Colipase,27878,121,1.40 [1.12-1.75],0.0032488094583634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLSPN,Claspin,27217,114,1.31 [0.93-1.85],0.11876667038594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLSTN1,Calsyntenin-1,27266,115,0.88 [0.62-1.24],0.4652043618734769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLSTN2,Calsyntenin-2,28265,122,0.84 [0.55-1.28],0.4171271349628288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLSTN3,Calsyntenin-3,24190,99,1.30 [0.73-2.34],0.3713775822065644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLTA,Clathrin light chain A,27425,119,1.17 [0.85-1.62],0.3396149831577482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLU,Clusterin,24294,101,0.99 [0.53-1.84],0.9757765927424328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CLUL1,Clusterin-like protein 1,27882,121,1.41 [1.02-1.95],0.0371334056945311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CMC1,COX assembly mitochondrial protein homolog,24257,99,1.08 [0.88-1.33],0.4441745736106884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CMIP,C-Maf-inducing protein,24145,101,1.19 [0.95-1.48],0.128628815856267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CNDP1,Beta-Ala-His dipeptidase,28004,119,0.89 [0.63-1.25],0.4949623301029835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CNGB3,Cyclic nucleotide-gated cation channel beta-3,23483,97,1.05 [0.75-1.47],0.764309834757838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",23535,96,1.10 [0.86-1.40],0.4383225369609506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CNPY2,Protein canopy homolog 2,27425,119,0.86 [0.63-1.17],0.3296473563184723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CNPY4,Protein canopy homolog 4,27803,121,1.05 [0.85-1.30],0.6301712356726064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CNST,Consortin,27929,121,1.10 [0.95-1.28],0.2019033385273628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CNTF,Ciliary neurotrophic factor,23483,97,1.36 [0.80-2.31],0.2579318431129931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CNTN1,Contactin-1,28272,122,0.58 [0.32-1.05],0.0732233325002945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CNTN2,Contactin-2,28179,121,1.05 [0.73-1.49],0.8063444167839833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CNTN3,Contactin-3,27919,121,1.10 [0.69-1.76],0.6867742253384406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CNTN4,Contactin-4,27919,121,0.65 [0.33-1.27],0.2046392475201816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CNTN5,Contactin-5,28008,121,0.89 [0.57-1.38],0.5944835589850577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CNTNAP2,Contactin-associated protein-like 2,27914,119,0.95 [0.65-1.41],0.8101602292255762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CNTNAP4,Contactin-associated protein-like 4,23584,95,0.97 [0.80-1.19],0.7903596446426508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,COCH,Cochlin,24257,99,1.24 [0.84-1.84],0.2839304398860762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,COL15A1,Collagen alpha-1(XV) chain,24251,100,0.68 [0.33-1.39],0.2904443319669718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,COL18A1,Collagen alpha-1(XVIII) chain,28023,120,2.85 [1.45-5.57],0.0022554687679128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,COL1A1,Collagen alpha-1(I) chain,28272,122,1.32 [0.70-2.47],0.3918667984801685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,COL24A1,Collagen alpha-1(XXIV) chain,24167,101,1.19 [0.85-1.67],0.3058614401925771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,COL28A1,Collagen alpha-1(XXVIII) chain,23584,95,1.18 [0.94-1.49],0.1503279184056764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,COL2A1,Collagen alpha-1(II) chain,23579,96,0.78 [0.61-1.01],0.0618554769907554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,COL3A1,Collagen alpha-1(III) chain,24251,100,1.47 [0.67-3.22],0.3340611081375359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,COL4A1,Collagen alpha-1(IV) chain,27929,121,1.39 [0.95-2.05],0.0907921941243001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,COL4A4,Collagen alpha-4(IV) chain,23770,95,0.93 [0.65-1.35],0.7103906612776776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,COL5A1,Collagen alpha-1(V) chain,23715,97,1.16 [0.73-1.86],0.5300606779706678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,COL6A3,Collagen alpha-3(VI) chain,28272,122,2.19 [1.45-3.33],0.0002177520630649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,COL9A1,Collagen alpha-1(IX) chain,27914,119,1.08 [0.76-1.55],0.6529464918720611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,COL9A2,Collagen alpha-2(IX) chain,23811,95,1.40 [1.06-1.84],0.0170182991194603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,COLEC12,Collectin-12,27905,121,2.52 [1.40-4.51],0.0019436776250936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,COMMD1,COMM domain-containing protein 1,23579,96,1.03 [0.75-1.40],0.8655421113766468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,COMMD9,COMM domain-containing protein 9,24145,101,1.11 [0.71-1.75],0.6492669945172194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,COMP,Cartilage oligomeric matrix protein,27614,119,0.89 [0.55-1.44],0.6260420190619573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,COMT,Catechol O-methyltransferase,27118,116,1.09 [0.90-1.33],0.3738595671777049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,COPB2,Coatomer subunit beta',23482,98,1.32 [0.87-2.00],0.1924040124881804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,COPE,Coatomer subunit epsilon,27266,115,0.96 [0.66-1.38],0.8203022104646903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",23579,96,1.32 [0.90-1.92],0.1515743810151975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CORO1A,Coronin-1A,27375,120,1.01 [0.84-1.20],0.9413998300868291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CORO6,Coronin-6,23483,97,1.25 [0.80-1.96],0.3304389152625385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",27803,121,1.18 [0.95-1.47],0.12758443698756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,COX6B1,Cytochrome c oxidase subunit 6B1,24257,99,1.25 [0.71-2.20],0.4325923119979864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CPA1,Carboxypeptidase A1,28272,122,1.23 [0.96-1.59],0.1045984398074525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CPA2,Carboxypeptidase A2,28092,121,1.28 [1.02-1.62],0.0362511689893557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CPA4,Carboxypeptidase A4,23241,94,1.14 [0.72-1.81],0.5658093051108657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CPB1,Carboxypeptidase B,28272,122,1.25 [0.97-1.61],0.0827963984900157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CPB2,Carboxypeptidase B2,24243,100,1.34 [0.59-3.04],0.4877259066366779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CPE,Carboxypeptidase E,27980,121,1.10 [0.72-1.67],0.6647297205997208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CPLX2,Complexin-2,23402,100,1.23 [0.71-2.14],0.4580728465285276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CPM,Carboxypeptidase M,28065,121,1.59 [1.04-2.43],0.0332012968398574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",23569,96,1.50 [0.80-2.80],0.2023009319362137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CPPED1,Serine/threonine-protein phosphatase CPPED1,28192,122,1.06 [0.84-1.34],0.613468958775327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CPQ,Carboxypeptidase Q,24211,100,0.87 [0.58-1.32],0.5194380934064486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CPTP,Ceramide-1-phosphate transfer protein,23482,98,1.19 [0.78-1.83],0.4204191165366121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CPVL,Probable serine carboxypeptidase CPVL,28127,121,1.55 [1.03-2.34],0.0366937812315517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CPXM1,Probable carboxypeptidase X1,27992,119,0.92 [0.73-1.17],0.5077710022284004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CPXM2,Inactive carboxypeptidase-like protein X2,24257,99,1.33 [0.62-2.84],0.4584184050104368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CR1,Complement receptor type 1,24189,100,1.17 [0.69-1.97],0.5650597669441358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CR2,Complement receptor type 2,28004,119,1.01 [0.71-1.44],0.9549679910552856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,27238,115,1.10 [0.92-1.32],0.3076277441018483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CRADD,Death domain-containing protein CRADD,27689,119,1.22 [0.98-1.51],0.0713053148631374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CREB3,Cyclic AMP-responsive element-binding protein 3,23402,100,0.68 [0.44-1.03],0.0672978766678152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CREBZF,CREB/ATF bZIP transcription factor,23402,100,1.15 [0.57-2.34],0.6941874077422199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CREG1,Protein CREG1,27534,119,1.20 [0.79-1.81],0.3979738340057969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CRELD1,Protein disulfide isomerase CRELD1,23715,97,1.29 [0.77-2.15],0.3303799917488147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CRELD2,Protein disulfide isomerase CRELD2,28007,121,1.25 [0.93-1.67],0.1363526193636552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CRH,Corticoliberin,27193,115,0.96 [0.80-1.16],0.6935885676609868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CRHBP,Corticotropin-releasing factor-binding protein,27905,121,2.47 [1.41-4.33],0.0015293796732063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CRHR1,Corticotropin-releasing factor receptor 1,27425,119,1.00 [0.77-1.31],0.9780121994375782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CRIM1,Cysteine-rich motor neuron 1 protein,28050,121,3.89 [2.04-7.41],3.7705894753107474e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CRIP2,Cysteine-rich protein 2,27738,120,1.54 [1.05-2.27],0.0282195678720193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CRISP2,Cysteine-rich secretory protein 2,28179,121,0.90 [0.68-1.17],0.4283401754217101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CRISP3,Cysteine-rich secretory protein 3,24045,98,0.73 [0.36-1.46],0.3695375063535708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CRKL,Crk-like protein,27952,121,1.11 [0.96-1.30],0.1703766181798344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CRLF1,Cytokine receptor-like factor 1,28050,121,1.68 [0.91-3.10],0.0942779871051457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CRNN,Cornulin,27097,114,0.98 [0.76-1.26],0.8737804200644975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CRTAC1,Cartilage acidic protein 1,28272,122,0.95 [0.56-1.60],0.8427350940833445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CRTAM,Cytotoxic and regulatory T-cell molecule,27738,120,1.24 [0.90-1.72],0.188639198107606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CRTAP,Cartilage-associated protein,23584,95,0.99 [0.66-1.48],0.9477419405469876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CRX,Cone-rod homeobox protein,27425,119,1.06 [0.92-1.21],0.4315170273379753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CRYBB1,Beta-crystallin B1,24257,99,1.06 [0.80-1.41],0.6855587303916144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CRYBB2,Beta-crystallin B2,24190,99,1.00 [0.71-1.40],0.9913345741550058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CRYGD,Gamma-crystallin D,24190,99,1.21 [1.00-1.47],0.0546562250268645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CRYM,Ketimine reductase mu-crystallin,23483,97,0.98 [0.75-1.27],0.8596503798196877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CRYZL1,Quinone oxidoreductase-like protein 1,23579,96,1.12 [0.90-1.38],0.3118704844309173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CSDE1,Cold shock domain-containing protein E1,23482,98,1.11 [0.96-1.28],0.1744882227562522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CSF1,Macrophage colony-stimulating factor 1,28050,121,2.22 [1.28-3.86],0.0046622026708797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CSF1R,Macrophage colony-stimulating factor 1 receptor,24282,100,1.16 [0.72-1.87],0.5395950733509933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CSF2,Granulocyte-macrophage colony-stimulating factor,23482,98,0.97 [0.56-1.66],0.9026381021421426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,27738,120,1.04 [0.80-1.35],0.7816102489482728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CSF2RB,Cytokine receptor common subunit beta,23569,96,0.76 [0.49-1.18],0.2166233760891058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CSF3,Granulocyte colony-stimulating factor,27408,119,0.93 [0.67-1.30],0.6742128222089299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CSF3R,Granulocyte colony-stimulating factor receptor,23569,96,1.81 [1.22-2.70],0.0034107547107076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CSH1,Chorionic somatomammotropin hormone 1,24282,100,1.34 [1.07-1.69],0.0110822987097386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CSNK1D,Casein kinase I isoform delta,23569,96,1.03 [0.76-1.39],0.8725794857729405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CSNK2A1,Casein kinase II subunit alpha,24223,100,1.29 [0.86-1.95],0.2159516642753615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CSPG4,Chondroitin sulfate proteoglycan 4,24251,100,1.15 [0.65-2.03],0.6346974505498506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CSPG5,Chondroitin sulfate proteoglycan 5,23483,97,1.23 [0.87-1.75],0.2487615042223863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CSRP3,Cysteine and glycine-rich protein 3,23482,98,1.00 [0.81-1.23],0.9948219817799144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CST1,Cystatin-SN,21022,87,1.14 [0.93-1.40],0.2130485733976336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CST3,Cystatin-C,27956,119,2.45 [1.46-4.11],0.0007003227041372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CST5,Cystatin-D,27414,117,1.08 [0.81-1.45],0.5907897006359581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CST6,Cystatin-M,27211,116,1.10 [0.78-1.56],0.5907876795241813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CST7,Cystatin-F,27952,121,1.03 [0.88-1.21],0.7122333006105254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CSTB,Cystatin-B,27544,118,1.48 [1.04-2.11],0.0275858265350096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CTAG1A_CTAG1B,Cancer/testis antigen 1,23760,94,1.34 [0.98-1.84],0.0672602100859592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CTBS,Di-N-acetylchitobiase,23946,98,1.17 [0.58-2.35],0.6575390838719184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CTF1,Cardiotrophin-1,27425,119,0.99 [0.82-1.20],0.927435095731622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CTHRC1,Collagen triple helix repeat-containing protein 1,24251,100,1.29 [0.65-2.53],0.4680770580598926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CTLA4,Cytotoxic T-lymphocyte protein 4,24251,100,1.27 [0.71-2.27],0.417028485963831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CTNNA1,Catenin alpha-1,23483,97,1.67 [1.21-2.30],0.001650114509407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CTRB1,Chymotrypsinogen B,27919,121,1.34 [1.02-1.78],0.0384781125827392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CTRC,Chymotrypsin-C,27906,121,1.25 [0.97-1.60],0.0809004568360131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CTRL,Chymotrypsin-like protease CTRL-1,24190,99,1.22 [0.92-1.62],0.1596796782867418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CTSB,Cathepsin B,27932,120,1.13 [0.82-1.54],0.4576797355638179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CTSC,Dipeptidyl peptidase 1,27860,121,1.06 [0.73-1.52],0.7717763150758649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CTSD,Cathepsin D,26035,107,1.09 [0.71-1.67],0.6907728144777878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CTSE,Cathepsin E,23715,97,1.10 [0.77-1.57],0.5943082454612213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CTSF,Cathepsin F,27992,119,1.77 [1.20-2.59],0.0037263852870985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CTSH,Pro-cathepsin H,27341,118,1.25 [1.00-1.56],0.0461848323792546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CTSL,Cathepsin L1,27929,121,1.68 [0.88-3.18],0.1141477104864148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CTSO,Cathepsin O,28265,122,1.59 [0.97-2.61],0.0659890169815365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CTSS,Cathepsin S,22040,97,2.01 [0.91-4.44],0.0842737056760815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CTSV,Cathepsin L2,28087,121,0.77 [0.53-1.14],0.1928747469075938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CTSZ,Cathepsin Z,27903,119,1.52 [0.91-2.53],0.1079098133146999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CUZD1,CUB and zona pellucida-like domain-containing protein 1,23584,95,0.73 [0.41-1.31],0.297047808583593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CWC15,Spliceosome-associated protein CWC15 homolog,24038,99,1.20 [0.93-1.56],0.1594517589206718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CX3CL1,Fractalkine,27738,120,1.32 [0.83-2.11],0.235033116434633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CXADR,Coxsackievirus and adenovirus receptor,27914,119,1.23 [0.91-1.66],0.178765470264353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CXCL1,Growth-regulated alpha protein,27863,121,1.08 [0.92-1.27],0.3480111711723194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CXCL10,C-X-C motif chemokine 10,28050,121,1.16 [0.93-1.45],0.1844042613047387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CXCL11,C-X-C motif chemokine 11,28192,122,1.11 [0.92-1.34],0.2695497653542529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CXCL12,Stromal cell-derived factor 1,27408,119,1.43 [0.98-2.08],0.0627363369686398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CXCL13,C-X-C motif chemokine 13,28192,122,1.47 [1.26-1.72],1.448637969302138e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CXCL14,C-X-C motif chemokine 14,27408,119,1.11 [0.89-1.39],0.3441543471996682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CXCL16,C-X-C motif chemokine 16,28219,122,1.85 [0.96-3.56],0.0676072631914383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CXCL17,C-X-C motif chemokine 17,28265,122,1.31 [0.94-1.82],0.1055507273574423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CXCL3,C-X-C motif chemokine 3,27909,121,1.07 [0.90-1.26],0.4613605820975828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CXCL5,C-X-C motif chemokine 5,27833,120,1.07 [0.93-1.23],0.3212337319981708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CXCL6,C-X-C motif chemokine 6,28265,122,1.09 [0.89-1.34],0.387520480588378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CXCL8,Interleukin-8,27705,119,1.00 [0.79-1.26],0.9738810717024978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CXCL9,C-X-C motif chemokine 9,28050,121,1.20 [0.97-1.50],0.0991796423817113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CYB5A,Cytochrome b5,23402,100,1.09 [0.86-1.38],0.4679382928683079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CYB5R2,NADH-cytochrome b5 reductase 2,23881,100,1.48 [1.10-1.98],0.0088299588368895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",23482,98,1.07 [0.87-1.31],0.5226344413944334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CYTH3,Cytohesin-3,23402,100,0.87 [0.65-1.17],0.3536101937559667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,CYTL1,Cytokine-like protein 1,24251,100,2.03 [0.92-4.48],0.08016068721763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DAAM1,Disheveled-associated activator of morphogenesis 1,23715,97,1.05 [0.83-1.32],0.7061852374312724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DAB2,Disabled homolog 2,28179,121,1.10 [0.96-1.28],0.174761147796668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DAG1,Dystroglycan,28050,121,1.39 [1.01-1.92],0.0459266659013193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DAND5,DAN domain family member 5,23569,96,1.13 [0.83-1.54],0.4196151036934462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DAPK2,Death-associated protein kinase 2,23569,96,1.32 [1.01-1.73],0.0449883566555677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,27914,119,1.03 [0.90-1.18],0.7032336943979655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DARS1,"Aspartate--tRNA ligase, cytoplasmic",27689,119,1.07 [0.85-1.34],0.5597822511858936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DBH,Dopamine beta-hydroxylase,24242,100,1.16 [0.95-1.41],0.1412341167468491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DBI,Acyl-CoA-binding protein,27778,121,1.17 [0.96-1.43],0.1113354023988517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DBN1,Drebrin,23569,96,1.33 [0.94-1.86],0.1048210980865566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DBNL,Drebrin-like protein,28050,121,1.15 [0.97-1.37],0.111838937751961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",27992,119,2.29 [1.51-3.48],9.478863130743904e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DCC,Netrin receptor DCC,23584,95,0.63 [0.23-1.72],0.3681312209001927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DCDC2C,Doublecortin domain-containing protein 2C,23402,100,1.05 [0.79-1.41],0.718641269783762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DCLRE1C,Protein artemis,23402,100,1.12 [0.62-2.03],0.7080471109143367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DCN,Decorin,27425,119,2.12 [1.04-4.34],0.0389599470365809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DCTD,Deoxycytidylate deaminase,23715,97,1.10 [0.89-1.35],0.3693167469770202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DCTN1,Dynactin subunit 1,28179,121,1.30 [1.03-1.66],0.030247254771178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DCTN2,Dynactin subunit 2,27803,121,0.99 [0.84-1.18],0.9460234834267204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DCTN6,Dynactin subunit 6,27266,115,1.33 [1.11-1.60],0.0023834108142547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DCTPP1,dCTP pyrophosphatase 1,27929,121,1.63 [1.00-2.67],0.0516399158141898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DCUN1D1,DCN1-like protein 1,23483,97,1.14 [0.91-1.44],0.2544343830246504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DCUN1D2,DCN1-like protein 2,23402,100,1.14 [0.92-1.41],0.2266581523620952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DCXR,L-xylulose reductase,27992,119,0.82 [0.61-1.11],0.1998190789232292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DDA1,DET1- and DDB1-associated protein 1,23482,98,1.05 [0.65-1.69],0.855497665966559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",27803,121,1.36 [0.98-1.88],0.0672156494651747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DDC,Aromatic-L-amino-acid decarboxylase,27897,121,0.82 [0.59-1.13],0.216540364843538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DDHD2,Phospholipase DDHD2,24223,100,1.22 [0.92-1.62],0.1642660470048515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DDI2,Protein DDI1 homolog 2,23715,97,1.16 [0.91-1.48],0.2365562489785515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DDR1,Epithelial discoidin domain-containing receptor 1,28192,122,1.92 [1.03-3.60],0.0400664260752604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DDT,D-dopachrome decarboxylase,24251,100,1.09 [0.70-1.70],0.70621868139721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DDX1,ATP-dependent RNA helicase DDX1,24167,101,1.14 [0.81-1.60],0.4666809864468019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DDX25,ATP-dependent RNA helicase DDX25,23584,95,1.12 [0.70-1.81],0.6297881451702818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DDX39A,ATP-dependent RNA helicase DDX39A,23569,96,1.91 [0.99-3.68],0.0526565200523381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DDX4,Probable ATP-dependent RNA helicase DDX4,23569,96,0.96 [0.67-1.39],0.8404563762853776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DDX53,Probable ATP-dependent RNA helicase DDX53,23584,95,0.84 [0.47-1.48],0.5388191727999689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DDX58,Antiviral innate immune response receptor RIG-I,27238,115,1.08 [0.83-1.40],0.5645331432596096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",27914,119,1.06 [0.90-1.25],0.5072184326030795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DEFA1_DEFA1B,Neutrophil defensin 1,27327,113,1.28 [0.97-1.70],0.0842264681292401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DEFB103A_DEFB103B,Beta-defensin 103,23403,96,1.64 [1.22-2.20],0.0009311537384009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DEFB104A_DEFB104B,Beta-defensin 104,23483,97,1.04 [0.74-1.44],0.8308851351224564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DEFB116,Beta-defensin 116,23483,97,0.98 [0.76-1.27],0.8907673397955156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DEFB118,Beta-defensin 118,23483,97,1.06 [0.77-1.44],0.7332806231445738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DEFB4A_DEFB4B,Beta-defensin 4A,27508,121,1.20 [1.08-1.33],0.0009199863620818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DENND2B,DENN domain-containing protein 2B,23482,98,0.79 [0.50-1.26],0.3315864770042451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DENR,Density-regulated protein,23569,96,1.11 [0.81-1.53],0.5131364772707803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DFFA,DNA fragmentation factor subunit alpha,28265,122,1.25 [1.00-1.56],0.0546225076484059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DGCR6,Protein DGCR6,23483,97,1.35 [0.99-1.84],0.0596863572113298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DGKA,Diacylglycerol kinase alpha,23569,96,1.27 [0.90-1.79],0.1704769413350343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DGKZ,Diacylglycerol kinase zeta,27408,119,1.29 [0.84-1.97],0.2457676049928068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DHODH,Dihydroorotate dehydrogenase,23482,98,1.16 [0.80-1.70],0.4327414534377075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DHPS,Deoxyhypusine synthase,24145,101,1.46 [1.04-2.04],0.0292677535659414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24190,99,1.20 [0.84-1.72],0.3231219315502083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DIABLO,"Diablo homolog, mitochondrial",27830,121,1.04 [0.90-1.20],0.6319254903750297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DIPK1C,Divergent protein kinase domain 1C,23584,95,1.26 [0.84-1.89],0.2690519792704395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DIPK2B,Divergent protein kinase domain 2B,23715,97,0.51 [0.29-0.91],0.021861845204329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DKK1,Dickkopf-related protein 1,28192,122,1.12 [0.87-1.46],0.381660253777948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DKK3,Dickkopf-related protein 3,28272,122,1.91 [1.12-3.24],0.0174972392902957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DKK4,Dickkopf-related protein 4,27687,120,1.64 [1.21-2.21],0.0012199928016983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DKKL1,Dickkopf-like protein 1,27803,121,1.39 [1.12-1.74],0.0032783416256133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DLG4,Disks large homolog 4,24190,99,1.27 [0.99-1.62],0.0637881364677087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DLGAP5,Disks large-associated protein 5,24223,100,1.16 [0.88-1.54],0.2997430563985002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DLK1,Protein delta homolog 1,28272,122,1.17 [0.88-1.54],0.2811221566880484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DLL1,Delta-like protein 1,27992,119,2.77 [1.66-4.62],9.879878962631156e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DLL4,Delta-like protein 4,23579,96,1.16 [1.01-1.34],0.0415086100384922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DMD,Dystrophin,23579,96,1.20 [0.86-1.67],0.2865306405959523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DMP1,Dentin matrix acidic phosphoprotein 1,23579,96,0.76 [0.58-0.99],0.0384203379443986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DNAJA1,DnaJ homolog subfamily A member 1,23402,100,0.93 [0.60-1.43],0.7266518710253679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DNAJA2,DnaJ homolog subfamily A member 2,28168,122,1.19 [0.98-1.45],0.0746076013793444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DNAJA4,DnaJ homolog subfamily A member 4,24190,99,1.00 [0.77-1.30],0.9941121346872324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DNAJB1,DnaJ homolog subfamily B member 1,27803,121,1.16 [0.97-1.40],0.1043664795658344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DNAJB14,DnaJ homolog subfamily B member 14,24167,101,1.12 [0.85-1.48],0.4053784522501824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DNAJB2,DnaJ homolog subfamily B member 2,23715,97,1.37 [0.98-1.91],0.0657322876273338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DNAJB6,DnaJ homolog subfamily B member 6,23494,97,1.14 [0.91-1.43],0.2620468330196647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DNAJB8,DnaJ homolog subfamily B member 8,27425,119,1.03 [0.78-1.37],0.8150382797749205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DNAJC21,DnaJ homolog subfamily C member 21,24190,99,1.22 [0.77-1.93],0.3886925831634404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DNAJC6,Putative tyrosine-protein phosphatase auxilin,23579,96,1.11 [0.89-1.39],0.3631067464413239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DNAJC9,DnaJ homolog subfamily C member 9,24167,101,1.21 [0.95-1.53],0.1273698692160987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DNER,Delta and Notch-like epidermal growth factor-related receptor,27864,121,0.66 [0.35-1.22],0.180321309535244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DNLZ,DNL-type zinc finger protein,23483,97,1.05 [0.84-1.29],0.6838846148034421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DNM1,Dynamin-1,24167,101,1.08 [0.91-1.27],0.3795177095091818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DNM3,Dynamin-3,24223,100,1.38 [1.02-1.85],0.0344281536680613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DNMBP,Dynamin-binding protein,27738,120,1.28 [1.01-1.62],0.0385093292781658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DNPEP,Aspartyl aminopeptidase,24190,99,0.89 [0.65-1.22],0.4553238794612089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,27995,121,1.24 [0.92-1.69],0.1562972897994871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DOC2B,Double C2-like domain-containing protein beta,23584,95,0.94 [0.54-1.63],0.8171184817645427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DOCK9,Dedicator of cytokinesis protein 9,23483,97,1.01 [0.86-1.20],0.8794088000504452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DOK1,Docking protein 1,24190,99,1.10 [0.95-1.27],0.2073798594655104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DOK2,Docking protein 2,27929,121,1.10 [0.97-1.25],0.1549109070358227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DPEP1,Dipeptidase 1,27689,119,1.04 [0.74-1.46],0.8070126824583872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DPEP2,Dipeptidase 2,27803,121,1.11 [0.65-1.90],0.704620816304157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DPP10,Inactive dipeptidyl peptidase 10,27914,119,1.06 [0.68-1.67],0.7942360482917016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DPP4,Dipeptidyl peptidase 4,27367,118,0.88 [0.51-1.52],0.655253906308435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DPP6,Dipeptidyl aminopeptidase-like protein 6,27803,121,0.98 [0.61-1.57],0.9249476975601216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DPP7,Dipeptidyl peptidase 2,27690,121,1.05 [0.81-1.37],0.6895912055523814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DPT,Dermatopontin,28272,122,1.89 [1.01-3.52],0.0450693549100773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DPY30,Protein dpy-30 homolog,28102,121,1.38 [1.10-1.73],0.0053122063930829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DRAXIN,Draxin,27738,120,1.37 [0.94-1.99],0.0992168530974772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DRG2,Developmentally-regulated GTP-binding protein 2,27803,121,1.12 [0.85-1.47],0.4276075820948812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DSC2,Desmocollin-2,27584,119,1.35 [0.85-2.14],0.207800314928191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DSCAM,Down syndrome cell adhesion molecule,24223,100,1.25 [0.74-2.10],0.4003588342894292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DSG2,Desmoglein-2,27919,121,1.57 [0.88-2.80],0.1293232653764678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DSG3,Desmoglein-3,28095,121,1.15 [0.72-1.84],0.5470476811262426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DSG4,Desmoglein-4,27708,120,1.16 [0.85-1.59],0.3566712491892096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DTD1,D-aminoacyl-tRNA deacylase 1,23715,97,1.17 [0.94-1.45],0.1619094931708743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DTNB,Dystrobrevin beta,24106,101,1.27 [0.86-1.87],0.2359650865889599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DTX2,Probable E3 ubiquitin-protein ligase DTX2,23584,95,1.23 [0.96-1.57],0.1003338894704569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DTX3,Probable E3 ubiquitin-protein ligase DTX3,27803,121,1.94 [1.07-3.50],0.028509771558141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DTYMK,Thymidylate kinase,24257,99,1.09 [0.83-1.43],0.5296171632821105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DUOX2,Dual oxidase 2,27425,119,1.23 [1.04-1.47],0.0166774950292141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DUSP13,Dual specificity protein phosphatase 13 isoform A,24145,101,1.10 [0.71-1.71],0.6793656121459827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DUSP29,Dual specificity phosphatase 29,23584,95,0.88 [0.64-1.22],0.4502057938004125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DUSP3,Dual specificity protein phosphatase 3,27266,115,1.00 [0.83-1.22],0.9693504301764504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24167,101,1.14 [0.95-1.36],0.1568219625665409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DXO,Decapping and exoribonuclease protein,24190,99,1.49 [1.01-2.21],0.04445122866622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24145,101,1.09 [0.75-1.58],0.6376389861227856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DYNLT1,Dynein light chain Tctex-type 1,23584,95,1.08 [0.86-1.36],0.4958357863500179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,DYNLT3,Dynein light chain Tctex-type 3,24145,101,0.89 [0.58-1.36],0.5920521915001506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,27738,120,1.15 [0.97-1.36],0.1092119378902733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EBI3_IL27,Interleukin-27,28142,121,1.81 [1.17-2.81],0.0076519361820013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ECE1,Endothelin-converting enzyme 1,27266,115,0.74 [0.46-1.18],0.2099945453487929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24257,99,1.01 [0.79-1.30],0.9185033475956272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ECHS1,"Enoyl-CoA hydratase, mitochondrial",23579,96,1.09 [0.89-1.32],0.4040920220021904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ECI2,Enoyl-CoA delta isomerase 2,23482,98,1.01 [0.75-1.38],0.9347423107556504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ECM1,Extracellular matrix protein 1,23606,98,0.93 [0.55-1.54],0.7682803588951141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ECSCR,Endothelial cell-specific chemotaxis regulator,23483,97,1.06 [0.73-1.54],0.7461173372566192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EDA2R,Tumor necrosis factor receptor superfamily member 27,28179,121,2.21 [1.50-3.24],5.5330980176362405e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EDAR,Tumor necrosis factor receptor superfamily member EDAR,27914,119,1.02 [0.86-1.22],0.7942982233018585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EDDM3B,Epididymal secretory protein E3-beta,24145,101,0.96 [0.65-1.41],0.8457924530560882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,23482,98,1.16 [0.72-1.89],0.5419571983681407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EDF1,Endothelial differentiation-related factor 1,24223,100,1.00 [0.76-1.31],0.9994842289247816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,27425,119,1.45 [0.95-2.20],0.0822127885404663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EDN1,Endothelin-1,23579,96,0.72 [0.36-1.44],0.358716753557441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EDNRB,Endothelin receptor type B,23569,96,1.25 [0.88-1.78],0.2041753286871833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EEF1D,Elongation factor 1-delta,24257,99,1.19 [0.98-1.45],0.0831545278687887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24167,101,1.73 [1.03-2.90],0.0382862958240516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EFCAB2,Dynein regulatory complex protein 8,23811,95,1.15 [0.68-1.96],0.6033953322693648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,27951,119,1.21 [0.72-2.05],0.4687891649244705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EFHD1,EF-hand domain-containing protein D1,24223,100,1.07 [0.62-1.82],0.8167211509087372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EFNA1,Ephrin-A1,27869,121,2.03 [1.17-3.55],0.0124285474944489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EFNA4,Ephrin-A4,27690,120,2.77 [1.75-4.39],1.3662071364013674e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EFNB2,Ephrin-B2,23584,95,0.71 [0.48-1.04],0.0812334315374362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EGF,Pro-epidermal growth factor,27859,121,1.02 [0.88-1.19],0.76033193195914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EGFL7,Epidermal growth factor-like protein 7,27238,115,1.50 [1.03-2.18],0.0338655086879448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EGFLAM,Pikachurin,24167,101,1.59 [0.93-2.70],0.0904725566812019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EGFR,Epidermal growth factor receptor,28272,122,0.68 [0.26-1.82],0.4487664364796032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EGLN1,Egl nine homolog 1,27914,119,1.31 [1.06-1.62],0.0108108659477281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EHBP1,EH domain-binding protein 1,24257,99,1.21 [0.95-1.55],0.1196580091707952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EHD3,EH domain-containing protein 3,23579,96,1.03 [0.87-1.22],0.7379108583257434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24190,99,1.28 [0.95-1.71],0.102553189387045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24092,101,1.18 [1.00-1.39],0.0488951687344863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,23482,98,1.03 [0.78-1.37],0.8148509511918215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,23579,96,1.45 [0.98-2.14],0.0621775238039383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EIF4B,Eukaryotic translation initiation factor 4B,27738,120,1.16 [0.87-1.54],0.3141926656814985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EIF4E,Eukaryotic translation initiation factor 4E,23569,96,1.08 [0.88-1.34],0.46179057301929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,27929,121,1.28 [1.02-1.60],0.0341636589663346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,28265,122,1.14 [0.97-1.34],0.1157651021514805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24223,100,1.20 [0.92-1.57],0.1683051549529282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EIF5,Eukaryotic translation initiation factor 5,23482,98,1.05 [0.69-1.60],0.8061517305619329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EIF5A,Eukaryotic translation initiation factor 5A-1,27408,119,1.17 [0.71-1.91],0.5442549698532966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ELAC1,Zinc phosphodiesterase ELAC protein 1,24223,100,1.08 [0.86-1.34],0.5188425501028526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ELAVL4,ELAV-like protein 4,23483,97,0.97 [0.77-1.22],0.7828397694386465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ELN,Elastin,24257,99,1.91 [1.12-3.26],0.0180135493943545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ELOA,Elongin-A,27803,121,1.18 [0.92-1.51],0.1937184987664228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ELOB,Elongin-B,23482,98,1.20 [0.78-1.85],0.4109724362775118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ENAH,Protein enabled homolog,27408,119,1.68 [1.26-2.23],0.0003473709641545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ENDOU,Poly(U)-specific endoribonuclease,22409,92,1.32 [0.93-1.87],0.126857688888811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ENG,Endoglin,28272,122,0.87 [0.34-2.22],0.7741027095930586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ENO1,Alpha-enolase,27895,120,1.11 [0.91-1.37],0.3074589815135022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ENO2,Gamma-enolase,28192,122,1.18 [0.93-1.49],0.1759115686871472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ENO3,Beta-enolase,23579,96,1.04 [0.76-1.42],0.8173569455646926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ENOPH1,Enolase-phosphatase E1,24145,101,1.12 [0.84-1.51],0.4276525890963796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,23482,98,1.43 [0.79-2.59],0.2321589528534946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ENPEP,Glutamyl aminopeptidase,23482,98,1.04 [0.67-1.63],0.8480844684514033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,28272,122,0.71 [0.39-1.29],0.2617790752275946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,28050,121,0.70 [0.53-0.92],0.0110817607800241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,23579,96,0.61 [0.36-1.02],0.0587431337991961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,27122,116,1.12 [0.93-1.35],0.2360830840363006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ENSA,Alpha-endosulfine,24145,101,1.12 [0.80-1.58],0.4975061692311601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,27238,115,1.05 [0.73-1.53],0.7808720920744763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,27425,119,0.63 [0.30-1.32],0.2209443068451542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,27425,119,1.59 [0.82-3.08],0.1732196805499167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ENTR1,Endosome-associated-trafficking regulator 1,23579,96,0.77 [0.54-1.10],0.1545230299890006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EP300,Histone acetyltransferase p300,23569,96,2.08 [1.44-3.00],9.577562015731904e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EPB41L5,Band 4.1-like protein 5,23584,95,1.21 [0.96-1.53],0.1140979673222499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EPCAM,Epithelial cell adhesion molecule,27915,120,0.91 [0.76-1.07],0.2563677216046341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EPGN,Epigen,24145,101,0.95 [0.62-1.44],0.798255611775514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EPHA1,Ephrin type-A receptor 1,27995,121,1.19 [0.74-1.92],0.4785023860396101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EPHA10,Ephrin type-A receptor 10,27266,115,1.13 [0.90-1.42],0.2987471570495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EPHA2,Ephrin type-A receptor 2,26915,118,2.22 [1.43-3.46],0.000398973794947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EPHA4,Ephrin type-A receptor 4,23715,97,1.81 [0.92-3.58],0.0869190845793016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EPHB4,Ephrin type-B receptor 4,28272,122,1.97 [1.07-3.63],0.029076411528763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EPHB6,Ephrin type-B receptor 6,27689,119,1.77 [1.06-2.97],0.0300230781511606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EPHX2,Bifunctional epoxide hydrolase 2,27425,119,0.96 [0.73-1.26],0.772788980305957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EPN1,Epsin-1,23811,95,1.34 [0.96-1.87],0.0814519535303616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EPO,Erythropoietin,27914,119,1.08 [0.89-1.31],0.4368120790742759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EPPK1,Epiplakin,23579,96,1.13 [0.90-1.43],0.2936308351431141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,28139,121,1.39 [0.85-2.29],0.1912110482393362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ERBB2,Receptor tyrosine-protein kinase erbB-2,27992,119,0.97 [0.52-1.83],0.927113676678169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ERBB3,Receptor tyrosine-protein kinase erbB-3,27802,121,0.89 [0.39-2.03],0.7731991688419368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ERBB4,Receptor tyrosine-protein kinase erbB-4,27992,119,1.03 [0.53-2.00],0.925637749795734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ERBIN,Erbin,27803,121,1.12 [0.95-1.31],0.1707896947216471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ERC2,ERC protein 2,23584,95,1.13 [0.90-1.42],0.3062385028255662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ERCC1,DNA excision repair protein ERCC-1,23402,100,0.78 [0.41-1.50],0.4582800210228938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EREG,Proepiregulin,27689,119,1.02 [0.84-1.25],0.8147179724561389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ERI1,3'-5' exoribonuclease 1,23811,95,1.23 [0.72-2.12],0.4433600577593705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ERMAP,Erythroid membrane-associated protein,23569,96,1.13 [0.74-1.73],0.5625330663669375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24145,101,0.89 [0.54-1.46],0.6457354570950733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ERP29,Endoplasmic reticulum resident protein 29,23715,97,1.08 [0.92-1.27],0.3528040822314953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ERP44,Endoplasmic reticulum resident protein 44,27763,120,1.93 [1.06-3.51],0.0306113888616473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,23482,98,1.25 [0.91-1.72],0.1620537981051898
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ESAM,Endothelial cell-selective adhesion molecule,28272,122,1.44 [0.89-2.32],0.1361373839742886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ESM1,Endothelial cell-specific molecule 1,27905,121,1.57 [1.00-2.47],0.0494459789116106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ESPL1,Separin,23402,100,0.94 [0.64-1.36],0.731119535971053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ESR1,Estrogen receptor,23569,96,1.04 [0.75-1.44],0.8103923233659063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ESYT2,Extended synaptotagmin-2,24190,99,1.18 [0.94-1.47],0.1458815774907928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EVI2B,Protein EVI2B,23402,100,0.92 [0.55-1.54],0.7473923943268885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EVI5,Ecotropic viral integration site 5 protein homolog,23569,96,1.23 [1.00-1.52],0.0491837390833032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EVPL,Envoplakin,23811,95,1.49 [0.92-2.42],0.1045616350374326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EXOSC10,Exosome component 10,23482,98,0.88 [0.62-1.26],0.4962097246118795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EXTL1,Exostosin-like 1,23482,98,0.75 [0.47-1.19],0.220642504840633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,EZR,Ezrin,28192,122,1.81 [0.98-3.33],0.058577399386658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,F10,Coagulation factor X,24282,100,0.53 [0.25-1.09],0.0832010015580256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,F11,Coagulation factor XI,23933,100,1.19 [0.73-1.93],0.4945281816351494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,F11R,Junctional adhesion molecule A,27919,121,1.33 [1.02-1.74],0.035932833700421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,F12,Coagulation factor XII,24294,101,1.68 [1.06-2.66],0.0281513912811804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,F13B,Coagulation factor XIII B chain,24162,100,1.03 [0.50-2.13],0.9410561180335536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,F2,Prothrombin,24294,101,2.86 [0.81-10.13],0.1037780866386356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,F2R,Proteinase-activated receptor 1,28007,121,1.24 [0.95-1.62],0.118799030188576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,F3,Tissue factor,28003,119,1.28 [0.73-2.24],0.391531228243866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,F7,Coagulation factor VII,27958,119,1.33 [0.77-2.28],0.3015990168539126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,F9,Coagulation factor IX,27970,119,1.36 [0.56-3.26],0.4970050026175934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FABP1,"Fatty acid-binding protein, liver",27905,121,0.98 [0.82-1.16],0.7718415467837954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FABP2,"Fatty acid-binding protein, intestinal",27929,121,0.95 [0.77-1.17],0.6313472305215804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FABP3,"Fatty acid-binding protein, heart",24257,99,1.28 [0.90-1.81],0.1727442983743887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FABP4,"Fatty acid-binding protein, adipocyte",28272,122,1.51 [1.13-2.04],0.006186037305437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FABP5,Fatty acid-binding protein 5,28112,122,1.25 [1.00-1.56],0.0512410058204358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FABP6,Gastrotropin,27389,119,1.09 [0.82-1.46],0.5535966767022353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FABP9,Fatty acid-binding protein 9,27914,119,1.02 [0.77-1.36],0.8724895556603118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FADD,FAS-associated death domain protein,27929,121,1.13 [0.92-1.39],0.2318191101564618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FAM13A,Protein FAM13A,24167,101,1.24 [0.95-1.61],0.1143107328510068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FAM171A2,Protein FAM171A2,24223,100,1.04 [0.93-1.16],0.5234513860200813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FAM171B,Protein FAM171B,24145,101,1.94 [1.24-3.06],0.0040731673523425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FAM172A,Cotranscriptional regulator FAM172A,23579,96,1.12 [0.82-1.53],0.4663247296377748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FAM20A,Pseudokinase FAM20A,24257,99,1.00 [0.52-1.95],0.9883609487577047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FAM3B,Protein FAM3B,27803,121,1.20 [0.79-1.83],0.3948207928022126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FAM3C,Protein FAM3C,27897,121,2.03 [1.21-3.40],0.0073797678028612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FAM3D,Protein FAM3D,24167,101,1.07 [0.85-1.34],0.5763841283879781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FAP,Prolyl endopeptidase FAP,28272,122,0.70 [0.39-1.23],0.2112968070369243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FARSA,Phenylalanine--tRNA ligase alpha subunit,23584,95,1.21 [0.94-1.56],0.1450064254586758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FAS,Tumor necrosis factor receptor superfamily member 6,28173,122,1.43 [1.01-2.02],0.0440338923242805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FASLG,Tumor necrosis factor ligand superfamily member 6,28265,122,0.89 [0.58-1.37],0.6068860007206853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FBLN2,Fibulin-2,24251,100,1.42 [0.79-2.54],0.2358304824589047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FBN2,Fibrillin-2,23584,95,1.17 [0.85-1.60],0.3386009777371673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FBP1,"Fructose-1,6-bisphosphatase 1",27929,121,0.99 [0.80-1.22],0.9019014258367992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24257,99,1.00 [0.77-1.31],0.971912987978843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FCAR,Immunoglobulin alpha Fc receptor,27914,119,1.01 [0.72-1.42],0.9457029017716972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24223,100,0.49 [0.23-1.05],0.0676529973766768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FCER2,Low affinity immunoglobulin epsilon Fc receptor,27919,121,1.51 [1.12-2.03],0.0068078117141924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,27784,118,0.96 [0.74-1.25],0.7485297528948044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,27238,115,1.25 [0.96-1.62],0.0985302033638853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,27915,119,1.07 [0.77-1.48],0.6787431089576677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FCN1,Ficolin-1,24242,100,1.22 [0.85-1.75],0.2705596827834091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FCN2,Ficolin-2,27788,118,1.00 [0.68-1.47],0.9846109996759642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FCRL1,Fc receptor-like protein 1,27929,121,1.11 [0.77-1.60],0.5819911468992522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FCRL2,Fc receptor-like protein 2,28141,122,1.38 [1.01-1.90],0.0463133124253527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FCRL3,Fc receptor-like protein 3,27408,119,1.08 [0.79-1.46],0.6295757828420563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FCRL5,Fc receptor-like protein 5,27919,121,1.16 [0.88-1.53],0.3013706409760109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FCRL6,Fc receptor-like protein 6,27914,119,0.95 [0.74-1.20],0.6523257602157682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FCRLB,Fc receptor-like B,27238,115,1.14 [0.87-1.49],0.3273853333581447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FDX1,"Adrenodoxin, mitochondrial",23482,98,1.00 [0.73-1.36],0.9873076884083272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FDX2,"Ferredoxin-2, mitochondrial",23482,98,1.04 [0.75-1.45],0.8085312666663947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FEN1,Flap endonuclease 1,27238,115,0.98 [0.76-1.26],0.8529073850018598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FES,Tyrosine-protein kinase Fes/Fps,27238,115,1.33 [0.99-1.78],0.0612347517552508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FETUB,Fetuin-B,27970,119,1.64 [0.99-2.72],0.0546876220411044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FGA,Fibrinogen alpha chain,23710,98,1.12 [0.60-2.10],0.7194482138617475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24223,100,1.18 [0.94-1.49],0.1544100772834361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FGF12,Fibroblast growth factor 12,23569,96,0.97 [0.62-1.51],0.8981736429893697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FGF16,Fibroblast growth factor 16,23569,96,0.98 [0.65-1.49],0.936973742909478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FGF19,Fibroblast growth factor 19,28050,121,1.18 [0.96-1.45],0.1070882810531525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FGF2,Fibroblast growth factor 2,27914,119,1.03 [0.82-1.31],0.7762179429035932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FGF20,Fibroblast growth factor 20,23569,96,0.76 [0.44-1.32],0.3292553337420523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FGF21,Fibroblast growth factor 21,28142,121,1.05 [0.92-1.19],0.4641060478204812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FGF23,Fibroblast growth factor 23,28129,121,1.30 [1.05-1.60],0.014005765796471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FGF3,Fibroblast growth factor 3,23569,96,1.04 [0.56-1.93],0.9130625871701182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FGF5,Fibroblast growth factor 5,27408,119,1.73 [1.13-2.65],0.0115165779140619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FGF6,Fibroblast growth factor 6,23569,96,1.01 [0.64-1.60],0.9562823179104032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FGF7,Fibroblast growth factor 7,23402,100,1.07 [0.86-1.34],0.5572255875932667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FGF9,Fibroblast growth factor 9,23355,99,0.93 [0.58-1.49],0.7589842769752001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FGFBP1,Fibroblast growth factor-binding protein 1,27992,119,0.62 [0.39-1.00],0.0494048607947314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FGFBP2,Fibroblast growth factor-binding protein 2,24251,100,0.95 [0.65-1.38],0.7890004036310757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FGFBP3,Fibroblast growth factor-binding protein 3,24190,99,0.73 [0.43-1.23],0.2340954379900815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FGFR2,Fibroblast growth factor receptor 2,27992,119,1.78 [0.89-3.57],0.1014503458306277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FGFR4,Fibroblast growth factor receptor 4,23715,97,1.17 [0.82-1.67],0.3872438152888561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FGL1,Fibrinogen-like protein 1,24282,100,1.48 [1.10-1.99],0.0095985148245416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FGR,Tyrosine-protein kinase Fgr,27266,115,1.21 [0.97-1.52],0.0879172644656188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FH,"Fumarate hydratase, mitochondrial",23483,97,0.86 [0.65-1.13],0.2769157651214361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FHIP2A,FHF complex subunit HOOK interacting protein 2A,23482,98,0.83 [0.54-1.28],0.4005548787940045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FHIT,Bis(5'-adenosyl)-triphosphatase,27266,115,1.02 [0.82-1.27],0.8656314745276581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FIS1,Mitochondrial fission 1 protein,27897,121,1.24 [1.02-1.51],0.0298392189396661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24223,100,1.08 [0.90-1.31],0.4008010412088449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,28044,122,1.03 [0.90-1.19],0.6641152939523662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,27738,120,1.38 [0.95-1.99],0.0880977599340938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,27738,120,1.08 [0.91-1.29],0.3548915461535094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,27217,114,1.13 [0.82-1.56],0.4614052090289124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FKBPL,FK506-binding protein-like,24167,101,1.38 [1.02-1.87],0.0396212660959183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FLI1,Friend leukemia integration 1 transcription factor,27238,115,1.16 [1.01-1.34],0.0382813935176596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,27738,120,1.77 [1.02-3.05],0.0416052563749659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FLT1,Vascular endothelial growth factor receptor 1,27757,120,2.07 [1.38-3.11],0.0004849279478453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FLT3,Receptor-type tyrosine-protein kinase FLT3,27238,115,0.62 [0.35-1.11],0.1095537173202174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FLT3LG,Fms-related tyrosine kinase 3 ligand,28265,122,1.38 [0.87-2.21],0.1752768731066385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FLT4,Vascular endothelial growth factor receptor 3,27992,119,1.91 [1.17-3.12],0.0098305440439944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FMNL1,Formin-like protein 1,27266,115,1.21 [0.99-1.47],0.0605818455592582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FMR1,Synaptic functional regulator FMR1,27238,115,1.36 [0.87-2.13],0.1750154712402987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FN1,Fibronectin,24294,101,1.57 [0.79-3.11],0.199071282595673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FNDC1,Fibronectin type III domain-containing protein 1,24190,99,1.02 [0.68-1.53],0.9135229899813668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24145,101,1.75 [1.22-2.50],0.0021279995485473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FOLH1,Glutamate carboxypeptidase 2,23569,96,0.98 [0.81-1.19],0.8469125563113021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FOLR1,Folate receptor alpha,27858,117,2.24 [1.32-3.79],0.0028105530588405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FOLR2,Folate receptor beta,28192,122,1.39 [0.81-2.37],0.2334692646679906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FOLR3,Folate receptor gamma,27901,119,0.94 [0.85-1.03],0.1822571052196181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FOS,Proto-oncogene c-Fos,23355,99,1.28 [0.76-2.14],0.3523783817678293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FOSB,Protein fosB,27266,115,0.81 [0.51-1.31],0.3967222082445237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FOXJ3,Forkhead box protein J3,23569,96,1.25 [0.85-1.82],0.2554889993429017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FOXO1,Forkhead box protein O1,27914,119,1.16 [0.96-1.39],0.1237564968914732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FOXO3,Forkhead box protein O3,27238,115,1.14 [0.97-1.34],0.106753263286632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FRMD4B,FERM domain-containing protein 4B,23482,98,1.12 [0.86-1.45],0.3898265891403336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FRMD7,FERM domain-containing protein 7,23584,95,1.09 [0.62-1.93],0.758471743263286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FRZB,Secreted frizzled-related protein 3,27642,120,1.82 [0.99-3.36],0.0552525168477955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FSHB,Follitropin subunit beta,23579,96,1.01 [0.75-1.36],0.9556717653539945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FST,Follistatin,28007,121,1.20 [0.89-1.63],0.2353517114805584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FSTL1,Follistatin-related protein 1,23579,96,1.04 [0.45-2.43],0.9234105115400054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FSTL3,Follistatin-related protein 3,27868,120,1.58 [0.96-2.60],0.0692100595910634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FTCD,Formimidoyltransferase-cyclodeaminase,24151,99,0.88 [0.70-1.10],0.2473336515141236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FUCA1,Tissue alpha-L-fucosidase,28078,120,0.91 [0.75-1.11],0.3489143139079146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FUOM,Fucose mutarotase,23715,97,0.85 [0.63-1.16],0.3056918529501622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FURIN,Furin,27992,119,1.15 [0.72-1.83],0.5552006047559118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FUS,RNA-binding protein FUS,27188,115,1.17 [0.79-1.74],0.4414957222198038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",23772,95,0.87 [0.62-1.22],0.4210227778978822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,28192,122,1.13 [0.80-1.59],0.4832503563172832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FUT8,"Alpha-(1,6)-fucosyltransferase",27738,120,1.10 [0.84-1.44],0.4960128926039857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FXN,"Frataxin, mitochondrial",28179,121,1.14 [0.92-1.41],0.2206916091997903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FXYD5,FXYD domain-containing ion transport regulator 5,27408,119,1.31 [1.05-1.65],0.0186377474690595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FYB1,FYN-binding protein 1,27878,121,1.14 [0.96-1.36],0.128130424281073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FZD10,Frizzled-10,23584,95,1.09 [0.80-1.47],0.5919259304635285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,FZD8,Frizzled-8,23483,97,1.08 [0.70-1.67],0.7149243608782135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24145,101,1.09 [0.76-1.57],0.6496382723406853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,23811,95,0.89 [0.64-1.24],0.4888123968270794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,23483,97,0.92 [0.67-1.27],0.6171099027294422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GAD1,Glutamate decarboxylase 1,23402,100,1.84 [0.90-3.76],0.0968991776847454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GAD2,Glutamate decarboxylase 2,23569,96,1.19 [0.84-1.71],0.3302904435454419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,23811,95,1.24 [0.93-1.64],0.1439020533279803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,23579,96,1.13 [0.80-1.61],0.4804948392654978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GAGE2A,G antigen 2A,23402,100,1.02 [0.75-1.39],0.9101023926909584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GAL,Galanin peptides,28050,121,0.97 [0.76-1.23],0.7860092900073365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,27803,121,1.21 [0.70-2.11],0.4992769981027909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,28179,121,0.79 [0.43-1.45],0.4456178578745372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,27408,119,1.16 [0.79-1.69],0.4551876368765873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24257,99,1.10 [0.55-2.18],0.7879202367775437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GALNT7,N-acetylgalactosaminyltransferase 7,27803,121,1.82 [0.85-3.93],0.1253161614154614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GAMT,Guanidinoacetate N-methyltransferase,23482,98,1.42 [0.96-2.11],0.0783468985549449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23211,94,0.62 [0.36-1.07],0.0871042866469417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GART,Trifunctional purine biosynthetic protein adenosine-3,24223,100,0.73 [0.33-1.63],0.4430128730804037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GAS2,Growth arrest-specific protein 2,23811,95,0.95 [0.65-1.40],0.8085911256100677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GAS6,Growth arrest-specific protein 6,28073,121,1.00 [0.54-1.85],0.9916765513341452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GASK1A,Golgi-associated kinase 1A,23482,98,0.71 [0.45-1.10],0.1240640450539875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GAST,Gastrin,24190,99,1.29 [1.14-1.46],5.4853413737021536e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,23402,100,1.40 [0.68-2.87],0.3615940360945996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",23579,96,1.06 [0.83-1.35],0.6320018949332216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GBA,Lysosomal acid glucosylceramidase,23584,95,1.23 [0.89-1.70],0.2049511621355689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GBP1,Guanylate-binding protein 1,24145,99,1.04 [0.78-1.40],0.7836010533122574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GBP2,Guanylate-binding protein 2,27408,119,1.12 [0.86-1.45],0.4048122103000428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GBP4,Guanylate-binding protein 4,27266,115,1.20 [0.87-1.65],0.262850730938248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GBP6,Guanylate-binding protein 6,23482,98,0.87 [0.54-1.40],0.5525420125200806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GC,Vitamin D-binding protein,24294,101,1.22 [0.59-2.52],0.5896058917419951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GCC1,GRIP and coiled-coil domain-containing protein 1,24190,99,1.16 [0.97-1.39],0.0990557152213312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GCG,Pro-glucagon,27238,115,1.16 [1.02-1.32],0.0290715684305005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23133,96,1.21 [0.86-1.71],0.2656573374003951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GCLM,Glutamate--cysteine ligase regulatory subunit,23482,98,1.19 [0.82-1.72],0.372030643648247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",27803,121,1.06 [0.66-1.68],0.8193210380890235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GDF15,Growth/differentiation factor 15,28272,122,1.85 [1.54-2.22],4.424105698747622e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GDF2,Growth/differentiation factor 2,27929,121,1.40 [0.90-2.18],0.132763856454406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GDNF,Glial cell line-derived neurotrophic factor,27266,115,1.22 [0.80-1.85],0.3594423993654099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GET3,ATPase GET3,24257,99,1.16 [0.85-1.57],0.3524508589607893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GFAP,Glial fibrillary acidic protein,27196,115,1.39 [0.97-2.00],0.071892957145831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GFER,FAD-linked sulfhydryl oxidase ALR,27238,115,1.14 [0.89-1.46],0.3094788579460358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,27238,115,0.99 [0.87-1.13],0.8465489494631615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GFRA1,GDNF family receptor alpha-1,28142,121,2.50 [1.47-4.26],0.0007726328620715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GFRA2,GDNF family receptor alpha-2,27803,121,0.76 [0.36-1.62],0.4825177380994463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GFRA3,GDNF family receptor alpha-3,27646,120,1.33 [0.75-2.36],0.3239131080205342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GFRAL,GDNF family receptor alpha-like,23486,94,0.86 [0.62-1.18],0.3473270769051436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GGA1,ADP-ribosylation factor-binding protein GGA1,27266,115,1.08 [0.87-1.35],0.4742563321573797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GGACT,Gamma-glutamylaminecyclotransferase,24257,99,1.10 [0.85-1.43],0.4685193056804098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GGCT,Gamma-glutamylcyclotransferase,24216,99,1.12 [0.76-1.64],0.5767380799154296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GGH,Gamma-glutamyl hydrolase,27406,115,1.50 [0.95-2.36],0.0785064967052418
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GGT1,Glutathione hydrolase 1 proenzyme,27869,121,1.11 [0.81-1.51],0.5100088204329292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GGT5,Glutathione hydrolase 5 proenzyme,27738,120,1.91 [1.04-3.51],0.0362865772791463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GH1,Somatotropin,27897,121,0.92 [0.84-1.01],0.072015820121518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GH2,Growth hormone variant,27238,115,1.00 [0.91-1.11],0.9463533167663156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GHR,Growth hormone receptor,23715,97,0.84 [0.43-1.63],0.604348042084706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GHRHR,Growth hormone-releasing hormone receptor,27266,115,1.13 [0.87-1.47],0.3580252921646932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GHRL,Appetite-regulating hormone,27929,121,1.08 [0.88-1.33],0.450382961942421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GID8,Glucose-induced degradation protein 8 homolog,24223,100,1.06 [0.62-1.82],0.8297130453810795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GIGYF2,GRB10-interacting GYF protein 2,24223,100,1.20 [0.95-1.51],0.1299798739215636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GIMAP7,GTPase IMAP family member 7,23715,97,1.10 [0.63-1.93],0.7308042866213935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GIMAP8,GTPase IMAP family member 8,23402,100,1.25 [0.89-1.75],0.2032647010868594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GIP,Gastric inhibitory polypeptide,23579,96,1.29 [0.84-1.97],0.2429421574172929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GIPC2,PDZ domain-containing protein GIPC2,24190,99,1.64 [0.91-2.98],0.1017994196393258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GIPC3,PDZ domain-containing protein GIPC3,24167,101,1.14 [0.94-1.39],0.1835806240688356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GIPR,Gastric inhibitory polypeptide receptor,23569,96,0.80 [0.49-1.30],0.3711099826845818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GIT1,ARF GTPase-activating protein GIT1,23569,96,1.16 [0.95-1.42],0.140216768255048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GJA8,Gap junction alpha-8 protein,23402,100,0.86 [0.61-1.22],0.405829513490519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GKN1,Gastrokine-1,26743,112,1.70 [0.96-2.99],0.0666292674839579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GLA,Alpha-galactosidase A,23663,97,1.49 [0.92-2.43],0.1085041382249647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GLB1,Beta-galactosidase,27738,120,1.35 [0.94-1.95],0.1045733191229556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GLI2,Zinc finger protein GLI2,23569,96,1.42 [0.92-2.22],0.1164907325824297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GLO1,Lactoylglutathione lyase,27425,119,1.42 [1.09-1.86],0.0101795788280162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GLOD4,Glyoxalase domain-containing protein 4,27854,121,1.46 [0.93-2.28],0.0964932664993421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GLP1R,Glucagon-like peptide 1 receptor,23483,97,1.36 [0.90-2.07],0.1424426412890555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GLRX,Glutaredoxin-1,27757,121,1.18 [0.90-1.54],0.2252169823075405
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",23715,97,1.14 [0.93-1.41],0.214601523423464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,27266,115,0.97 [0.68-1.39],0.8727227936904046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GLYR1,Putative oxidoreductase GLYR1,24145,101,1.07 [0.80-1.44],0.647156330366939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GM2A,Ganglioside GM2 activator,23682,98,1.19 [0.76-1.87],0.4503636800067799
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GMFG,Glia maturation factor gamma,24257,99,1.15 [0.88-1.49],0.3014775814372363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GMPR,GMP reductase 1,28265,122,1.13 [0.82-1.56],0.4537712400958661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GMPR2,GMP reductase 2,23715,97,1.16 [0.87-1.54],0.3050770172281491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GNAS,Neuroendocrine secretory protein 55,24223,100,1.05 [0.86-1.29],0.6163870720781706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,27238,115,1.02 [0.79-1.31],0.8992752947488499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,23584,95,0.98 [0.66-1.45],0.9129515879438704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GNLY,Granulysin,27919,121,1.18 [0.87-1.60],0.2814444101304549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GNPDA1,Glucosamine-6-phosphate isomerase 1,23579,96,0.95 [0.52-1.74],0.8599857456006001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GNPDA2,Glucosamine-6-phosphate isomerase 2,23715,97,0.92 [0.55-1.56],0.7683152455060961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GOLGA3,Golgin subfamily A member 3,24223,100,1.25 [0.99-1.57],0.0581833327781453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GOLM2,Protein GOLM2,28192,122,1.96 [1.01-3.82],0.0478895294372948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,27914,119,1.06 [0.90-1.25],0.4614494315780456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GORASP2,Golgi reassembly-stacking protein 2,24167,101,1.52 [1.05-2.21],0.0259715425401806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GOT1,"Aspartate aminotransferase, cytoplasmic",24251,100,0.73 [0.46-1.15],0.1729174582372786
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GP1BA,Platelet glycoprotein Ib alpha chain,27789,119,1.18 [0.73-1.92],0.4955564410854761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GP1BB,Platelet glycoprotein Ib beta chain,23482,98,1.05 [0.79-1.40],0.7144354363671462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,27067,117,0.82 [0.66-1.01],0.0607968937206295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GP5,Platelet glycoprotein V,23715,97,0.98 [0.58-1.65],0.9267645889889504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GP6,Platelet glycoprotein VI,27878,121,1.12 [0.93-1.34],0.2314781159673079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GPA33,Cell surface A33 antigen,27803,121,0.93 [0.82-1.05],0.2560504354349611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GPC1,Glypican-1,28179,121,0.94 [0.55-1.63],0.8353553637866908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GPC5,Glypican-5,27738,120,1.17 [0.88-1.56],0.2754508438688257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GPD1,Glycerol-3-phosphate dehydrogenase,24145,101,1.10 [0.79-1.54],0.5765789814958233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GPHA2,Glycoprotein hormone alpha-2,24167,101,1.22 [0.88-1.70],0.2358012250581007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GPI,Glucose-6-phosphate isomerase,24282,100,1.16 [0.80-1.70],0.4311099391005883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24167,101,1.37 [1.02-1.84],0.0358472915373877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GPKOW,G-patch domain and KOW motifs-containing protein,27266,115,1.27 [0.78-2.06],0.3310836219937038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GPNMB,Transmembrane glycoprotein NMB,27174,118,1.28 [0.72-2.27],0.4054723374712908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GPR101,Probable G-protein coupled receptor 101,23483,97,0.94 [0.67-1.32],0.7365580946483943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GPR158,Probable G-protein coupled receptor 158,24223,100,1.32 [0.86-2.05],0.2048228557920603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GPR15L,Protein GPR15L,24167,101,1.09 [0.81-1.46],0.5736366026451245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GPR37,Prosaposin receptor GPR37,27425,119,1.47 [1.15-1.89],0.0023445508671386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GPRC5C,G-protein coupled receptor family C group 5 member C,24145,101,1.29 [0.98-1.68],0.0663619610568333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GRAP2,GRB2-related adapter protein 2,27929,121,1.07 [0.94-1.21],0.3079668587251339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24257,99,1.07 [0.80-1.44],0.63739169263537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GRIK2,"Glutamate receptor ionotropic, kainate 2",24223,100,1.16 [0.75-1.80],0.5011890848941212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",23483,97,1.05 [0.76-1.46],0.7637656503303575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GRK5,G protein-coupled receptor kinase 5,27425,119,1.12 [0.84-1.49],0.4426552842734863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GRN,Progranulin,27780,121,2.56 [1.46-4.47],0.0009685823712176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GRP,Gastrin-releasing peptide,23579,96,0.98 [0.67-1.41],0.8946901444664059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GRPEL1,"GrpE protein homolog 1, mitochondrial",27803,121,1.10 [0.86-1.41],0.4596215150425439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GRSF1,G-rich sequence factor 1,23268,98,1.22 [0.98-1.52],0.0781529229349438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GSAP,Gamma-secretase-activating protein,27238,115,0.98 [0.81-1.19],0.8532826328469643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GSN,Gelsolin,24183,100,0.48 [0.19-1.21],0.1190895093095905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GSR,"Glutathione reductase, mitochondrial",24149,100,0.62 [0.27-1.44],0.2673991169403674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GSTA1,Glutathione S-transferase A1,27891,121,0.92 [0.77-1.11],0.4033169047854077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GSTA3,Glutathione S-transferase A3,27238,115,0.93 [0.75-1.16],0.5238939431414975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GSTM4,Glutathione S-transferase Mu 4,23482,98,0.99 [0.76-1.31],0.968470840304107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GSTP1,Glutathione S-transferase P,27093,114,0.95 [0.74-1.21],0.6630712809854642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GSTT2B,Glutathione S-transferase theta-2B,24190,99,1.02 [0.94-1.10],0.7036576490977743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,23811,95,1.06 [0.82-1.37],0.6453525427931076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GTPBP2,GTP-binding protein 2,23584,95,1.14 [0.90-1.44],0.2919922824055427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GUCA2A,Guanylin,27787,121,1.82 [1.13-2.92],0.0134302187223746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GUCY2C,Heat-stable enterotoxin receptor,23811,95,1.04 [0.84-1.30],0.7162854715223442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GUK1,Guanylate kinase,23482,98,1.10 [0.71-1.68],0.678032842214121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GUSB,Beta-glucuronidase,28030,121,1.08 [0.84-1.40],0.546600037292692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GYS1,"Glycogen [starch] synthase, muscle",27425,119,1.14 [0.96-1.36],0.1258102104037107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GZMA,Granzyme A,28265,122,1.11 [0.70-1.75],0.6617914466911641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GZMB,Granzyme B,27914,119,1.03 [0.81-1.31],0.8253490990325253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,GZMH,Granzyme H,27425,119,1.14 [0.95-1.37],0.173192830586667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,H2AP,Huntingtin-interacting protein M,23402,100,0.70 [0.41-1.17],0.1723856215534754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",23482,98,1.01 [0.75-1.36],0.9547025542122822
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",28105,120,1.10 [0.89-1.37],0.3819452568028578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HAO1,Hydroxyacid oxidase 1,28179,121,0.96 [0.84-1.08],0.4684149048281839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HARS1,"Histidine--tRNA ligase, cytoplasmic",27919,121,1.11 [0.90-1.36],0.3364480389047504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HAVCR1,Hepatitis A virus cellular receptor 1,28142,120,1.63 [1.31-2.03],1.4906871676787516e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HAVCR2,Hepatitis A virus cellular receptor 2,27919,121,1.45 [0.92-2.30],0.1117210961641144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HBEGF,Proheparin-binding EGF-like growth factor,28105,120,1.03 [0.83-1.28],0.7650595105412011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HBQ1,Hemoglobin subunit theta-1,28179,121,1.01 [0.79-1.31],0.9160883937414798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HBZ,Hemoglobin subunit zeta,24257,99,0.92 [0.77-1.10],0.3579370572251575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HCG22,Protein PBMUCL2,23482,98,0.91 [0.62-1.35],0.651106175547829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HCLS1,Hematopoietic lineage cell-specific protein,28265,122,1.32 [0.99-1.77],0.0570396453009867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HDAC8,Histone deacetylase 8,23569,96,1.07 [0.80-1.43],0.6504727725667985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HDAC9,Histone deacetylase 9,23483,97,1.20 [0.94-1.53],0.1503177953774513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HDDC2,5'-deoxynucleotidase HDDC2,24167,101,1.36 [0.92-2.02],0.1197141692428531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HDGF,Hepatoma-derived growth factor,28147,121,1.04 [0.88-1.24],0.6342258890174122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HDGFL2,Hepatoma-derived growth factor-related protein 2,24190,99,1.06 [0.79-1.42],0.7022354717080384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HEBP1,Heme-binding protein 1,27425,119,1.13 [0.87-1.48],0.3484367552592969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HEG1,Protein HEG homolog 1,23715,97,1.48 [0.74-2.97],0.2709319768116663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HEPACAM2,HEPACAM family member 2,24190,99,0.86 [0.54-1.35],0.5054209479281186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HEPH,Hephaestin,24257,99,1.09 [0.53-2.22],0.8197481455678031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HEXIM1,Protein HEXIM1,27914,119,1.07 [0.88-1.30],0.5021426685609987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HGF,Hepatocyte growth factor,28265,122,1.76 [1.16-2.68],0.0082823752020241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HGFAC,Hepatocyte growth factor activator,24053,98,0.74 [0.38-1.43],0.372096819353421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,27238,115,1.15 [0.93-1.40],0.1923392881612183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HHEX,Hematopoietically-expressed homeobox protein HHEX,24190,99,1.26 [0.99-1.60],0.0609098459986621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HIF1A,Hypoxia-inducible factor 1-alpha,23569,96,1.01 [0.77-1.35],0.9176483901487466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HIP1,Huntingtin-interacting protein 1,23482,98,1.20 [0.73-1.97],0.4836290703777348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HIP1R,Huntingtin-interacting protein 1-related protein,24153,99,1.42 [1.06-1.89],0.0176308789353073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HJV,Hemojuvelin,24223,100,1.29 [0.88-1.88],0.1878272514163277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HK2,Hexokinase-2,27425,119,0.97 [0.54-1.76],0.9244111298129666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",24223,100,2.01 [1.10-3.64],0.0223168838064754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",27825,118,1.38 [0.89-2.14],0.1513158981714353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",27914,119,2.38 [1.45-3.92],0.0006301036689372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HMBS,Porphobilinogen deaminase,28179,121,1.18 [0.82-1.71],0.3617137759918603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HMCN2,Hemicentin-2,23668,97,1.05 [0.75-1.47],0.7918234509220234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",23579,96,1.06 [0.73-1.55],0.7529941098142756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",23482,98,1.16 [0.78-1.72],0.4740592677184974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HMMR,Hyaluronan mediated motility receptor,23363,100,1.04 [0.70-1.54],0.8443645905891681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HMOX1,Heme oxygenase 1,27615,121,0.73 [0.52-1.03],0.075573983675025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HMOX2,Heme oxygenase 2,27266,115,1.36 [1.02-1.81],0.0377313781469409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HNF1A,Hepatocyte nuclear factor 1-alpha,23584,95,0.99 [0.76-1.30],0.9591393504555048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HNMT,Histamine N-methyltransferase,27604,119,1.41 [1.01-1.96],0.0418315270022271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,27326,118,1.17 [0.96-1.43],0.1127389200490541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24223,100,1.36 [0.99-1.87],0.0539540226001652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HPCAL1,Hippocalcin-like protein 1,28265,122,1.13 [0.91-1.41],0.2578577606725132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HPGDS,Hematopoietic prostaglandin D synthase,27238,115,1.22 [0.80-1.85],0.3532744844714276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HPSE,Heparanase,23939,100,1.04 [0.85-1.27],0.6836297438056824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HRAS,GTPase Hras,23778,95,0.98 [0.80-1.21],0.8490958607053996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,23579,96,1.02 [0.59-1.78],0.9323798337522214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HRG,Histidine-rich glycoprotein,24162,100,1.16 [0.64-2.07],0.6288706647110348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HS1BP3,HCLS1-binding protein 3,23579,96,1.08 [0.87-1.34],0.4834972675119792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,27803,121,1.69 [1.12-2.54],0.0124701751637914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,28179,121,1.80 [1.25-2.58],0.0014778298046393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,23569,96,0.91 [0.50-1.66],0.7640219750978977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HSBP1,Heat shock factor-binding protein 1,23579,96,1.17 [0.96-1.43],0.1285497006935093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,27914,119,0.95 [0.64-1.41],0.788282169763928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24190,99,0.77 [0.56-1.05],0.0936823489671632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HSD17B3,Testosterone 17-beta-dehydrogenase 3,23482,98,1.12 [0.78-1.63],0.5358331725964232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,23579,96,0.97 [0.65-1.45],0.8792104214741916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HSP90B1,Endoplasmin,27136,115,0.94 [0.72-1.23],0.6595809601489204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HSPA1A,Heat shock 70 kDa protein 1A,27995,121,1.29 [1.05-1.59],0.0145301194682233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HSPA2,Heat shock-related 70 kDa protein 2,24145,101,1.66 [1.20-2.30],0.0021858310161437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HSPB1,Heat shock protein beta-1,27463,121,1.19 [0.93-1.52],0.1722589186043562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HSPB6,Heat shock protein beta-6,28179,121,1.55 [1.06-2.27],0.0236112773083359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,27695,118,2.14 [1.25-3.67],0.0057093323485132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HTR1A,5-hydroxytryptamine receptor 1A,23483,97,1.13 [0.91-1.41],0.2696820443284594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HTR1B,5-hydroxytryptamine receptor 1B,23483,97,1.19 [0.78-1.82],0.4226425039223588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HTRA2,"Serine protease HTRA2, mitochondrial",27992,119,1.17 [0.91-1.51],0.2182227835475748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HYAL1,Hyaluronidase-1,27735,116,1.48 [0.74-2.94],0.2675662674144682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,HYOU1,Hypoxia up-regulated protein 1,28272,122,1.47 [0.71-3.02],0.2980196894516348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ICA1,Islet cell autoantigen 1,27408,119,1.24 [1.02-1.50],0.0317037542125382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ICAM1,Intercellular adhesion molecule 1,27792,119,1.27 [0.73-2.21],0.4009876149150019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ICAM2,Intercellular adhesion molecule 2,28272,122,1.51 [0.90-2.54],0.1146070553339372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ICAM3,Intercellular adhesion molecule 3,28272,122,1.17 [0.64-2.17],0.606515054929351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ICAM4,Intercellular adhesion molecule 4,27914,119,1.07 [0.78-1.45],0.6840725808646344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ICAM5,Intercellular adhesion molecule 5,27929,121,1.14 [0.80-1.62],0.4611477574339381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ICOSLG,ICOS ligand,27803,121,1.38 [0.60-3.20],0.4528103899480623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ID4,DNA-binding protein inhibitor ID-4,23811,95,1.03 [0.68-1.57],0.8818105948884516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IDI2,Isopentenyl-diphosphate delta-isomerase 2,27266,115,1.40 [1.04-1.90],0.0280942355483956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IDO1,"Indoleamine 2,3-dioxygenase 1",23579,96,0.91 [0.67-1.24],0.5610932518103913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IDS,Iduronate 2-sulfatase,28265,122,0.48 [0.15-1.56],0.2247038522620602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IDUA,Alpha-L-iduronidase,28179,121,1.02 [0.73-1.43],0.9165207490074376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,23596,98,1.82 [1.18-2.80],0.0066565535786164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,23811,95,0.91 [0.61-1.36],0.6507805312918303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,23811,95,1.54 [1.02-2.34],0.0411723890068305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IFNAR1,Interferon alpha/beta receptor 1,24167,101,1.38 [0.71-2.70],0.3458827888630591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IFNG,Interferon gamma,27408,119,1.03 [0.90-1.19],0.6423290333478571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IFNGR1,Interferon gamma receptor 1,28050,121,1.86 [0.94-3.66],0.0733547096168199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IFNGR2,Interferon gamma receptor 2,27738,120,1.12 [0.83-1.50],0.4663929551768846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IFNL1,Interferon lambda-1,27266,115,1.34 [0.96-1.87],0.0903941492809583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IFNL2,Interferon lambda-2,23483,97,1.02 [0.75-1.38],0.901632212584575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IFNLR1,Interferon lambda receptor 1,27914,119,0.93 [0.59-1.46],0.7498187064350341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IFNW1,Interferon omega-1,23482,98,0.88 [0.49-1.58],0.6760685005471317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IFT20,Intraflagellar transport protein 20 homolog,23584,95,0.86 [0.54-1.37],0.5151139098559216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IGBP1,Immunoglobulin-binding protein 1,24223,100,1.22 [0.90-1.64],0.1941116669150303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,23483,97,0.93 [0.61-1.42],0.7369949988901052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24251,100,0.64 [0.32-1.30],0.2193620786599615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IGF1R,Insulin-like growth factor 1 receptor,27803,121,1.65 [0.97-2.79],0.063949434961024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,23482,98,1.22 [0.85-1.76],0.2836985515628692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IGF2R,Cation-independent mannose-6-phosphate receptor,27919,121,1.30 [0.67-2.54],0.4400198569418476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IGFBP1,Insulin-like growth factor-binding protein 1,28225,122,0.97 [0.85-1.10],0.6019867944696364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IGFBP2,Insulin-like growth factor-binding protein 2,28219,121,1.43 [1.12-1.83],0.0046513657329766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IGFBP3,Insulin-like growth factor-binding protein 3,28004,119,1.21 [0.68-2.15],0.5138967975016185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IGFBP4,Insulin-like growth factor-binding protein 4,27563,117,2.08 [1.52-2.87],6.058878208504959e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IGFBP6,Insulin-like growth factor-binding protein 6,27795,119,1.86 [1.14-3.04],0.0127550741336672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IGFBP7,Insulin-like growth factor-binding protein 7,28272,122,1.45 [0.90-2.33],0.1239637142892876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IGFBPL1,Insulin-like growth factor-binding protein-like 1,27929,121,1.57 [1.01-2.44],0.0453049151340021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IGFL4,Insulin growth factor-like family member 4,23569,96,1.23 [1.03-1.47],0.0257980329123611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IGHMBP2,DNA-binding protein SMUBP-2,23482,98,1.20 [0.88-1.62],0.2514207097733537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IGLC2,Immunoglobulin lambda constant 2,24256,101,1.34 [0.75-2.41],0.3236846707175588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IGLON5,IgLON family member 5,23402,100,0.95 [0.76-1.19],0.6779489767281293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IGSF21,Immunoglobulin superfamily member 21,23579,96,0.77 [0.45-1.31],0.3283090021870303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IGSF3,Immunoglobulin superfamily member 3,27803,121,1.52 [1.07-2.16],0.019741124546241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IGSF8,Immunoglobulin superfamily member 8,27929,121,2.13 [1.31-3.44],0.0021574297207086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IGSF9,Protein turtle homolog A,24257,99,0.93 [0.74-1.17],0.531134194363603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IKBKG,NF-kappa-B essential modulator,27914,119,1.15 [0.96-1.38],0.1201753870430774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IKZF2,Zinc finger protein Helios,27238,115,0.90 [0.73-1.11],0.3216445912317673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL10,Interleukin-10,27408,119,1.28 [1.09-1.49],0.0019119326793993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL10RA,Interleukin-10 receptor subunit alpha,27408,119,1.05 [0.80-1.36],0.7422364705500069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL10RB,Interleukin-10 receptor subunit beta,28050,121,1.80 [1.11-2.93],0.0166028592312762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL11,Interleukin-11,27408,119,1.25 [1.01-1.53],0.0370077151247172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL12A_IL12B,Interleukin-12,27803,121,1.22 [0.99-1.50],0.0607866959747305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL12B,Interleukin-12 subunit beta,28265,122,1.19 [0.89-1.60],0.2481767423125889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL12RB1,Interleukin-12 receptor subunit beta-1,27408,119,1.46 [0.95-2.23],0.0836265750472469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL12RB2,Interleukin-12 receptor subunit beta-2,23569,96,0.75 [0.45-1.24],0.2608502065192711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL13,Interleukin-13,27408,119,1.02 [0.74-1.41],0.9122996619429526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL13RA1,Interleukin-13 receptor subunit alpha-1,27551,118,1.26 [0.61-2.59],0.5361388466773779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL13RA2,Interleukin-13 receptor subunit alpha-2,23483,97,1.30 [0.66-2.56],0.4478304033604726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL15,Interleukin-15,27914,119,1.25 [0.78-2.02],0.3560026383010931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL15RA,Interleukin-15 receptor subunit alpha,27408,119,1.81 [1.14-2.87],0.0116471234877008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL16,Pro-interleukin-16,28265,122,1.29 [0.93-1.80],0.1318911607653804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL17A,Interleukin-17A,27366,119,1.23 [0.90-1.69],0.1905066175094636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL17C,Interleukin-17C,27408,119,1.23 [0.99-1.53],0.0581731349989069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL17D,Interleukin-17D,27408,119,1.25 [0.83-1.88],0.276824237388029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL17F,Interleukin-17F,27408,119,0.95 [0.76-1.18],0.6236270245895941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL17RA,Interleukin-17 receptor A,27919,121,0.94 [0.66-1.33],0.7093581393766482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL17RB,Interleukin-17 receptor B,27550,119,1.07 [0.80-1.44],0.6368307135681992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL18,Interleukin-18,27807,121,1.34 [0.97-1.84],0.071707160318663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL18BP,Interleukin-18-binding protein,28004,119,1.86 [1.14-3.04],0.013077544523679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL18R1,Interleukin-18 receptor 1,28265,122,1.88 [1.20-2.95],0.006066461743841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL18RAP,Interleukin-18 receptor accessory protein,27559,119,0.98 [0.89-1.08],0.684814609258414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL19,Interleukin-19,27241,120,1.15 [0.92-1.43],0.2231122090569579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL1A,Interleukin-1 alpha,27408,119,1.22 [0.96-1.54],0.105638367253977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL1B,Interleukin-1 beta,27269,118,1.12 [0.86-1.46],0.3841848761184173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL1R1,Interleukin-1 receptor type 1,27869,121,1.38 [0.69-2.76],0.3599486453662459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL1R2,Interleukin-1 receptor type 2,27859,121,1.06 [0.48-2.36],0.8786456888310545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL1RAP,Interleukin-1 receptor accessory protein,27919,121,0.82 [0.56-1.20],0.3066340986034001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL1RL1,Interleukin-1 receptor-like 1,28173,122,1.18 [0.84-1.67],0.3380904530341238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL1RL2,Interleukin-1 receptor-like 2,27408,119,1.44 [0.95-2.17],0.0865845090865516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL1RN,Interleukin-1 receptor antagonist protein,27855,121,1.22 [0.95-1.58],0.1211772325111417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL2,Interleukin-2,27408,119,1.80 [1.07-3.03],0.0265696302808984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL20,Interleukin-20,27408,119,1.13 [0.84-1.51],0.4127679391149997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL20RA,Interleukin-20 receptor subunit alpha,27408,119,0.89 [0.60-1.31],0.5449060931206349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL20RB,Interleukin-20 receptor subunit beta,23569,96,1.07 [0.69-1.67],0.7633864479839932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL21R,Interleukin-21 receptor,23569,96,0.88 [0.59-1.31],0.5208536756571747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL22,Interleukin-22,24145,101,1.08 [0.82-1.42],0.5907402240853487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL22RA1,Interleukin-22 receptor subunit alpha-1,27408,119,1.27 [0.94-1.73],0.1210982257092136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL24,Interleukin-24,27408,119,0.91 [0.63-1.31],0.6097090061870545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL25,Interleukin-25,23318,99,0.51 [0.30-0.88],0.0157798527491653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL2RA,Interleukin-2 receptor subunit alpha,27748,120,1.16 [0.78-1.73],0.4598863435490298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL2RB,Interleukin-2 receptor subunit beta,27408,119,1.62 [1.23-2.14],0.0006053163999394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL2RG,Cytokine receptor common subunit gamma,24145,101,1.65 [1.28-2.13],0.0001194738850244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL3,Interleukin-3,23402,100,1.16 [0.83-1.62],0.4003643979677073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL31,Interleukin-31,23569,96,1.04 [0.75-1.45],0.8106601120835696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL31RA,Interleukin-31 receptor subunit alpha,23486,94,1.12 [0.69-1.83],0.6372183479207333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL32,Interleukin-32,27914,119,0.89 [0.61-1.30],0.561166171670879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL33,Interleukin-33,27408,119,1.27 [0.84-1.90],0.2573287103107468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL34,Interleukin-34,27216,115,1.17 [0.73-1.89],0.5116426410627051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL36A,Interleukin-36 alpha,23569,96,1.07 [0.79-1.46],0.6510661600004313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL36G,Interleukin-36 gamma,23492,95,1.39 [1.14-1.70],0.0010652065569938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL3RA,Interleukin-3 receptor subunit alpha,27408,119,1.90 [1.20-3.02],0.0064451842634417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL4,Interleukin-4,27408,119,1.07 [0.88-1.29],0.5067818631451146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL4R,Interleukin-4 receptor subunit alpha,27914,119,1.52 [0.99-2.33],0.0568929171553824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL5,Interleukin-5,27408,119,1.05 [0.94-1.17],0.4152322129801152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL5RA,Interleukin-5 receptor subunit alpha,27914,119,0.99 [0.74-1.33],0.944672089772864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL6,Interleukin-6,27803,121,1.20 [1.01-1.44],0.0431271118552437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL6R,Interleukin-6 receptor subunit alpha,27738,119,1.31 [0.82-2.11],0.2557841431845733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL6ST,Interleukin-6 receptor subunit beta,27929,121,2.52 [1.14-5.58],0.0224221131430503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL7,Interleukin-7,27914,119,1.06 [0.83-1.36],0.6148857184584613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL7R,Interleukin-7 receptor subunit alpha,27919,121,1.01 [0.74-1.37],0.9432045701691228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IL9,Interleukin-9,23811,95,0.90 [0.61-1.32],0.5963415956301623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,27227,115,1.18 [0.91-1.54],0.2093824011849261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IMMT,MICOS complex subunit MIC60,24145,101,1.02 [0.67-1.54],0.9360728303399014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IMPA1,Inositol monophosphatase 1,27738,120,1.11 [0.86-1.44],0.4120466401468119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IMPACT,Protein IMPACT,24190,99,1.26 [0.90-1.76],0.1766779600330114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IMPG1,Interphotoreceptor matrix proteoglycan 1,23483,97,1.18 [0.65-2.13],0.5900786973563317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ING1,Inhibitor of growth protein 1,27217,114,1.22 [0.90-1.66],0.2033198514869612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,INHBB,Inhibin beta B chain,23715,97,1.26 [0.87-1.83],0.2240872481530871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,INHBC,Inhibin beta C chain,27919,121,1.52 [1.01-2.27],0.0428111314604069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,INPP1,Inositol polyphosphate 1-phosphatase,27803,121,1.14 [0.86-1.52],0.3707070976599959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",23579,96,1.20 [0.87-1.67],0.2713684881583054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24223,100,0.96 [0.60-1.54],0.8623801240405322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",27803,121,1.12 [0.95-1.32],0.1703312284994066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,INSL3,Insulin-like 3,24190,99,0.78 [0.61-0.99],0.0437513741383214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,INSL4,Early placenta insulin-like peptide,24145,101,1.39 [1.17-1.66],0.000201788282781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,INSL5,Insulin-like peptide INSL5,24167,101,1.01 [0.83-1.23],0.9117402830028372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,INSR,Insulin receptor,23569,96,1.34 [0.42-4.29],0.6231513234006991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IPCEF1,Interactor protein for cytohesin exchange factors 1,27690,120,1.16 [0.96-1.39],0.115413279361691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IQGAP2,Ras GTPase-activating-like protein IQGAP2,27803,121,0.96 [0.72-1.29],0.796796409016807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",27425,119,1.16 [0.99-1.37],0.0674839546497605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IRAK1,Interleukin-1 receptor-associated kinase 1,27408,119,1.25 [1.01-1.56],0.0435312323331455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IRAK4,Interleukin-1 receptor-associated kinase 4,27914,119,1.10 [0.94-1.29],0.2316176559577539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,26858,111,1.04 [0.67-1.63],0.8532987970873216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ISM1,Isthmin-1,27914,119,0.93 [0.62-1.38],0.7117636270218832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ISM2,Isthmin-2,24251,100,1.25 [0.89-1.76],0.1963053133428646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IST1,IST1 homolog,23992,100,1.18 [0.97-1.44],0.0890848059797258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ITGA11,Integrin alpha-11,27914,119,0.49 [0.31-0.78],0.0023696300571311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ITGA2,Integrin alpha-2,23715,97,1.13 [0.64-2.00],0.6704432317272666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ITGA5,Integrin alpha-5,27919,121,1.17 [0.62-2.20],0.631007125476082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ITGA6,Integrin alpha-6,27914,119,1.03 [0.77-1.39],0.8195831668218123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ITGAL,Integrin alpha-L,23569,96,1.27 [0.81-2.00],0.3010879406355704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ITGAM,Integrin alpha-M,27919,121,0.71 [0.43-1.17],0.1769637425343392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ITGAV,Integrin alpha-V,28179,121,0.51 [0.20-1.30],0.1585067881546615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ITGAX,Integrin alpha-X,23811,95,0.98 [0.67-1.43],0.900787603030042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ITGB1,Integrin beta-1,27866,119,0.98 [0.46-2.07],0.9557590029549708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ITGB1BP1,Integrin beta-1-binding protein 1,27238,115,1.36 [0.93-2.00],0.1171376989321524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ITGB1BP2,Integrin beta-1-binding protein 2,27425,119,1.06 [0.91-1.22],0.4638300180936728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ITGB2,Integrin beta-2,27760,119,0.65 [0.37-1.15],0.1414259559552861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ITGB5,Integrin beta-5,27992,119,1.41 [0.96-2.08],0.0790432415723884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ITGB6,Integrin beta-6,27408,119,0.96 [0.56-1.65],0.8786722338836032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ITGB7,Integrin beta-7,28179,121,1.04 [0.74-1.48],0.804829360608876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ITGBL1,Integrin beta-like protein 1,24251,100,1.46 [0.90-2.36],0.1258120935186993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24294,101,1.96 [0.87-4.41],0.1026463472697864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,28004,119,1.59 [1.05-2.42],0.0299254876592227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24294,101,1.75 [1.02-3.02],0.0427573755706486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24145,101,1.21 [0.82-1.76],0.3353021560238897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ITM2A,Integral membrane protein 2A,27914,119,1.12 [0.85-1.47],0.417820181224476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ITPA,Inosine triphosphate pyrophosphatase,23482,98,0.89 [0.67-1.18],0.4142421006048903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",23579,96,0.69 [0.50-0.96],0.0273778805520161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",23483,97,1.00 [0.66-1.51],0.9868882849564564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",27266,115,1.12 [0.81-1.54],0.5062772842175554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,IZUMO1,Izumo sperm-egg fusion protein 1,23402,100,1.15 [0.82-1.61],0.4165827887890047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,JAM2,Junctional adhesion molecule B,28192,122,2.41 [1.36-4.26],0.0025146211801301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,JAM3,Junctional adhesion molecule C,23715,97,1.19 [0.83-1.70],0.3406840765239323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,JCHAIN,Immunoglobulin J chain,27408,119,1.03 [0.79-1.35],0.8189807814411931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,23402,100,1.09 [0.79-1.51],0.6087640247972186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,JPT2,Jupiter microtubule associated homolog 2,24167,101,1.17 [0.94-1.45],0.150657905130529
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,JUN,Transcription factor AP-1,27408,119,1.36 [1.10-1.69],0.0045213496635687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,27803,121,1.88 [1.28-2.76],0.0012194583062596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KAZN,Kazrin,24167,101,1.15 [0.96-1.38],0.1319223027242863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KCNC4,Potassium voltage-gated channel subfamily C member 4,23483,97,1.21 [0.90-1.63],0.2108892101132064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KCNH2,Potassium voltage-gated channel subfamily H member 2,23584,95,0.95 [0.72-1.25],0.7023579500989829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KCNIP4,Kv channel-interacting protein 4,27266,115,0.98 [0.70-1.36],0.8862149251367536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KCTD5,BTB/POZ domain-containing protein KCTD5,23724,98,1.41 [1.01-1.99],0.0455628946604707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KDM3A,Lysine-specific demethylase 3A,23569,96,0.94 [0.74-1.19],0.5949288026641391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KDR,Vascular endothelial growth factor receptor 2,27992,119,1.15 [0.61-2.16],0.6616353819591628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KEL,Kell blood group glycoprotein,27266,115,0.91 [0.57-1.44],0.6849240983455297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KHDC3L,KH domain-containing protein 3,23402,100,0.89 [0.64-1.23],0.4895043005070429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KHK,Ketohexokinase,23579,96,0.94 [0.70-1.27],0.6984289310292562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KIAA0319,Dyslexia-associated protein KIAA0319,24190,99,1.83 [1.13-2.98],0.0147073661675189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KIAA1549,UPF0606 protein KIAA1549,23811,95,1.20 [0.93-1.56],0.1584638068540068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KIAA1549L,UPF0606 protein KIAA1549L,23811,95,1.46 [0.77-2.76],0.2438312261622618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KIAA2013,Uncharacterized protein KIAA2013,24145,101,1.10 [0.82-1.48],0.5093384752168958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KIF1C,Kinesin-like protein KIF1C,23482,98,1.38 [0.93-2.04],0.1093813316969593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KIF20B,Kinesin-like protein KIF20B,23483,97,1.13 [0.89-1.42],0.3123315387414453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KIF22,Kinesin-like protein KIF22,23482,98,1.02 [0.87-1.20],0.8004507910615208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KIFBP,KIF-binding protein,27803,121,1.19 [0.98-1.45],0.0852001220300304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24145,101,1.04 [0.84-1.30],0.7208296004941164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,27238,115,1.01 [0.82-1.26],0.905332140625112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24167,101,0.99 [0.89-1.11],0.8701154566099547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,27238,115,0.97 [0.85-1.12],0.6905313305939056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,23402,100,0.90 [0.69-1.17],0.4206895461098106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KIRREL1,Kin of IRRE-like protein 1,23483,97,1.19 [0.92-1.53],0.1770569911387129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KIRREL2,Kin of IRRE-like protein 2,27266,115,0.91 [0.60-1.37],0.6494352676288327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KIT,Mast/stem cell growth factor receptor Kit,27970,119,0.58 [0.34-0.99],0.0448238589373884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KITLG,Kit ligand,27929,121,1.13 [0.74-1.73],0.5718198022540807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KLB,Beta-klotho,27266,115,1.22 [0.99-1.52],0.0680420204889424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KLF4,Krueppel-like factor 4,23483,97,0.88 [0.54-1.44],0.6111344271332397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KLHL41,Kelch-like protein 41,24223,100,1.11 [0.79-1.57],0.5461383919744438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KLK1,Kallikrein-1,27640,116,1.08 [0.95-1.22],0.2522042909249282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KLK10,Kallikrein-10,27904,119,2.01 [1.44-2.80],4.06562777152306e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KLK11,Kallikrein-11,27717,117,2.11 [1.42-3.14],0.0002349360374148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KLK12,Kallikrein-12,27238,115,1.11 [0.98-1.26],0.0889584558101352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KLK13,Kallikrein-13,27285,119,1.39 [0.97-2.00],0.0712649460735408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KLK14,Kallikrein-14,28179,121,1.39 [0.99-1.94],0.0553512486309251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KLK15,Kallikrein-15,24107,101,0.96 [0.65-1.42],0.8487476234816883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KLK3,Prostate-specific antigen,24251,100,0.93 [0.72-1.19],0.5534862672258305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KLK4,Kallikrein-4,28179,121,1.20 [0.94-1.53],0.1388959476017784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KLK6,Kallikrein-6,27953,119,1.43 [0.83-2.45],0.1948578286200414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KLK7,Kallikrein-7,23100,95,0.99 [0.60-1.63],0.9713752969052446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KLK8,Kallikrein-8,26975,115,1.42 [0.90-2.25],0.1325109644275294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KLKB1,Plasma kallikrein,23817,99,0.71 [0.34-1.48],0.3554317374215389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KLRB1,Killer cell lectin-like receptor subfamily B member 1,28265,122,1.18 [0.77-1.79],0.4515966010599914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,23483,97,1.10 [0.82-1.47],0.5109629818558679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KLRD1,Natural killer cells antigen CD94,28265,122,1.07 [0.76-1.50],0.7026963459308432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KLRF1,Killer cell lectin-like receptor subfamily F member 1,23569,96,1.13 [0.77-1.65],0.5333710071209595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KLRK1,NKG2-D type II integral membrane protein,24190,99,1.09 [0.71-1.68],0.6788802858285548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KRT14,"Keratin, type I cytoskeletal 14",26397,111,0.96 [0.53-1.75],0.8971360739315682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KRT17,"Keratin, type I cytoskeletal 17",23482,98,0.62 [0.36-1.07],0.0882717271531614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KRT18,"Keratin, type I cytoskeletal 18",27803,121,1.01 [0.84-1.23],0.8801300892772703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KRT19,"Keratin, type I cytoskeletal 19",27876,119,1.12 [0.88-1.42],0.3545907777940937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KRT5,"Keratin, type II cytoskeletal 5",27266,115,0.82 [0.58-1.16],0.260330620445919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KRT6C,"Keratin, type II cytoskeletal 6C",23482,98,0.96 [0.58-1.59],0.8833409015248821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KRT8,"Keratin, type II cytoskeletal 8",23483,97,1.01 [0.76-1.34],0.9400154681535968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KYAT1,Kynurenine--oxoglutarate transaminase 1,27876,121,1.08 [0.82-1.42],0.5800852318107386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,KYNU,Kynureninase,28265,122,1.04 [0.74-1.45],0.8275271663156085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,L1CAM,Neural cell adhesion molecule L1,27992,119,0.95 [0.55-1.66],0.8661758428625546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24257,99,1.13 [0.92-1.40],0.2405328917828036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LACRT,Extracellular glycoprotein lacritin,24102,101,1.29 [0.94-1.77],0.1209761392356894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LACTB2,Endoribonuclease LACTB2,27929,121,1.15 [0.91-1.45],0.2575401739308944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LAG3,Lymphocyte activation gene 3 protein,27803,121,1.51 [1.09-2.09],0.0135108158737725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,27905,121,1.40 [1.04-1.89],0.0280206946372485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,27738,120,1.07 [0.91-1.26],0.408477320144767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LAMA1,Laminin subunit alpha-1,23482,98,1.07 [0.77-1.49],0.6862605433286445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LAMA4,Laminin subunit alpha-4,28050,121,1.28 [0.81-2.02],0.2931984697426226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LAMB1,Laminin subunit beta-1,23579,96,1.63 [0.85-3.10],0.1395740427253379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LAMP1,Lysosome-associated membrane glycoprotein 1,23594,99,0.36 [0.16-0.82],0.015038168989433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LAMP2,Lysosome-associated membrane glycoprotein 2,27081,118,1.12 [0.48-2.60],0.7872619815988023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LAMP3,Lysosome-associated membrane glycoprotein 3,28217,122,1.14 [0.84-1.54],0.4011114739886895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LAMTOR5,Ragulator complex protein LAMTOR5,24145,101,0.82 [0.50-1.33],0.4166234956421772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LAP3,Cytosol aminopeptidase,27408,119,1.04 [0.75-1.45],0.8222164553538293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LARP1,La-related protein 1,24145,101,1.04 [0.78-1.39],0.7962820597642953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LAT,Linker for activation of T-cells family member 1,28265,122,1.08 [0.87-1.33],0.4789221472448952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LAT2,Linker for activation of T-cells family member 2,27803,121,1.09 [0.96-1.24],0.1756268081557138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LATS1,Serine/threonine-protein kinase LATS1,23569,96,1.19 [0.95-1.49],0.1237725455453461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LAYN,Layilin,27689,119,2.11 [1.36-3.26],0.000866799108286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LBP,Lipopolysaccharide-binding protein,28004,119,1.16 [0.88-1.52],0.2850495459476923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LBR,Delta(14)-sterol reductase LBR,28192,122,1.21 [0.99-1.47],0.0652714383475582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LCAT,Phosphatidylcholine-sterol acyltransferase,24282,100,1.20 [0.51-2.86],0.6731065402951957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LCN15,Lipocalin-15,24223,100,1.21 [0.94-1.55],0.1448177866650176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LCN2,Neutrophil gelatinase-associated lipocalin,27035,116,1.59 [1.08-2.36],0.0195372612243323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LCP1,Plastin-2,24251,100,1.10 [0.75-1.61],0.6407594361011176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LDLR,Low-density lipoprotein receptor,28007,122,1.21 [0.91-1.63],0.1949639691850594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24223,100,1.13 [0.93-1.37],0.2217412839515164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LECT2,Leukocyte cell-derived chemotaxin-2,24257,99,1.07 [0.80-1.42],0.6434454530926377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LEFTY2,Left-right determination factor 2,28142,121,1.02 [0.76-1.36],0.9044523469420632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LEG1,Protein LEG1 homolog,22874,95,1.05 [0.80-1.37],0.7196988899474981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LELP1,Late cornified envelope-like proline-rich protein 1,23483,97,1.10 [0.87-1.40],0.4091603759590435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LEO1,RNA polymerase-associated protein LEO1,24223,100,1.33 [0.82-2.17],0.2434178525935165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LEP,Leptin,27929,121,1.07 [0.85-1.36],0.5652587246069887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LEPR,Leptin receptor,27929,121,1.28 [0.78-2.09],0.3255425020821701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LETM1,Mitochondrial proton/calcium exchanger protein,24223,100,1.14 [0.81-1.59],0.4549801035991647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LGALS1,Galectin-1,27929,121,1.61 [1.04-2.50],0.032648183866463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LGALS3,Galectin-3,27999,121,1.26 [0.74-2.15],0.3986574011865574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LGALS3BP,Galectin-3-binding protein,24294,101,1.57 [0.94-2.63],0.083186354795329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LGALS4,Galectin-4,27905,121,1.64 [1.25-2.14],0.0003030378988985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LGALS7_LGALS7B,Galectin-7,27877,120,1.51 [1.09-2.10],0.0123109172255824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LGALS8,Galectin-8,28192,122,1.23 [0.96-1.58],0.0977621931728634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LGALS9,Galectin-9,27909,121,2.41 [1.53-3.78],0.0001379204740739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LGMN,Legumain,28050,121,1.58 [1.03-2.40],0.0349602747982596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LHB,Lutropin subunit beta,27238,115,0.93 [0.76-1.14],0.4751019620879383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,27953,121,1.18 [0.91-1.52],0.2194970500631475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LIF,Leukemia inhibitory factor,27266,115,1.02 [0.74-1.40],0.8905393656115497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LIFR,Leukemia inhibitory factor receptor,27914,119,1.73 [0.96-3.12],0.0687587187375198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,27919,121,0.92 [0.62-1.38],0.696753824212699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24251,100,0.94 [0.84-1.07],0.352236702940959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,23482,98,1.09 [0.77-1.56],0.6255999202963882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,27897,121,1.70 [1.05-2.76],0.0323351602434395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24257,99,1.28 [0.99-1.66],0.0599980801768376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,28272,122,0.96 [0.54-1.70],0.8932808454607922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,28120,121,0.93 [0.59-1.47],0.7596096654233896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,27408,119,1.38 [0.95-1.99],0.0882388638775944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,28272,122,0.98 [0.78-1.24],0.8881999867422389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LIPF,Gastric triacylglycerol lipase,23579,96,1.10 [0.81-1.50],0.5343134598829993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LMNB1,Lamin-B1,24117,100,1.11 [0.84-1.49],0.4574945190966301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LMNB2,Lamin-B2,24190,99,1.14 [0.58-2.25],0.7036783577386798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LMOD1,Leiomodin-1,24223,100,1.46 [0.97-2.19],0.0704460530347542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LMOD2,Leiomodin-2,23483,97,0.80 [0.56-1.14],0.2136103205715546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LONP1,"Lon protease homolog, mitochondrial",23579,96,1.17 [0.94-1.44],0.158985908313622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LPA,Apolipoprotein(a),23699,100,1.03 [0.93-1.15],0.5671053133853308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LPCAT2,Lysophosphatidylcholine acyltransferase 2,27803,121,1.22 [0.92-1.62],0.1761045463221411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LPL,Lipoprotein lipase,27929,121,0.91 [0.66-1.26],0.5683578715815449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LPO,Lactoperoxidase,27037,117,1.17 [0.90-1.51],0.2429848586897628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LPP,Lipoma-preferred partner,23482,98,1.10 [0.83-1.47],0.4959560441284965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,23482,98,1.26 [0.97-1.62],0.079932535458037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,23584,95,0.97 [0.64-1.47],0.8790298741395336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LRG1,Leucine-rich alpha-2-glycoprotein,24294,101,2.99 [1.68-5.31],0.000184089843099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,28105,120,1.54 [0.98-2.43],0.0625522013259668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,23486,96,1.53 [0.90-2.58],0.113033043968273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LRP1,Prolow-density lipoprotein receptor-related protein 1,27803,121,1.07 [0.59-1.95],0.8200499280331948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LRP11,Low-density lipoprotein receptor-related protein 11,27929,121,1.72 [1.12-2.65],0.0135207108761335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LRP2,Low-density lipoprotein receptor-related protein 2,23584,95,0.81 [0.45-1.45],0.4753364465215999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LRP2BP,LRP2-binding protein,23584,95,1.07 [0.85-1.33],0.566148110112369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,28192,122,1.15 [0.89-1.49],0.2813269720548546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LRRC25,Leucine-rich repeat-containing protein 25,27803,121,1.05 [0.70-1.58],0.815839329557797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24167,101,1.83 [1.17-2.84],0.0074571851058936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LRRC38,Leucine-rich repeat-containing protein 38,23584,95,0.76 [0.49-1.18],0.2202759129977188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LRRC59,Leucine-rich repeat-containing protein 59,24257,99,1.24 [0.86-1.80],0.2557155120095896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24145,101,1.30 [0.91-1.86],0.1458096277608866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LRRN1,Leucine-rich repeat neuronal protein 1,27408,119,0.81 [0.53-1.22],0.3055364196379526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,23584,95,0.86 [0.52-1.43],0.5624297376348291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24223,100,0.87 [0.42-1.83],0.7167278181216612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LSM1,U6 snRNA-associated Sm-like protein LSm1,27238,115,0.85 [0.61-1.19],0.3514457282296153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LSM8,U6 snRNA-associated Sm-like protein LSm8,23811,95,1.00 [0.80-1.25],0.9977023014164522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LSP1,Lymphocyte-specific protein 1,27914,119,1.48 [1.02-2.14],0.0398271295423538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LTA,Lymphotoxin-alpha,27914,119,0.98 [0.65-1.49],0.938705487560526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LTA4H,Leukotriene A-4 hydrolase,28179,121,1.03 [0.79-1.34],0.8465121795635785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LTB,Lymphotoxin-beta,24145,101,1.06 [0.62-1.81],0.8211123139138443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LTBP2,Latent-transforming growth factor beta-binding protein 2,28272,122,1.74 [1.06-2.83],0.0273375624593599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LTBP3,Latent-transforming growth factor beta-binding protein 3,27238,115,1.16 [0.89-1.51],0.2788453247099483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LTBR,Tumor necrosis factor receptor superfamily member 3,27752,121,1.49 [0.85-2.60],0.1601002450731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LTO1,Protein LTO1 homolog,27408,119,0.95 [0.63-1.43],0.8088966566660011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LUZP2,Leucine zipper protein 2,24145,101,1.53 [1.11-2.10],0.0089847986014219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LXN,Latexin,27597,119,1.02 [0.80-1.29],0.8892256739534357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LY6D,Lymphocyte antigen 6D,27757,121,1.59 [1.08-2.33],0.0190647585972732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LY75,Lymphocyte antigen 75,27914,119,1.26 [0.82-1.94],0.2859981114982068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LY9,T-lymphocyte surface antigen Ly-9,27642,121,1.38 [0.79-2.40],0.2522042157752236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LY96,Lymphocyte antigen 96,27738,120,1.46 [0.98-2.18],0.0598670153913868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LYAR,Cell growth-regulating nucleolar protein,27238,115,1.09 [0.83-1.44],0.5319347388615188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LYN,Tyrosine-protein kinase Lyn,27803,121,1.04 [0.86-1.25],0.7143820234218918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LYPD1,Ly6/PLAUR domain-containing protein 1,27266,115,0.98 [0.75-1.28],0.8718402283708757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LYPD3,Ly6/PLAUR domain-containing protein 3,27779,117,1.24 [0.78-1.96],0.3676574191878937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LYPD8,Ly6/PLAUR domain-containing protein 8,27238,115,0.96 [0.71-1.32],0.8164148657999164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LYPLA2,Acyl-protein thioesterase 2,23483,97,1.15 [0.99-1.34],0.061186770203445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,23584,95,1.04 [0.87-1.26],0.6529640091257902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24294,101,2.09 [0.80-5.41],0.1306101877497882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LYZL2,Lysozyme-like protein 2,23402,100,1.08 [0.65-1.80],0.7615044158109202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,LZTFL1,Leucine zipper transcription factor-like protein 1,23715,97,1.25 [0.96-1.62],0.0939038615505644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,M6PR,Cation-dependent mannose-6-phosphate receptor,23579,96,1.18 [0.77-1.80],0.4600208235598951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,27650,119,1.27 [0.98-1.64],0.0677464977734836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MAEA,E3 ubiquitin-protein transferase MAEA,27238,115,1.29 [0.91-1.84],0.1586097549722461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MAG,Myelin-associated glycoprotein,23584,95,1.24 [0.82-1.89],0.3130088117412578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MAGEA3,Melanoma-associated antigen 3,23811,95,0.97 [0.78-1.21],0.782312684361687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MAGED1,Melanoma-associated antigen D1,27238,115,1.29 [0.94-1.77],0.1186529331718714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MAMDC2,MAM domain-containing protein 2,24257,99,2.32 [1.43-3.74],0.0005960791889329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MAMDC4,Apical endosomal glycoprotein,24145,101,1.08 [0.77-1.49],0.6652551483781879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",23579,96,1.14 [0.54-2.42],0.7331135048971797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MAN2B2,Epididymis-specific alpha-mannosidase,24257,99,0.91 [0.66-1.25],0.5518741926130444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",23402,100,1.00 [0.69-1.46],0.9950112481926934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MANF,Mesencephalic astrocyte-derived neurotrophic factor,28050,121,1.07 [0.93-1.23],0.3191409136015711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MANSC1,MANSC domain-containing protein 1,27992,119,1.31 [0.73-2.33],0.362889579933585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MANSC4,MANSC domain-containing protein 4,23482,98,0.98 [0.72-1.34],0.9021565711463476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,23483,97,1.29 [0.72-2.33],0.3966487573249481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,23482,98,1.02 [0.77-1.37],0.8732207419284197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MAP2,Microtubule-associated protein 2,24190,99,1.45 [1.02-2.07],0.0389677227492993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24167,101,1.16 [0.87-1.54],0.311753997139012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,27914,119,1.03 [0.88-1.21],0.7326926249904445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,27238,115,1.06 [0.90-1.25],0.456246009359269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,27689,119,1.11 [0.96-1.28],0.1720870504633959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MAPK13,Mitogen-activated protein kinase 13,23402,100,0.95 [0.61-1.48],0.8320856291589047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MAPK9,Mitogen-activated protein kinase 9,27914,119,1.27 [0.89-1.83],0.1924878634036564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MAPKAPK2,MAP kinase-activated protein kinase 2,23811,95,1.10 [0.85-1.42],0.4719262068212292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MAPRE3,Microtubule-associated protein RP/EB family member 3,23402,100,1.03 [0.90-1.17],0.6641628428742327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MAPT,Microtubule-associated protein tau,27266,115,1.24 [0.89-1.73],0.2013835993323126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MARCO,Macrophage receptor MARCO,27929,121,0.93 [0.50-1.70],0.8018752800045497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MARS1,"Methionine--tRNA ligase, cytoplasmic",23663,97,1.12 [0.89-1.40],0.3249564983379373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MASP1,Mannan-binding lectin serine protease 1,27689,119,1.24 [0.63-2.44],0.5331614802791445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MATN2,Matrilin-2,27955,121,1.50 [0.89-2.53],0.1265609671905332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MATN3,Matrilin-3,27690,120,1.02 [0.62-1.66],0.9500839775887454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MAVS,Mitochondrial antiviral-signaling protein,27238,115,1.10 [0.92-1.31],0.3006196912096754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MAX,Protein max,27266,115,1.09 [0.94-1.28],0.2620075457299541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MB,Myoglobin,28272,122,1.14 [0.85-1.52],0.3766483926770826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MBL2,Mannose-binding protein C,23941,99,0.93 [0.78-1.11],0.4103396062501088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MCAM,Cell surface glycoprotein MUC18,28004,119,0.99 [0.61-1.60],0.9557042640508948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24223,100,0.75 [0.45-1.23],0.2510187596587781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MCEMP1,Mast cell-expressed membrane protein 1,23569,96,1.01 [0.82-1.25],0.9073077189229468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MCFD2,Multiple coagulation factor deficiency protein 2,27809,121,1.45 [1.03-2.04],0.0338433469926993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MCTS1,Malignant T-cell-amplified sequence 1,24167,101,1.72 [1.02-2.92],0.042570919299422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,27738,120,1.08 [0.86-1.35],0.5036032650353526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MDH1,"Malate dehydrogenase, cytoplasmic",24146,100,1.22 [0.78-1.89],0.3836260333912324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MDK,Midkine,27900,119,1.28 [0.97-1.70],0.0846051231603779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MDM1,Nuclear protein MDM1,23584,95,1.32 [0.72-2.41],0.3652353907136965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",23579,96,1.08 [0.88-1.33],0.4491218878210768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MED18,Mediator of RNA polymerase II transcription subunit 18,27238,115,1.13 [0.91-1.40],0.2784266246168343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MED21,Mediator of RNA polymerase II transcription subunit 21,23482,98,1.08 [0.75-1.55],0.6837984255589096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MEGF10,Multiple epidermal growth factor-like domains protein 10,27905,121,0.94 [0.63-1.39],0.7593980634729017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MEGF11,Multiple epidermal growth factor-like domains protein 11,23482,98,0.91 [0.48-1.71],0.7660723851993044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MEGF9,Multiple epidermal growth factor-like domains protein 9,28173,122,0.58 [0.27-1.27],0.1734253169458404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MELTF,Melanotransferrin,24257,99,1.46 [0.77-2.76],0.2519095650239867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MENT,Protein MENT,23715,97,1.67 [0.71-3.96],0.2424654771379803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MEP1A,Meprin A subunit alpha,24167,101,1.02 [0.79-1.32],0.8645473753990038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MEP1B,Meprin A subunit beta,27929,121,0.99 [0.86-1.13],0.8485373140350453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MEPE,Matrix extracellular phosphoglycoprotein,27905,121,0.99 [0.53-1.83],0.9625971074388094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MERTK,Tyrosine-protein kinase Mer,28265,122,2.89 [1.62-5.13],0.0003078103419371
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MESD,LRP chaperone MESD,27919,121,1.07 [0.94-1.22],0.3096187568378933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MET,Hepatocyte growth factor receptor,28008,119,1.39 [0.61-3.13],0.4317230399674051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,METAP1,Methionine aminopeptidase 1,27266,115,0.87 [0.49-1.53],0.6208697380615824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",27914,119,1.05 [0.87-1.27],0.6322816033531227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,METAP2,Methionine aminopeptidase 2,28142,121,1.17 [0.88-1.55],0.2900087218468403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MFAP3,Microfibril-associated glycoprotein 3,27425,119,0.88 [0.62-1.26],0.485637593327012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MFAP3L,Microfibrillar-associated protein 3-like,23584,95,0.77 [0.52-1.13],0.1836712921936957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MFAP4,Microfibril-associated glycoprotein 4,23715,97,1.95 [1.08-3.53],0.0266219161236825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MFAP5,Microfibrillar-associated protein 5,28272,122,1.45 [0.98-2.14],0.060321163151181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MFGE8,Lactadherin,27919,121,1.37 [0.97-1.92],0.0717283809638994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MGLL,Monoglyceride lipase,28007,121,1.19 [0.98-1.44],0.0727531476115442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MGMT,Methylated-DNA--protein-cysteine methyltransferase,27914,119,1.02 [0.90-1.17],0.7182547090767188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MIA,Melanoma-derived growth regulatory protein,27992,119,1.75 [1.17-2.62],0.0062422919166573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MICALL2,MICAL-like protein 2,23584,95,1.03 [0.78-1.37],0.8167684903223987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,27914,119,1.00 [0.90-1.11],0.9682664963032525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MIF,Macrophage migration inhibitory factor,27870,121,1.15 [0.90-1.46],0.2586445605968154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MILR1,Allergin-1,27408,119,1.05 [0.76-1.45],0.7865956390811164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24145,101,1.09 [0.91-1.30],0.3395974361670739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MINK1,Misshapen-like kinase 1,24190,99,1.19 [0.96-1.46],0.1090152993708674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MITD1,MIT domain-containing protein 1,27738,120,1.09 [0.92-1.29],0.2957052174003591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MKI67,Proliferation marker protein Ki-67,23569,96,1.72 [1.32-2.23],5.997684057741465e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MLLT1,Protein ENL,23402,100,0.97 [0.73-1.28],0.8231062621187902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MLN,Promotilin,27914,119,0.89 [0.75-1.06],0.2018343801157658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MME,Neprilysin,27803,121,1.07 [0.88-1.30],0.486045334193383
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MMP1,Interstitial collagenase,26942,119,1.03 [0.86-1.23],0.7216350327329721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MMP10,Stromelysin-2,27877,121,1.14 [0.87-1.47],0.3394418086854312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MMP12,Macrophage metalloelastase,27971,120,1.20 [0.88-1.63],0.2555971445205447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MMP13,Collagenase 3,27266,115,1.45 [0.86-2.43],0.1640128548020871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MMP15,Matrix metalloproteinase-15,24257,99,0.68 [0.39-1.19],0.1774013914650092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MMP3,Stromelysin-1,27919,121,1.16 [0.83-1.60],0.3845337919476559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MMP7,Matrilysin,27383,119,2.28 [1.61-3.24],3.3370007986690774e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MMP8,Neutrophil collagenase,28150,122,1.24 [1.01-1.52],0.0355878023738222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MMP9,Matrix metalloproteinase-9,27880,121,1.34 [1.03-1.73],0.0281268810453998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",23482,98,0.97 [0.65-1.43],0.867274947653352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MN1,Transcriptional activator MN1,23584,95,0.94 [0.66-1.33],0.7172798883944982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MNAT1,CDK-activating kinase assembly factor MAT1,23811,95,1.36 [0.96-1.92],0.0811434940139542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MNDA,Myeloid cell nuclear differentiation antigen,27891,121,1.13 [0.99-1.30],0.0781941168608682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MOCS2,Molybdopterin synthase catalytic subunit,23715,97,1.11 [0.84-1.47],0.471162334579675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MOG,Myelin-oligodendrocyte glycoprotein,28179,121,1.45 [0.90-2.36],0.1294625947473218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MORC3,MORC family CW-type zinc finger protein 3,24190,99,1.16 [0.62-2.18],0.638790625763139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MORF4L1,Mortality factor 4-like protein 1,23811,95,1.23 [0.82-1.84],0.3156264948777653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MORF4L2,Mortality factor 4-like protein 2,23402,100,1.35 [0.87-2.10],0.1799849524189272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MORN4,MORN repeat-containing protein 4,23402,100,0.85 [0.65-1.13],0.2712743703575608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MPHOSPH8,M-phase phosphoprotein 8,27425,119,1.05 [0.86-1.30],0.6196300992381772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MPI,Mannose-6-phosphate isomerase,27803,121,1.06 [0.88-1.27],0.533572633462323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,28007,121,1.16 [0.93-1.44],0.2012835786832438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MPO,Myeloperoxidase,27919,121,1.38 [1.02-1.87],0.0371820382641703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MPRIP,Myosin phosphatase Rho-interacting protein,24106,101,1.22 [0.82-1.81],0.3205488639216463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MRC1,Macrophage mannose receptor 1,24282,100,1.73 [0.90-3.30],0.0994795615816517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MRI1,Methylthioribose-1-phosphate isomerase,23584,95,1.00 [0.75-1.34],0.9991895587747728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MRPL24,"39S ribosomal protein L24, mitochondrial",23482,98,0.91 [0.54-1.54],0.7207291419979514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MRPL28,"39S ribosomal protein L28, mitochondrial",24223,100,1.20 [0.81-1.80],0.3653743252920557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MRPL46,"39S ribosomal protein L46, mitochondrial",27266,115,1.38 [0.81-2.35],0.2434217690900411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MRPL52,"39S ribosomal protein L52, mitochondrial",23363,100,0.99 [0.47-2.12],0.9889640688814884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24223,100,1.35 [1.11-1.64],0.0026229068909252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MRPS16,"28S ribosomal protein S16, mitochondrial",23569,96,1.32 [0.77-2.25],0.3134735806314406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MSLN,Mesothelin,27764,120,1.22 [0.92-1.62],0.1619810434841869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MSLNL,Mesothelin-like protein,23584,95,1.23 [0.75-2.01],0.4171429045673049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MSMB,Beta-microseminoprotein,27852,121,1.22 [0.96-1.55],0.1125656440193309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MSR1,Macrophage scavenger receptor types I and II,28192,122,1.26 [0.89-1.77],0.1868439039898302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MSRA,Mitochondrial peptide methionine sulfoxide reductase,27992,119,1.20 [0.96-1.49],0.1081164503390953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MST1,Hepatocyte growth factor-like protein,23921,97,1.28 [0.86-1.89],0.220889483838664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MSTN,Growth/differentiation factor 8,27425,119,0.93 [0.69-1.27],0.6573525660616732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MTDH,Protein LYRIC,23569,96,1.23 [1.00-1.51],0.0519080844327743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24190,99,1.60 [0.91-2.81],0.1059461709235324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,23811,95,1.22 [1.03-1.44],0.0217193303158813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MTIF3,"Translation initiation factor IF-3, mitochondrial",24167,101,1.11 [0.90-1.38],0.3118540823912006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MTPN,Myotrophin,27425,119,1.19 [0.77-1.84],0.4390410267983954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MTR,Methionine synthase,23482,98,1.05 [0.79-1.40],0.7221725557966137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MTSS1,Protein MTSS 1,24167,101,1.15 [0.97-1.36],0.1125635997060807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MTSS2,Protein MTSS 2,24145,101,1.29 [1.07-1.55],0.0071673285943459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MTUS1,Microtubule-associated tumor suppressor 1,23811,95,1.01 [0.72-1.43],0.9350022050676028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MUC13,Mucin-13,27266,115,1.25 [0.91-1.71],0.1731873161983879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MUC16,Mucin-16,27803,121,1.00 [0.91-1.08],0.9176658460162652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MUC2,Mucin-2,24251,100,0.94 [0.77-1.16],0.5825001677853376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MUCL3,Mucin-like protein 3,23402,100,1.19 [0.83-1.71],0.3426263160548999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MVK,Mevalonate kinase,27408,119,1.23 [1.01-1.48],0.0348913836061318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MXRA8,Matrix remodeling-associated protein 8,23715,97,0.66 [0.35-1.23],0.1897575500118414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MYBPC1,"Myosin-binding protein C, slow-type",24257,99,1.11 [0.86-1.44],0.4258205429934445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MYBPC2,"Myosin-binding protein C, fast-type",23579,96,1.09 [0.88-1.35],0.419775922022136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24223,100,1.32 [1.05-1.65],0.0160918375935855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MYDGF,Myeloid-derived growth factor,24257,99,1.07 [0.89-1.29],0.4634403833931388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MYH4,Myosin-4,23482,98,1.25 [0.90-1.74],0.1817395956293124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MYH7B,Myosin-7B,23402,100,0.91 [0.57-1.44],0.6770295481569634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MYH9,Myosin-9,24251,100,1.08 [0.92-1.28],0.3510746715225866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",23482,98,1.15 [0.76-1.72],0.510919080646306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MYL3,Myosin light chain 3,23579,96,1.05 [0.81-1.36],0.7098733539080839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MYL4,Myosin light chain 4,23579,96,1.06 [0.75-1.51],0.7413082552713581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MYL6B,Myosin light chain 6B,23584,95,1.10 [0.91-1.34],0.3153065444655087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",23584,95,1.23 [0.88-1.71],0.2238106575151252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MYO6,Unconventional myosin-VI,24223,100,1.56 [1.14-2.12],0.0048077081525449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MYO9B,Unconventional myosin-IXb,27408,119,1.27 [1.03-1.57],0.0274034800111335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MYOC,Myocilin,27919,121,1.60 [1.13-2.26],0.0081988314047551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MYOM1,Myomesin-1,23483,97,1.19 [0.84-1.69],0.3362998281945455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MYOM2,Myomesin-2,23482,98,1.02 [0.70-1.47],0.9269394506623004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MYOM3,Myomesin-3,23715,97,0.97 [0.79-1.19],0.7506723539113247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MZB1,Marginal zone B- and B1-cell-specific protein,27998,121,1.10 [0.81-1.51],0.5394130415339871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,MZT1,Mitotic-spindle organizing protein 1,27238,115,1.05 [0.77-1.42],0.7672213406732887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NAA10,N-alpha-acetyltransferase 10,23482,98,1.13 [0.78-1.64],0.5185773816631156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NAA80,N-alpha-acetyltransferase 80,23584,95,1.05 [0.89-1.23],0.5579174354430265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NAAA,N-acylethanolamine-hydrolyzing acid amidase,27601,119,1.01 [0.78-1.32],0.9371932473821808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NACC1,Nucleus accumbens-associated protein 1,24145,101,1.22 [0.89-1.66],0.2234787782386659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NADK,NAD kinase,27929,121,1.33 [1.05-1.67],0.0176956953740082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NAGA,Alpha-N-acetylgalactosaminidase,23533,94,1.01 [0.73-1.41],0.9351043499884988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NAGK,N-acetyl-D-glucosamine kinase,23535,96,1.04 [0.74-1.45],0.8309743897464806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,23715,97,0.85 [0.35-2.04],0.7175541061904385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NAMPT,Nicotinamide phosphoribosyltransferase,27238,115,1.13 [0.86-1.48],0.3806162651462674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NAP1L4,Nucleosome assembly protein 1-like 4,24128,101,1.29 [0.80-2.07],0.2913479118450944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NAPRT,Nicotinate phosphoribosyltransferase,24190,99,1.29 [0.75-2.20],0.359897731539193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24223,100,1.16 [0.77-1.75],0.4649730561573622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NBL1,Neuroblastoma suppressor of tumorigenicity 1,27992,119,2.06 [1.13-3.76],0.0176395918631787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NBN,Nibrin,27408,119,1.18 [0.92-1.51],0.1928694382796413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NCAM1,Neural cell adhesion molecule 1,28004,119,0.87 [0.51-1.48],0.5997184790522081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NCAM2,Neural cell adhesion molecule 2,27919,121,0.74 [0.41-1.34],0.3210465448947912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NCAN,Neurocan core protein,28192,122,0.97 [0.63-1.47],0.8759387353787247
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NCF2,Neutrophil cytosol factor 2,27862,119,1.20 [1.02-1.41],0.0304471584739407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NCK2,Cytoplasmic protein NCK2,28050,121,1.15 [0.99-1.33],0.0759710481553662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NCLN,Nicalin,27408,119,1.05 [0.78-1.41],0.7414848809695362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NCR1,Natural cytotoxicity triggering receptor 1,27876,119,1.16 [0.74-1.81],0.5189040319587487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24167,101,2.35 [1.43-3.86],0.0006965130869597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NCS1,Neuronal calcium sensor 1,28179,121,3.40 [1.98-5.83],8.679049390106132e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NDRG1,Protein NDRG1,27266,115,0.95 [0.74-1.22],0.6708903550710186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24145,101,0.77 [0.53-1.12],0.1761222809418339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,23520,96,1.57 [0.96-2.58],0.0750333462928487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24167,101,1.19 [0.97-1.46],0.1002847531419547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",27238,115,1.20 [1.02-1.40],0.028180827834294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NEB,Nebulin,23482,98,1.02 [0.61-1.72],0.9343532705351104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NECAP2,Adaptin ear-binding coat-associated protein 2,23482,98,1.11 [0.84-1.46],0.474798260264398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NECTIN1,Nectin-1,23569,96,1.47 [0.91-2.39],0.1144122851450243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NECTIN2,Nectin-2,27897,121,2.16 [1.31-3.58],0.0027126684752287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NECTIN4,Nectin-4,27992,119,1.62 [1.00-2.63],0.0519964996899354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,23569,96,1.26 [0.82-1.93],0.2841275360206556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NEDD9,Enhancer of filamentation 1,23569,96,1.48 [0.96-2.28],0.0723430606963001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NEFL,Neurofilament light polypeptide,27176,112,1.64 [1.22-2.20],0.0009216023820099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NEK7,Serine/threonine-protein kinase Nek7,23811,95,1.02 [0.79-1.32],0.8648880148732176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NELL1,Protein kinase C-binding protein NELL1,27992,119,0.93 [0.63-1.37],0.7028546673081204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NELL2,Protein kinase C-binding protein NELL2,28050,121,0.99 [0.56-1.73],0.9675393532689353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NENF,Neudesin,24145,101,1.04 [0.88-1.23],0.6429642954568824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NEO1,Neogenin,24223,100,1.47 [0.71-3.01],0.2983764988273086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NEXN,Nexilin,24282,100,1.19 [0.92-1.55],0.1831781354912696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NFASC,Neurofascin,28265,122,1.10 [0.63-1.92],0.7313523326470576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NFAT5,Nuclear factor of activated T-cells 5,23569,96,1.15 [0.93-1.42],0.1905847216491396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",27914,119,1.10 [0.94-1.30],0.2348461955938464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",27408,119,1.12 [0.86-1.46],0.3908934733463362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NFE2,Transcription factor NF-E2 45 kDa subunit,23579,96,1.11 [0.86-1.43],0.4331923893899249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NFIC,Nuclear factor 1 C-type,24223,100,1.01 [0.65-1.59],0.9483525555403304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NFKB1,Nuclear factor NF-kappa-B p105 subunit,23482,98,1.28 [1.00-1.65],0.0542368302572893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NFKB2,Nuclear factor NF-kappa-B p100 subunit,23811,95,1.18 [0.92-1.53],0.1974040506238528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NFKBIE,NF-kappa-B inhibitor epsilon,27238,115,1.50 [1.10-2.03],0.0093348465696783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24167,101,1.15 [0.96-1.37],0.1349863135699527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NFX1,Transcriptional repressor NF-X1,23482,98,1.18 [0.90-1.54],0.242738761902382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NFYA,Nuclear transcription factor Y subunit alpha,23482,98,1.21 [0.79-1.86],0.3784942410451565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NGF,Beta-nerve growth factor,27738,120,2.15 [0.67-6.87],0.198891004253711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NGFR,Tumor necrosis factor receptor superfamily member 16,24257,99,0.80 [0.40-1.60],0.5235266384318982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NGRN,Neugrin,24190,99,1.98 [1.02-3.87],0.044873128875187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NHLRC3,NHL repeat-containing protein 3,23168,96,1.37 [0.74-2.55],0.3193960250853818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NID1,Nidogen-1,27925,119,1.53 [1.01-2.30],0.0437243339232001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NID2,Nidogen-2,27919,121,1.14 [0.92-1.40],0.2356298709598932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NINJ1,Ninjurin-1,27238,115,1.31 [1.06-1.62],0.0131884754537926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NIT1,Deaminated glutathione amidase,23579,96,1.02 [0.67-1.56],0.9210501822187356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NIT2,Omega-amidase NIT2,24164,99,1.08 [0.84-1.39],0.5699115743297027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NLGN1,Neuroligin-1,23584,95,1.14 [0.90-1.46],0.2774948100137178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NLGN2,Neuroligin-2,23483,97,1.03 [0.68-1.55],0.8986854337357746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NME1,Nucleoside diphosphate kinase A,23569,96,2.78 [1.37-5.65],0.0048066000353829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NME3,Nucleoside diphosphate kinase 3,27955,121,0.76 [0.37-1.55],0.450571855162042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NMI,N-myc-interactor,24042,100,1.32 [1.04-1.67],0.0238000791299942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,27738,120,1.16 [0.96-1.40],0.1218766526761539
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NMRK2,Nicotinamide riboside kinase 2,23402,100,1.14 [0.75-1.72],0.5463498959673403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24223,100,1.15 [0.89-1.49],0.2815461763222544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NOMO1,Nodal modulator 1,27919,121,1.31 [0.69-2.50],0.414193157725445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NOP56,Nucleolar protein 56,23482,98,1.04 [0.88-1.23],0.6334580127085003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NOS1,"Nitric oxide synthase, brain",27266,115,1.18 [0.88-1.57],0.2754327585286856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NOS2,"Nitric oxide synthase, inducible",23482,98,0.90 [0.54-1.51],0.6969964889714495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NOS3,"Nitric oxide synthase, endothelial",27266,115,1.52 [1.21-1.91],0.0003356776243742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NOTCH1,Neurogenic locus notch homolog protein 1,28272,122,1.60 [0.59-4.36],0.3593942546799211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NOTCH2,Neurogenic locus notch homolog protein 2,24251,100,0.84 [0.39-1.83],0.6660534236082538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NOTCH3,Neurogenic locus notch homolog protein 3,28272,122,1.08 [0.68-1.69],0.7528336937951313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NPC2,NPC intracellular cholesterol transporter 2,23853,99,1.50 [0.87-2.59],0.1462952142658033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NPDC1,Neural proliferation differentiation and control protein 1,27929,121,1.98 [1.29-3.04],0.0018519307971768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NPHS1,Nephrin,23569,96,0.97 [0.55-1.73],0.925023307581268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NPHS2,Podocin,23569,96,0.84 [0.68-1.05],0.1341504115363943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NPL,N-acetylneuraminate lyase,24257,99,1.13 [0.74-1.71],0.5749253529845355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NPPB,Natriuretic peptides B,27425,119,1.19 [1.04-1.37],0.0120824877396424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NPPC,C-type natriuretic peptide,27914,119,1.45 [1.07-1.97],0.0176314401235717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NPR1,Atrial natriuretic peptide receptor 1,23482,98,1.00 [0.62-1.63],0.9944405112068034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NPTN,Neuroplastin,27238,115,0.99 [0.81-1.21],0.9069416577077308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NPTX1,Neuronal pentraxin-1,27919,121,1.15 [0.78-1.68],0.4879351851470609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NPTX2,Neuronal pentraxin-2,24251,100,0.94 [0.54-1.65],0.8292603347802161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NPTXR,Neuronal pentraxin receptor,27929,121,1.07 [0.69-1.67],0.752070744969757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NPY,Pro-neuropeptide Y,28179,121,1.48 [1.16-1.91],0.0020014326648391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NRCAM,Neuronal cell adhesion molecule,27929,121,1.63 [0.95-2.79],0.0780597322096829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NRGN,Neurogranin,24282,100,1.14 [0.93-1.40],0.2223448748830892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NRN1,Neuritin,24223,100,0.81 [0.44-1.50],0.512079921243479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NRP1,Neuropilin-1,28060,119,1.70 [0.97-2.99],0.065617784229658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NRP2,Neuropilin-2,27919,121,1.42 [0.84-2.40],0.1895571562818492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NRTN,Neurturin,27408,119,1.19 [0.89-1.58],0.2332277691106907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NRXN3,Neurexin-3,23584,95,1.14 [0.68-1.94],0.6140891003066107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NSFL1C,NSFL1 cofactor p47,28192,122,1.21 [0.95-1.53],0.121691832762662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24257,99,1.06 [0.82-1.37],0.6463840854443392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NT5C1A,Cytosolic 5'-nucleotidase 1A,24190,99,1.67 [1.13-2.45],0.0095195888430514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NT5C3A,Cytosolic 5'-nucleotidase 3A,27867,119,1.10 [0.91-1.32],0.3171156571165538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NT5E,5'-nucleotidase,27992,119,1.08 [0.82-1.44],0.5812961746348704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NTF3,Neurotrophin-3,27914,119,1.71 [1.15-2.53],0.0080837334249321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NTF4,Neurotrophin-4,27238,115,1.21 [0.87-1.68],0.2568531626788671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NTRK2,BDNF/NT-3 growth factors receptor,27929,121,1.38 [0.74-2.56],0.3115536813635474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NTRK3,NT-3 growth factor receptor,28192,122,0.60 [0.29-1.22],0.1603041568302693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NTproBNP,N-terminal prohormone of brain natriuretic peptide,27929,121,1.41 [1.22-1.64],5.771066430148543e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NUB1,NEDD8 ultimate buster 1,27914,119,1.14 [0.94-1.37],0.1748242996382233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24145,101,1.03 [0.85-1.24],0.7942053058165983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NUCB2,Nucleobindin-2,28141,121,1.93 [1.31-2.84],0.0008460348697779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NUDC,Nuclear migration protein nudC,28265,122,1.22 [0.94-1.57],0.1299271893049324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,23579,96,0.78 [0.33-1.84],0.5733953887768803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,23482,98,1.01 [0.70-1.48],0.9438918534083524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NUDT16,U8 snoRNA-decapping enzyme,24130,101,1.15 [0.93-1.41],0.1955143878928453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],27803,121,1.04 [0.79-1.37],0.7804905459669836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NUDT5,ADP-sugar pyrophosphatase,27919,121,1.26 [0.93-1.70],0.1292777814622379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NUMB,Protein numb homolog,23569,96,1.23 [0.98-1.56],0.0780346696831295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NUP50,Nuclear pore complex protein Nup50,23482,98,0.99 [0.55-1.77],0.9604503128425748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NXPE4,NXPE family member 4,23482,98,0.86 [0.47-1.58],0.6278342401345849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NXPH1,Neurexophilin-1,27266,115,1.40 [0.98-2.00],0.0662122550177733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,NXPH3,Neurexophilin-3,23569,96,0.84 [0.44-1.60],0.5890072887481641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,OBP2B,Odorant-binding protein 2b,27640,120,1.07 [0.84-1.38],0.5794458054641991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,OCLN,Occludin,24223,100,1.36 [0.91-2.06],0.1377362123363329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ODAM,Odontogenic ameloblast-associated protein,27216,115,0.82 [0.58-1.15],0.2467714875009113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,OFD1,Oral-facial-digital syndrome 1 protein,23811,95,1.07 [0.81-1.40],0.639329573667667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,OGA,Protein O-GlcNAcase,24167,101,1.27 [0.98-1.65],0.0697152510550603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,OGFR,Opioid growth factor receptor,27803,121,1.76 [1.12-2.78],0.0151864079703616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,OGN,Mimecan,27919,121,2.02 [1.39-2.92],0.0002130376054248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,23811,95,1.01 [0.74-1.38],0.9463813172142386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,OLFM4,Olfactomedin-4,22837,91,1.00 [0.85-1.18],0.9951134215885736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,OLR1,Oxidized low-density lipoprotein receptor 1,27661,120,1.38 [1.10-1.73],0.0053208422584065
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,OMD,Osteomodulin,28050,121,1.31 [0.91-1.89],0.1521890486221702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,OMG,Oligodendrocyte-myelin glycoprotein,27803,121,0.83 [0.65-1.06],0.1320488433887067
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,OMP,Olfactory marker protein,23483,97,1.16 [0.81-1.66],0.4158842603159884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,OPHN1,Oligophrenin-1,24190,99,1.10 [0.92-1.31],0.304407583736936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,OPLAH,5-oxoprolinase,23579,96,1.23 [0.94-1.62],0.1299648636153313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,OPTC,Opticin,27803,121,1.34 [1.00-1.80],0.0520822564852728
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ORM1,Alpha-1-acid glycoprotein 1,24210,99,2.00 [0.80-5.02],0.1381760891504894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,OSBPL2,Oxysterol-binding protein-related protein 2,24190,99,1.11 [0.71-1.74],0.6380500629746467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,OSCAR,Osteoclast-associated immunoglobulin-like receptor,27955,121,1.33 [0.83-2.15],0.240334166099484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,OSM,Oncostatin-M,27774,119,1.32 [1.06-1.65],0.0116813713320357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,OSMR,Oncostatin-M-specific receptor subunit beta,28060,119,2.28 [1.06-4.91],0.0350968450641456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,OSTN,Osteocrin,23584,95,1.20 [0.84-1.71],0.3119333251755362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,OTOA,Otoancorin,23483,97,0.99 [0.68-1.43],0.947635800998889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,OTUD6B,Deubiquitinase OTUD6B,24167,101,1.18 [0.86-1.61],0.309304177511796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,OTUD7B,OTU domain-containing protein 7B,24223,100,1.21 [0.91-1.62],0.1822663053530485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",23579,96,1.18 [0.90-1.54],0.2226130195954165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,OXT,Oxytocin-neurophysin 1,28192,122,1.02 [0.91-1.14],0.7470643280256645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,P4HB,Protein disulfide-isomerase,27771,119,1.38 [0.92-2.06],0.1172327609195082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PACS2,Phosphofurin acidic cluster sorting protein 2,23482,98,1.19 [0.88-1.61],0.2484949531059108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PADI2,Protein-arginine deiminase type-2,27408,119,1.10 [0.86-1.43],0.4434555204896648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PADI4,Protein-arginine deiminase type-4,27216,115,1.00 [0.81-1.25],0.9700940016753734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PAEP,Glycodelin,27738,120,1.01 [0.90-1.13],0.9055008244238664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24223,100,1.07 [0.92-1.25],0.361764611276379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",23811,95,1.26 [0.87-1.82],0.223960196184294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,27425,119,1.36 [1.05-1.77],0.020362750577278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PAGR1,PAXIP1-associated glutamate-rich protein 1,23579,96,1.05 [0.68-1.61],0.8381713033471082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23355,99,1.27 [0.92-1.76],0.1451471158619355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PAK4,Serine/threonine-protein kinase PAK 4,27266,115,1.09 [0.84-1.41],0.5081022830835196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PALLD,Palladin,23569,96,1.45 [1.03-2.03],0.032595810507127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PALM,Paralemmin-1,24040,100,1.43 [0.77-2.65],0.2590569294773579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PALM2,Paralemmin-2,24190,99,1.58 [1.03-2.43],0.0364071569003964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PALM3,Paralemmin-3,23482,98,1.16 [0.94-1.43],0.1636036013802309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PAM,Peptidyl-glycine alpha-amidating monooxygenase,28132,120,1.55 [0.84-2.87],0.1601813815299684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PAMR1,Inactive serine protease PAMR1,27919,121,1.41 [0.79-2.49],0.2447689728137781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PAPPA,Pappalysin-1,27408,119,1.13 [0.80-1.58],0.4950000752621204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PARD3,Partitioning defective 3 homolog,23811,95,1.09 [0.85-1.40],0.5017962330444976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PARK7,Parkinson disease protein 7,27919,121,1.19 [0.88-1.60],0.2559585001339965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PARP1,Poly [ADP-ribose] polymerase 1,27914,119,1.08 [0.84-1.40],0.546475803256336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PAXX,Protein PAXX,23715,97,1.38 [0.94-2.02],0.1013142757004798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PBK,Lymphokine-activated killer T-cell-originated protein kinase,23402,100,0.95 [0.51-1.77],0.8683285267697913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PBLD,Phenazine biosynthesis-like domain-containing protein,27266,115,0.86 [0.62-1.18],0.3426381078557663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24167,101,1.52 [0.95-2.46],0.0831883249454289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PCARE,Photoreceptor cilium actin regulator,23483,97,0.78 [0.57-1.05],0.0980677208937263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,23663,97,1.04 [0.70-1.53],0.852040568119091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PCBP2,Poly(rC)-binding protein 2,24223,100,1.23 [0.95-1.60],0.111153188099917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PCDH1,Protocadherin-1,28178,122,1.10 [0.52-2.29],0.8077744506466333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PCDH12,Protocadherin-12,24223,100,0.90 [0.43-1.91],0.7857158286570964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PCDH17,Protocadherin-17,27929,121,1.18 [0.76-1.85],0.4604560191562996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PCDH7,Protocadherin-7,24167,101,1.54 [1.04-2.30],0.0330849479543651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PCDH9,Protocadherin-9,24167,101,1.10 [0.63-1.91],0.745040105427039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PCDHB15,Protocadherin beta-15,24145,101,1.21 [0.78-1.88],0.3979633250430699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PCNA,Proliferating cell nuclear antigen,23402,100,0.98 [0.73-1.32],0.9101352480207014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PCSK7,Proprotein convertase subtilisin/kexin type 7,24145,101,1.06 [0.71-1.60],0.7629629870418642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PCSK9,Proprotein convertase subtilisin/kexin type 9,28272,122,1.16 [0.78-1.72],0.4683651730257483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24167,101,1.21 [0.95-1.55],0.1239414324342871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24257,99,1.07 [0.89-1.30],0.4643542193315083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PDCD1,Programmed cell death protein 1,28136,120,1.78 [1.27-2.49],0.0008200032016225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PDCD1LG2,Programmed cell death 1 ligand 2,27803,121,1.41 [0.86-2.33],0.1744390594616243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PDCD5,Programmed cell death protein 5,28192,122,1.25 [0.96-1.63],0.0930233313015627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PDCD6,Programmed cell death protein 6,27929,121,0.99 [0.79-1.25],0.9577756829667904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PDCL2,Phosducin-like protein 2,23402,100,0.84 [0.56-1.27],0.4167068094784595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",23402,100,1.01 [0.72-1.42],0.9596414018308596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",23482,98,1.18 [0.91-1.54],0.2067072391000286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",23715,97,1.12 [0.93-1.36],0.2303016464643221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PDGFA,Platelet-derived growth factor subunit A,28272,122,1.05 [0.85-1.31],0.6357962091138871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PDGFB,Platelet-derived growth factor subunit B,28050,121,1.09 [0.91-1.32],0.3403389927207678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PDGFC,Platelet-derived growth factor C,27238,115,0.96 [0.54-1.69],0.8767982614264875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PDGFRA,Platelet-derived growth factor receptor alpha,27929,121,2.19 [1.31-3.68],0.0029864556087568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PDGFRB,Platelet-derived growth factor receptor beta,28272,122,0.78 [0.50-1.21],0.2698894439175577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PDIA2,Protein disulfide-isomerase A2,23402,100,0.81 [0.47-1.38],0.4338819872246746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PDIA3,Protein disulfide-isomerase A3,23715,97,1.59 [0.97-2.61],0.0640725581926913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PDIA4,Protein disulfide-isomerase A4,24251,100,1.15 [0.86-1.55],0.3500257286187648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PDIA5,Protein disulfide-isomerase A5,23402,100,0.99 [0.72-1.35],0.93710540800473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PDLIM5,PDZ and LIM domain protein 5,24223,100,1.12 [0.95-1.32],0.1663001080411995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PDLIM7,PDZ and LIM domain protein 7,28050,121,1.12 [0.99-1.27],0.0746319558194006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",27238,115,1.07 [0.78-1.45],0.6832340370434391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PDRG1,p53 and DNA damage-regulated protein 1,23584,95,0.93 [0.63-1.38],0.7117782959349124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,23402,100,0.96 [0.69-1.35],0.8252675763373524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PDZD2,PDZ domain-containing protein 2,23482,98,1.15 [0.86-1.54],0.3434679885974075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,23569,96,1.07 [0.70-1.64],0.7420845484719467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PEAR1,Platelet endothelial aggregation receptor 1,28272,122,1.73 [0.86-3.47],0.1261329369827504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PEBP1,Phosphatidylethanolamine-binding protein 1,27919,121,1.16 [0.89-1.52],0.2685831504517927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PECAM1,Platelet endothelial cell adhesion molecule,27919,121,1.52 [0.92-2.51],0.1024998493525732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PECR,Peroxisomal trans-2-enoyl-CoA reductase,23579,96,1.37 [0.76-2.47],0.2940708078920048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PENK,Proenkephalin-A,23715,97,1.21 [0.64-2.26],0.5603190015003034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PEPD,Xaa-Pro dipeptidase,24282,100,0.46 [0.23-0.93],0.0311178877556983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PER3,Period circadian protein homolog 3,23569,96,1.15 [0.98-1.35],0.0850691677834129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PF4,Platelet factor 4,24116,101,0.95 [0.79-1.16],0.6352213756344857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PFDN2,Prefoldin subunit 2,27266,115,0.94 [0.69-1.27],0.6751635703156534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PFDN4,Prefoldin subunit 4,23402,100,1.23 [0.93-1.63],0.1485983461939991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PFDN6,Prefoldin subunit 6,23584,95,1.15 [0.89-1.48],0.2790701788846711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",27763,120,1.10 [0.89-1.36],0.3640553217613045
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PGA4,Pepsin A-4,24282,100,1.39 [1.04-1.86],0.0268714266129104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24257,99,1.05 [0.74-1.48],0.796711086922202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PGF,Placenta growth factor,28265,122,2.15 [1.59-2.91],5.774375806415392e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PGLYRP1,Peptidoglycan recognition protein 1,28120,121,1.26 [0.88-1.80],0.2021940923386871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,23976,100,0.62 [0.34-1.13],0.1196482451064578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PGLYRP4,Peptidoglycan recognition protein 4,23482,98,0.92 [0.66-1.29],0.639377696842282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PGM2,Phosphoglucomutase-2,23584,95,0.98 [0.70-1.37],0.9108619054436048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PGR,Progesterone receptor,23569,96,0.99 [0.81-1.20],0.9104006299138454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PHACTR2,Phosphatase and actin regulator 2,24223,100,1.12 [0.95-1.32],0.176550438861142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PHLDB1,Pleckstrin homology-like domain family B member 1,24167,101,1.43 [1.03-1.98],0.0349688727198966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PHLDB2,Pleckstrin homology-like domain family B member 2,23402,100,0.88 [0.70-1.12],0.2965677314373639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,27738,120,1.79 [1.03-3.11],0.03969573777208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,23715,97,0.75 [0.48-1.18],0.2139791494105877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PI16,Peptidase inhibitor 16,24282,100,0.57 [0.26-1.22],0.14683138860102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PI3,Elafin,27537,117,1.40 [1.07-1.83],0.0138248144823013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24223,100,1.18 [0.93-1.49],0.178305828692303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PIGR,Polymeric immunoglobulin receptor,27560,120,1.76 [1.18-2.62],0.0054539497648999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,27914,119,1.34 [1.05-1.72],0.0183783622628666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,27919,121,2.38 [1.39-4.05],0.0015196953989498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,23569,96,1.28 [0.97-1.70],0.0843719339957128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PILRA,Paired immunoglobulin-like type 2 receptor alpha,27919,121,1.23 [0.84-1.82],0.2876466008875249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PILRB,Paired immunoglobulin-like type 2 receptor beta,27929,121,1.15 [0.86-1.54],0.3304072798034396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,23715,97,0.88 [0.67-1.17],0.3836107294914104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PITHD1,PITH domain-containing protein 1,23355,99,0.99 [0.78-1.27],0.9614529973160512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PKD1,Polycystin-1,24257,99,1.49 [0.72-3.08],0.2783364573972358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PKD2,Polycystin-2,23482,98,1.19 [0.89-1.61],0.2478021208673604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PKLR,Pyruvate kinase PKLR,27952,121,1.20 [0.96-1.51],0.1123545275526625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PKN3,Serine/threonine-protein kinase N3,23811,95,1.00 [0.77-1.29],0.9836726490068326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PLA2G10,Group 10 secretory phospholipase A2,27738,120,1.44 [1.11-1.88],0.0068104403594878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PLA2G15,Phospholipase A2 group XV,27992,119,1.64 [0.92-2.95],0.0957891172479573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PLA2G1B,Phospholipase A2,28220,120,1.36 [0.94-1.98],0.1066545833985277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PLA2G2A,"Phospholipase A2, membrane associated",27872,122,1.16 [0.90-1.49],0.2449845397045444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PLA2G4A,Cytosolic phospholipase A2,28050,121,1.14 [0.95-1.37],0.1455434049428096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PLA2G7,Platelet-activating factor acetylhydrolase,27919,121,0.63 [0.41-0.97],0.0364449279833736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PLAT,Tissue-type plasminogen activator,28173,122,1.13 [0.83-1.53],0.4544710290702415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PLAU,Urokinase-type plasminogen activator,27919,121,1.21 [0.76-1.92],0.4316030210895984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PLAUR,Urokinase plasminogen activator surface receptor,27717,121,2.52 [1.46-4.34],0.0008921294727363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PLB1,"Phospholipase B1, membrane-associated",24190,99,0.85 [0.62-1.16],0.2983617612167412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",23569,96,1.26 [0.89-1.78],0.1945729164441028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24190,99,1.10 [0.91-1.34],0.3383779718542946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24190,99,1.27 [0.98-1.65],0.076317116561852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PLG,Plasminogen,23663,99,1.51 [0.69-3.30],0.2980612451113894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PLIN1,Perilipin-1,27266,115,1.18 [0.76-1.84],0.4586824543073343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PLIN3,Perilipin-3,27929,121,1.47 [1.04-2.06],0.0274989397661797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PLPBP,Pyridoxal phosphate homeostasis protein,27929,121,1.21 [0.96-1.53],0.0987555247708847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PLSCR3,Phospholipid scramblase 3,24150,99,1.27 [0.93-1.74],0.1266213219451456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PLTP,Phospholipid transfer protein,28170,120,1.01 [0.65-1.55],0.9805523453015956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PLXDC1,Plexin domain-containing protein 1,27238,115,0.88 [0.53-1.48],0.6383429134674967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PLXDC2,Plexin domain-containing protein 2,24190,99,0.82 [0.40-1.68],0.5892825436414506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PLXNA4,Plexin-A4,27914,119,1.07 [0.87-1.30],0.5290063932686595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PLXNB2,Plexin-B2,28140,122,1.60 [0.84-3.02],0.150470427540561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PLXNB3,Plexin-B3,27827,120,1.24 [0.90-1.72],0.183957393972352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,27817,121,1.03 [0.95-1.12],0.4785926563036338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PMCH,Pro-MCH,23482,98,1.11 [0.92-1.36],0.2822259014004099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PMM2,Phosphomannomutase 2,23482,98,1.18 [0.86-1.61],0.3030818055399537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PMS1,PMS1 protein homolog 1,23584,95,1.08 [0.74-1.58],0.6809925685682385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PMVK,Phosphomevalonate kinase,27225,115,1.10 [0.94-1.29],0.22753762226684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PNLIP,Pancreatic triacylglycerol lipase,24282,100,1.13 [0.84-1.53],0.4076346291317272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24190,99,1.23 [0.97-1.56],0.0937201479955092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PNLIPRP2,Pancreatic lipase-related protein 2,27905,121,1.06 [1.00-1.12],0.0705208630576166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PNMA1,Paraneoplastic antigen Ma1,23579,96,0.97 [0.69-1.37],0.8823987099593895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PNMA2,Paraneoplastic antigen Ma2,23483,97,0.86 [0.54-1.38],0.5319362245042982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",27408,119,1.12 [1.00-1.26],0.0603112501637256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PODXL,Podocalyxin,27803,121,1.11 [0.39-3.17],0.8388710363332168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PODXL2,Podocalyxin-like protein 2,27992,119,1.31 [0.74-2.31],0.3582195480109871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,POF1B,Protein POF1B,23569,96,1.87 [1.44-2.42],2.486969489494284e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,POLR2A,DNA-directed RNA polymerase II subunit RPB1,23569,96,1.10 [0.59-2.07],0.7623859198566235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",27803,121,1.54 [1.11-2.13],0.0090350708327074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,POMC,Pro-opiomelanocortin,23579,96,0.75 [0.57-0.99],0.0444944546513827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PON1,Serum paraoxonase/arylesterase 1,24282,100,0.68 [0.36-1.29],0.2396698557239118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PON2,Serum paraoxonase/arylesterase 2,27425,119,0.94 [0.59-1.50],0.8011319349944233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PON3,Serum paraoxonase/lactonase 3,28050,121,0.88 [0.57-1.37],0.5831661695086585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,POSTN,Periostin,24251,100,0.88 [0.53-1.45],0.6056486009267303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PPBP,Platelet basic protein,24104,100,1.01 [0.81-1.27],0.898731320025114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PPCDC,Phosphopantothenoylcysteine decarboxylase,28192,122,1.36 [0.99-1.87],0.0586577304708266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PPIB,Peptidyl-prolyl cis-trans isomerase B,27928,120,1.05 [0.89-1.24],0.549138018045337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PPIE,Peptidyl-prolyl cis-trans isomerase E,23811,95,1.04 [0.77-1.41],0.8022031007684164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24251,100,1.18 [0.89-1.55],0.2442447946303558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PPL,Periplakin,23569,96,1.68 [1.08-2.63],0.0213675637193421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PPM1A,Protein phosphatase 1A,27238,115,1.07 [0.65-1.78],0.7801235876664852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PPM1B,Protein phosphatase 1B,23569,96,1.03 [0.76-1.40],0.84885309192188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PPM1F,Protein phosphatase 1F,24257,99,1.21 [0.85-1.71],0.2927933456980686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PPME1,Protein phosphatase methylesterase 1,27803,121,1.16 [0.89-1.51],0.2765667437069403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24145,101,1.28 [1.03-1.59],0.0259712062894579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,27992,119,1.22 [1.04-1.44],0.0160247898497469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,23811,95,1.02 [0.78-1.32],0.90735819124079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24223,100,0.99 [0.78-1.27],0.9625740045076284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24223,100,1.10 [0.67-1.80],0.7184629233048259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PPP1R2,Protein phosphatase inhibitor 2,27929,121,1.13 [0.93-1.37],0.2127897527065036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PPP1R9B,Neurabin-2,28265,122,1.18 [1.00-1.39],0.05038378369239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24167,101,1.14 [0.98-1.33],0.0919126052084622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PPP3R1,Calcineurin subunit B type 1,27738,120,1.25 [0.85-1.82],0.2527235597957525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PPT1,Palmitoyl-protein thioesterase 1,23584,95,1.18 [0.96-1.44],0.1155663320491064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PPY,Pancreatic prohormone,27855,119,1.07 [0.91-1.25],0.4293113132608004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PQBP1,Polyglutamine-binding protein 1,27238,115,1.26 [1.00-1.59],0.0477570214669827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRAME,Melanoma antigen preferentially expressed in tumors,23402,100,1.09 [0.52-2.26],0.8223611709224232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRAP1,Proline-rich acidic protein 1,24251,100,1.41 [0.88-2.27],0.1538235586437283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRC1,Protein regulator of cytokinesis 1,24145,101,0.91 [0.57-1.45],0.6945428886840477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRCP,Lysosomal Pro-X carboxypeptidase,28077,119,1.03 [0.62-1.70],0.9063935534247984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRDX1,Peroxiredoxin-1,27158,116,0.98 [0.81-1.18],0.8173482176522925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRDX2,Peroxiredoxin-2,23891,98,1.07 [0.79-1.44],0.6745368482414249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",27408,119,1.38 [1.12-1.69],0.0022787581473853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRDX5,"Peroxiredoxin-5, mitochondrial",28265,122,1.05 [0.83-1.33],0.6804043500062763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRDX6,Peroxiredoxin-6,28179,121,1.03 [0.80-1.34],0.8083844858384428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PREB,Prolactin regulatory element-binding protein,27408,119,1.77 [1.29-2.44],0.0004304011473805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRELP,Prolargin,27905,121,2.78 [1.28-6.06],0.0099218537934979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRG2,Bone marrow proteoglycan,24251,100,1.26 [0.89-1.79],0.1878235062290522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRG3,Proteoglycan 3,24251,100,0.97 [0.68-1.39],0.8868008110373549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,27408,119,1.26 [0.97-1.65],0.0855024703969363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,23584,95,0.87 [0.45-1.69],0.6802501486010805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,27929,121,1.08 [0.89-1.31],0.4150031120115443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24142,99,1.20 [0.95-1.51],0.1253317733455388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRKCQ,Protein kinase C theta type,27408,119,1.31 [0.96-1.79],0.0845666319725926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRKD2,Serine/threonine-protein kinase D2,23482,98,1.09 [0.73-1.61],0.6761877091517172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRKG1,cGMP-dependent protein kinase 1,23715,97,1.11 [0.95-1.30],0.1740983570826141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,27238,115,1.39 [1.10-1.74],0.0054513513503502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRL,Prolactin,28192,122,1.28 [1.07-1.55],0.0081064297272049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRND,Prion-like protein doppel,24190,99,0.93 [0.64-1.34],0.6854285915065894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PROC,Vitamin K-dependent protein C,27970,119,1.79 [0.96-3.34],0.0660170488653192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PROCR,Endothelial protein C receptor,23482,98,1.48 [1.06-2.08],0.0228556363446495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PROK1,Prokineticin-1,27914,119,1.02 [0.80-1.31],0.8722633264319091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PROS1,Vitamin K-dependent protein S,24294,101,0.55 [0.25-1.21],0.1380520972103589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRR4,Proline-rich protein 4,23555,96,1.02 [0.78-1.34],0.8637758605913131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRR5,Proline-rich protein 5,23569,96,0.88 [0.57-1.37],0.5768253502245955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRRT3,Proline-rich transmembrane protein 3,23579,96,0.86 [0.51-1.46],0.584019084505117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRSS2,Trypsin-2,28004,119,1.33 [1.00-1.76],0.0467205423940388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRSS22,Brain-specific serine protease 4,23569,96,1.57 [1.03-2.39],0.0339966413276117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRSS27,Serine protease 27,27830,121,1.20 [0.82-1.77],0.3438952629574704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRSS53,Serine protease 53,24190,99,1.33 [0.85-2.07],0.2083267924032816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRSS8,Prostasin,27815,121,1.62 [1.12-2.33],0.0100293041940053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,27266,115,1.04 [0.89-1.20],0.648011883069858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRTG,Protogenin,28179,121,1.90 [1.09-3.32],0.0238228991133143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRTN3,Myeloblastin,27238,119,1.16 [0.85-1.59],0.3569246394489569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PRUNE2,Protein prune homolog 2,23811,95,1.35 [0.74-2.46],0.3324647966959591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PSAP,Prosaposin,24032,100,1.17 [0.61-2.25],0.6285444092556679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PSAPL1,Proactivator polypeptide-like 1,24167,101,1.59 [1.11-2.26],0.0106253832946693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PSCA,Prostate stem cell antigen,24167,101,0.99 [0.92-1.06],0.7727571287496859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PSG1,Pregnancy-specific beta-1-glycoprotein 1,27738,120,1.00 [0.86-1.16],0.9959075261649916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PSIP1,PC4 and SFRS1-interacting protein,27914,119,1.19 [0.96-1.47],0.1119908178187777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PSMA1,Proteasome subunit alpha type-1,27238,115,0.92 [0.63-1.33],0.6584862331942118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PSMC3,26S proteasome regulatory subunit 6A,23402,100,1.24 [0.67-2.31],0.495176676097021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24223,100,1.27 [0.90-1.80],0.1732067890512592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PSMD5,26S proteasome non-ATPase regulatory subunit 5,23584,95,1.21 [0.91-1.62],0.1904041472895756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PSMD9,26S proteasome non-ATPase regulatory subunit 9,27803,121,1.17 [0.90-1.53],0.2447190650318666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PSME1,Proteasome activator complex subunit 1,27705,120,1.57 [1.03-2.39],0.0351474282814594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PSME2,Proteasome activator complex subunit 2,27616,117,1.43 [0.93-2.22],0.1052364533875355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PSMG3,Proteasome assembly chaperone 3,27914,119,1.31 [0.96-1.77],0.0849051965206845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PSMG4,Proteasome assembly chaperone 4,23569,96,1.15 [0.84-1.59],0.3878693184327236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PSPN,Persephin,27914,119,0.90 [0.76-1.06],0.2102203177163145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PSRC1,Proline/serine-rich coiled-coil protein 1,27238,115,1.31 [1.02-1.67],0.0316022345614511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,22845,93,1.05 [0.87-1.27],0.6061427178979253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",27266,115,0.86 [0.50-1.49],0.5938013070121722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PTGDS,Prostaglandin-H2 D-isomerase,27706,119,1.98 [1.24-3.16],0.0040398423074653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PTGES2,Prostaglandin E synthase 2,23387,94,1.13 [0.80-1.60],0.489509631033996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PTGR1,Prostaglandin reductase 1,24257,99,1.12 [0.90-1.41],0.3085223859193429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PTH,Parathyroid hormone,23584,95,1.21 [0.96-1.53],0.1008433882639432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,27914,119,1.09 [0.73-1.61],0.6812648553561954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PTK7,Inactive tyrosine-protein kinase 7,27266,115,1.22 [0.80-1.87],0.3631940324245334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PTN,Pleiotrophin,27425,119,1.39 [1.03-1.89],0.0329229458013958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PTP4A3,Protein tyrosine phosphatase type IVA 3,23569,96,1.24 [0.89-1.73],0.2028062652853773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,27738,120,1.19 [0.98-1.45],0.0831469934048856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,28007,121,1.12 [0.93-1.35],0.2439148381855526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,23520,96,1.01 [0.61-1.66],0.9790579772489878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24257,99,0.73 [0.39-1.38],0.3292159286043437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PTPRC,Receptor-type tyrosine-protein phosphatase C,24251,100,1.02 [0.44-2.36],0.970343961791022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PTPRF,Receptor-type tyrosine-protein phosphatase F,28272,122,1.03 [0.60-1.79],0.9095733918044216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PTPRH,Receptor-type tyrosine-protein phosphatase H,24167,101,1.48 [1.03-2.12],0.0326118798101493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24167,101,1.41 [0.68-2.94],0.3548989789593536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PTPRM,Receptor-type tyrosine-protein phosphatase mu,27861,117,1.22 [0.64-2.33],0.5488672392592362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,27638,119,1.59 [0.98-2.59],0.061408617619801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PTPRR,Receptor-type tyrosine-protein phosphatase R,24190,99,1.01 [0.60-1.69],0.9701674840205012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PTPRS,Receptor-type tyrosine-protein phosphatase S,28272,122,1.30 [0.69-2.48],0.4173216407756965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24257,99,1.11 [0.61-2.00],0.7321213100452127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,23715,97,1.18 [0.86-1.62],0.3107173795131183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PTS,6-pyruvoyl tetrahydrobiopterin synthase,27143,115,0.96 [0.72-1.29],0.7944416012766878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PTTG1,Securin,23811,95,0.73 [0.43-1.22],0.2285973094157142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PTX3,Pentraxin-related protein PTX3,27914,119,1.67 [1.15-2.41],0.0068869147125263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PVALB,Parvalbumin alpha,28068,120,1.00 [0.87-1.15],0.986594017865044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PVR,Poliovirus receptor,28192,122,0.97 [0.64-1.47],0.8931412014843035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PXDNL,Peroxidasin-like protein,24145,101,1.10 [0.83-1.46],0.5172720044378969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PXN,Paxillin,27266,115,1.36 [1.05-1.76],0.0202346497412992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PYDC1,Pyrin domain-containing protein 1,23579,96,1.47 [1.03-2.09],0.0334219617847703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PYY,Peptide YY,23482,98,1.09 [0.89-1.33],0.3990316414821199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,PZP,Pregnancy zone protein,24294,101,1.18 [0.86-1.61],0.3151526778574622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,QDPR,Dihydropteridine reductase,27794,121,1.32 [0.92-1.88],0.1325081493158522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,QPCT,Glutaminyl-peptide cyclotransferase,27931,119,1.04 [0.58-1.87],0.8851896574655437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,QSOX1,Sulfhydryl oxidase 1,23788,97,0.98 [0.60-1.61],0.9429000298419168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RAB10,Ras-related protein Rab-10,24257,99,1.03 [0.73-1.46],0.862639283443954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RAB11FIP3,Rab11 family-interacting protein 3,24257,99,1.09 [0.92-1.30],0.3223038915253674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RAB27B,Ras-related protein Rab-27B,24257,99,1.01 [0.80-1.27],0.949972496640649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RAB2B,Ras-related protein Rab-2B,24145,101,1.20 [0.89-1.60],0.2333413215047581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RAB33A,Ras-related protein Rab-33A,23482,98,1.07 [0.81-1.41],0.6531443262065564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RAB37,Ras-related protein Rab-37,27408,119,1.19 [1.00-1.40],0.0447294958419586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RAB39B,Ras-related protein Rab-39B,23482,98,1.20 [1.03-1.40],0.0179239918017038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,23483,97,0.97 [0.68-1.37],0.847212068492029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RAB44,Ras-related protein Rab-44,24145,101,1.35 [1.04-1.76],0.0252032076994751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RAB6A,Ras-related protein Rab-6A,27914,119,0.99 [0.71-1.39],0.9642151038310772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RAB6B,Ras-related protein Rab-6B,27266,115,1.22 [0.90-1.66],0.2071211962450714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RABEP1,Rab GTPase-binding effector protein 1,23715,97,1.11 [0.87-1.42],0.4069262476086139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RABEPK,Rab9 effector protein with kelch motifs,27238,115,1.08 [0.83-1.41],0.5491249557238634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RABGAP1L,Rab GTPase-activating protein 1-like,27408,119,1.41 [1.11-1.80],0.0054777785242694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RAC3,Ras-related C3 botulinum toxin substrate 3,23584,95,0.99 [0.74-1.32],0.9237185661327872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RAD23B,UV excision repair protein RAD23 homolog B,27238,115,1.18 [0.83-1.66],0.3541717575036249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RAD51,DNA repair protein RAD51 homolog 1,23811,95,1.15 [0.86-1.54],0.3547978325873957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RALB,Ras-related protein Ral-B,23569,96,1.52 [0.82-2.82],0.1846069291451211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RALY,RNA-binding protein Raly,24145,101,1.16 [0.84-1.62],0.3715867224261669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RANBP1,Ran-specific GTPase-activating protein,23579,96,0.97 [0.67-1.40],0.8525823433261788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RANBP2,E3 SUMO-protein ligase RanBP2,23483,97,1.33 [0.78-2.28],0.2991925415603877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RANGAP1,Ran GTPase-activating protein 1,27238,115,0.99 [0.71-1.39],0.9562320867827568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RAP1A,Ras-related protein Rap-1A,23569,96,0.80 [0.56-1.14],0.215048666684543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RAPGEF2,Rap guanine nucleotide exchange factor 2,23811,95,1.37 [0.99-1.91],0.0572194270578648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RARRES1,Retinoic acid receptor responder protein 1,27238,115,1.50 [1.08-2.09],0.0150658227186983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RARRES2,Retinoic acid receptor responder protein 2,28060,119,1.64 [1.27-2.13],0.0001897491695189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RASA1,Ras GTPase-activating protein 1,27266,115,1.20 [0.75-1.91],0.4511406362486423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,23402,100,0.92 [0.58-1.45],0.7158139426377672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RASSF2,Ras association domain-containing protein 2,27238,115,1.27 [1.03-1.58],0.0284829464965545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RBFOX3,RNA binding protein fox-1 homolog 3,24223,100,1.53 [1.03-2.28],0.0350402654422061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RBKS,Ribokinase,27289,119,1.11 [0.81-1.51],0.5249615485442652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RBM17,Splicing factor 45,24223,100,1.17 [0.92-1.48],0.2062785865204002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RBM19,Probable RNA-binding protein 19,23482,98,1.15 [0.80-1.66],0.4374214565136525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RBM25,RNA-binding protein 25,23402,100,1.29 [0.87-1.90],0.2055528611740704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RBP1,Retinol-binding protein 1,23584,95,1.06 [0.82-1.38],0.6508867903915776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RBP2,Retinol-binding protein 2,27803,121,0.96 [0.78-1.18],0.693066855355682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RBP5,Retinol-binding protein 5,27803,121,1.07 [0.82-1.40],0.6120863827346832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RBP7,Retinoid-binding protein 7,24167,101,1.27 [0.98-1.65],0.0718850953902428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RBPMS,RNA-binding protein with multiple splicing,23569,96,1.11 [0.86-1.44],0.4173535950888005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RBPMS2,RNA-binding protein with multiple splicing 2,23579,96,1.05 [0.87-1.26],0.6275666398167542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RCC1,Regulator of chromosome condensation,24145,101,1.19 [0.87-1.63],0.2856397762450986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RCOR1,REST corepressor 1,27425,119,0.93 [0.63-1.38],0.7249365195782103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,23579,96,0.54 [0.22-1.36],0.1923735222719851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,REEP4,Receptor expression-enhancing protein 4,24223,100,1.16 [0.88-1.54],0.2953861570233253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,REG1A,Lithostathine-1-alpha,27760,119,1.28 [0.94-1.74],0.1212632732224461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,REG1B,Lithostathine-1-beta,28272,122,1.22 [0.94-1.58],0.1324837944293575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,REG3A,Regenerating islet-derived protein 3-alpha,28272,122,1.28 [1.00-1.63],0.053572179260951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,REG3G,Regenerating islet-derived protein 3-gamma,24145,101,1.02 [0.64-1.64],0.9273900279198672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,REG4,Regenerating islet-derived protein 4,27955,121,1.36 [0.98-1.87],0.0633983016163802
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RELB,Transcription factor RelB,23569,96,1.14 [0.80-1.61],0.4802972267018881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RELT,Tumor necrosis factor receptor superfamily member 19L,27919,121,3.03 [1.80-5.09],2.850079212011023e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,REN,Renin,27929,121,1.06 [0.84-1.32],0.6354171411832263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,REPS1,RalBP1-associated Eps domain-containing protein 1,23569,96,1.02 [0.62-1.68],0.9517573957375078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,REST,RE1-silencing transcription factor,23402,100,1.07 [0.65-1.78],0.7838843679009744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,27803,121,1.15 [0.77-1.72],0.5059391734693397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RETN,Resistin,27854,119,1.46 [1.04-2.05],0.0292881135545286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,REXO2,"Oligoribonuclease, mitochondrial",23482,98,0.79 [0.49-1.27],0.3347873390613561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RFC4,Replication factor C subunit 4,24145,101,2.19 [1.20-4.00],0.0108328194795553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RGCC,Regulator of cell cycle RGCC,24223,100,1.26 [0.98-1.62],0.0693857192864156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,23811,95,1.07 [0.81-1.42],0.6114815288142809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RGMA,Repulsive guidance molecule A,28192,122,0.78 [0.47-1.29],0.3291893141429037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RGMB,RGM domain family member B,28192,122,2.02 [1.12-3.65],0.0190494457617982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RGS10,Regulator of G-protein signaling 10,24223,100,1.11 [0.82-1.51],0.5014136467458469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RGS8,Regulator of G-protein signaling 8,27408,119,1.08 [0.86-1.36],0.4842461027987514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RHOC,Rho-related GTP-binding protein RhoC,27573,120,1.06 [0.92-1.22],0.4258727964485366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RICTOR,Rapamycin-insensitive companion of mTOR,23569,96,1.10 [0.76-1.59],0.6021961175712933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,23715,97,0.98 [0.67-1.44],0.9259198997749212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RILP,Rab-interacting lysosomal protein,28105,120,1.31 [1.01-1.69],0.040922494568164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RILPL2,RILP-like protein 2,24257,99,1.10 [0.91-1.34],0.3243953522704146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,23482,98,0.98 [0.74-1.31],0.9144999992999606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RLN1,Prorelaxin H1,24223,100,0.99 [0.78-1.26],0.9320112983565316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RLN2,Prorelaxin H2,23675,97,1.01 [0.88-1.16],0.922488052376975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RNASE1,Ribonuclease pancreatic,24282,100,1.60 [0.75-3.43],0.2270872893288513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RNASE10,Inactive ribonuclease-like protein 10,23579,96,1.29 [0.90-1.86],0.1622746738837621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RNASE3,Eosinophil cationic protein,27792,121,1.10 [0.96-1.25],0.158737559059873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RNASE4,Ribonuclease 4,23501,94,1.18 [0.57-2.46],0.6548412477216803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RNASE6,Ribonuclease K6,24109,99,2.06 [1.41-3.02],0.0002048460321494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RNASEH2A,Ribonuclease H2 subunit A,24223,100,1.17 [0.84-1.65],0.3501140208640774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RNASET2,Ribonuclease T2,28125,119,2.20 [1.28-3.78],0.0045324166912891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RNF149,E3 ubiquitin-protein ligase RNF149,23579,96,1.02 [0.53-1.96],0.9481832615438724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RNF168,E3 ubiquitin-protein ligase RNF168,23569,96,1.04 [0.66-1.66],0.8599627406871986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RNF31,E3 ubiquitin-protein ligase RNF31,23569,96,1.13 [0.70-1.84],0.6132087996728566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RNF4,E3 ubiquitin-protein ligase RNF4,23811,95,0.93 [0.67-1.28],0.647643010569336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RNF41,E3 ubiquitin-protein ligase NRDP1,27238,115,1.28 [1.02-1.61],0.0326420473595764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RNF43,E3 ubiquitin-protein ligase RNF43,23811,95,0.90 [0.63-1.30],0.5883302363623923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RNF5,E3 ubiquitin-protein ligase RNF5,23579,96,1.09 [0.83-1.43],0.5317353401628224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ROBO1,Roundabout homolog 1,27955,121,0.99 [0.51-1.95],0.9833186157378706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ROBO2,Roundabout homolog 2,28192,122,1.01 [0.51-2.02],0.9697294051246066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ROBO4,Roundabout homolog 4,23579,96,1.24 [0.41-3.72],0.6999531573041042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,27929,121,1.31 [0.79-2.17],0.2969586544623295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RP2,Protein XRP2,27803,121,1.17 [0.82-1.67],0.379262162608226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RPA2,Replication protein A 32 kDa subunit,23569,96,1.37 [0.81-2.32],0.2368245271457973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RPE,Ribulose-phosphate 3-epimerase,23811,95,1.12 [0.86-1.45],0.4014759465975989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RPGR,X-linked retinitis pigmentosa GTPase regulator,23584,95,1.16 [0.76-1.78],0.4990430078947772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RPL14,60S ribosomal protein L14,23579,96,1.35 [0.91-2.01],0.1309146302188732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RPS10,40S ribosomal protein S10,23482,98,0.99 [0.63-1.56],0.9615498870195668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RRAS,Ras-related protein R-Ras,23584,95,1.06 [0.92-1.23],0.4260937931993296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RRM2,Ribonucleoside-diphosphate reductase subunit M2,27238,115,1.35 [1.06-1.71],0.01460222675415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,27238,115,1.16 [0.92-1.47],0.2178461746514223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RRP15,RRP15-like protein,23483,97,1.00 [0.81-1.23],0.9695948259930384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RSPO1,R-spondin-1,27738,120,1.31 [0.85-2.03],0.2218998653729651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RSPO3,R-spondin-3,28179,121,1.75 [1.02-3.00],0.0435878927749855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RTBDN,Retbindin,27803,121,1.44 [0.85-2.44],0.1727681112711198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RTKN2,Rhotekin-2,23482,98,1.06 [0.76-1.49],0.7267608866851756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24223,100,1.12 [0.92-1.37],0.2603894866513289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RTN4R,Reticulon-4 receptor,28179,121,1.40 [0.91-2.14],0.1243515540968887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RUVBL1,RuvB-like 1,27238,115,1.00 [0.85-1.18],0.9714245316285692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RWDD1,RWD domain-containing protein 1,28192,122,1.23 [0.96-1.57],0.09981801956404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,RYR1,Ryanodine receptor 1,23482,98,1.06 [0.60-1.86],0.8394138815470766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,S100A11,Protein S100-A11,27703,121,1.22 [0.91-1.62],0.1832099330295122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,S100A12,Protein S100-A12,27538,120,1.12 [0.90-1.38],0.3098483803657579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,S100A13,Protein S100-A13,23569,96,1.01 [0.58-1.77],0.97515849733558
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,S100A14,Protein S100-A14,24223,100,0.90 [0.62-1.32],0.5996775102340787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,S100A16,Protein S100-A16,27216,115,0.94 [0.71-1.23],0.6508604937576965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,S100A3,Protein S100-A3,24145,101,1.17 [0.82-1.66],0.3809825126390986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,S100A4,Protein S100-A4,27992,119,1.22 [0.91-1.62],0.182010493590195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,S100G,Protein S100-G,24223,100,0.57 [0.35-0.91],0.0181993070815598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,S100P,Protein S100-P,27425,119,1.34 [1.06-1.70],0.0138237041589863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SAA4,Serum amyloid A-4 protein,24294,101,1.07 [0.62-1.85],0.8183899357731201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SAFB2,Scaffold attachment factor B2,24223,100,1.51 [0.83-2.76],0.1764666028399157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SAG,S-arrestin,23483,97,1.06 [0.74-1.52],0.750266219225804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SAMD9L,Sterile alpha motif domain-containing protein 9-like,27914,119,1.10 [0.89-1.37],0.3634632728675457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SAP18,Histone deacetylase complex subunit SAP18,23811,95,1.05 [0.82-1.35],0.7003467121157085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SARG,Specifically androgen-regulated gene protein,24177,99,1.11 [0.93-1.32],0.2353777813190442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SART1,U4/U6.U5 tri-snRNP-associated protein 1,23482,98,0.99 [0.59-1.64],0.9611888056814034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SAT1,Diamine acetyltransferase 1,23482,98,0.94 [0.62-1.42],0.7731393800593005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SAT2,Thialysine N-epsilon-acetyltransferase,23811,95,1.08 [0.83-1.40],0.5638779141056174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SATB1,DNA-binding protein SATB1,24223,100,0.87 [0.44-1.70],0.6798145291509219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SBSN,Suprabasin,24207,100,0.60 [0.34-1.05],0.074866068973273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SCAMP3,Secretory carrier-associated membrane protein 3,27803,121,1.20 [1.00-1.44],0.0531682775482465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SCARA5,Scavenger receptor class A member 5,28192,122,1.68 [0.99-2.87],0.0564746933577407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SCARB1,Scavenger receptor class B member 1,27266,115,0.84 [0.59-1.19],0.3207142859484476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SCARB2,Lysosome membrane protein 2,27204,117,2.88 [1.88-4.42],1.136983708377187e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SCARF1,Scavenger receptor class F member 1,28272,122,1.20 [0.83-1.71],0.3290567074778998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SCARF2,Scavenger receptor class F member 2,28192,122,1.90 [1.09-3.33],0.0244082872293095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SCG2,Secretogranin-2,28067,120,1.78 [1.09-2.91],0.0214783641947396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SCG3,Secretogranin-3,27955,121,1.14 [0.70-1.86],0.592936542854509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SCGB1A1,Uteroglobin,27972,121,1.10 [0.82-1.47],0.5165491764354777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SCGB2A2,Mammaglobin-A,23482,98,1.27 [0.75-2.14],0.3712975383273513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SCGB3A1,Secretoglobin family 3A member 1,23715,97,1.60 [0.74-3.46],0.2344513514457803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SCGB3A2,Secretoglobin family 3A member 2,28007,121,1.02 [0.84-1.24],0.8171956399192508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SCGN,Secretagogin,27408,119,1.18 [0.82-1.69],0.379321829334155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SCIN,Adseverin,23483,97,1.03 [0.79-1.34],0.8372554156046841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SCLY,Selenocysteine lyase,28105,120,0.94 [0.69-1.30],0.7132179700547339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SCN2A,Sodium channel protein type 2 subunit alpha,23483,97,1.28 [0.93-1.77],0.1310313819983745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SCN2B,Sodium channel subunit beta-2,23584,95,0.98 [0.49-1.98],0.9581063758965536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SCN3A,Sodium channel protein type 3 subunit alpha,23584,95,1.13 [0.71-1.81],0.6110094625475029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SCN3B,Sodium channel subunit beta-3,23483,97,0.98 [0.64-1.52],0.940254479712584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SCN4B,Sodium channel subunit beta-4,23579,96,0.75 [0.47-1.19],0.2207500854093941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SCP2,Non-specific lipid-transfer protein,27238,115,0.98 [0.79-1.22],0.8708240571278089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SCPEP1,Retinoid-inducible serine carboxypeptidase,23497,96,1.30 [0.90-1.88],0.1578705285384457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SCRG1,Scrapie-responsive protein 1,24257,99,1.53 [0.84-2.78],0.1675313774884204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SCRIB,Protein scribble homolog,23579,96,1.19 [0.99-1.43],0.0573544864405453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SCRN1,Secernin-1,27914,119,1.35 [1.05-1.75],0.021302097662208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SCT,Secretin,23584,95,0.65 [0.41-1.04],0.0735189821998502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SDC1,Syndecan-1,27929,121,1.70 [1.24-2.32],0.0009669555556583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SDC4,Syndecan-4,27929,121,1.06 [0.75-1.50],0.7547471866300046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SDCCAG8,Serologically defined colon cancer antigen 8,24145,101,1.21 [1.03-1.43],0.0213342287394582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SDHB,Succinate dehydrogenase,24167,101,1.19 [0.93-1.51],0.1663928454335279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SDK2,Protein sidekick-2,23715,97,1.10 [0.66-1.84],0.7183899507553775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SEC31A,Protein transport protein Sec31A,23579,96,1.17 [0.90-1.52],0.2373478107146353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SEL1L,Protein sel-1 homolog 1,23579,96,1.37 [0.87-2.16],0.1678324314481104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SELE,E-selectin,28272,122,1.29 [0.94-1.77],0.1178524463244101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SELENOP,Selenoprotein P,24294,101,0.97 [0.42-2.27],0.948966902770781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SELL,L-selectin,24294,101,1.50 [0.67-3.37],0.32180991065266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SELP,P-selectin,28004,119,1.18 [0.90-1.55],0.2382864556305733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SELPLG,P-selectin glycoprotein ligand 1,27914,119,1.57 [0.92-2.67],0.0946733997016119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SEMA3F,Semaphorin-3F,27929,121,2.73 [1.53-4.89],0.0007035446142783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SEMA3G,Semaphorin-3G,23715,97,1.68 [1.14-2.48],0.0090760089297843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SEMA4C,Semaphorin-4C,27803,121,1.45 [0.92-2.29],0.10998447115958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SEMA4D,Semaphorin-4D,28192,122,1.31 [0.77-2.23],0.3172590543261281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SEMA6C,Semaphorin-6C,23569,96,1.39 [0.73-2.64],0.3195726609729791
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SEMA7A,Semaphorin-7A,28173,122,0.96 [0.53-1.74],0.8887051045892876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SEPTIN3,Neuronal-specific septin-3,24223,100,1.02 [0.80-1.31],0.8707725182793128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SEPTIN7,Septin-7,23811,95,1.34 [1.03-1.74],0.0279087948394941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SEPTIN8,Septin-8,24136,99,1.87 [1.18-2.94],0.0071615069419229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SEPTIN9,Septin-9,27803,121,1.44 [0.88-2.35],0.1497786526249346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SERPINA1,Alpha-1-antitrypsin,23858,100,5.54 [1.02-29.98],0.047082323257714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SERPINA11,Serpin A11,28272,122,1.62 [1.10-2.40],0.015477685808761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SERPINA12,Serpin A12,27155,120,1.00 [0.89-1.13],0.9487364182300326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SERPINA3,Alpha-1-antichymotrypsin,24216,101,2.47 [0.88-6.99],0.0876214033548979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SERPINA4,Kallistatin,23852,99,0.83 [0.37-1.86],0.6499747416937309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SERPINA5,Plasma serine protease inhibitor,23942,100,1.46 [0.95-2.24],0.0822043722690541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SERPINA6,Corticosteroid-binding globulin,24294,101,0.75 [0.25-2.22],0.6026831020868583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SERPINA7,Thyroxine-binding globulin,24294,101,2.07 [0.79-5.45],0.1402526402600107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SERPINA9,Serpin A9,27671,120,1.16 [0.94-1.44],0.1758710248572911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SERPINB1,Leukocyte elastase inhibitor,27831,121,1.09 [0.91-1.29],0.3438105330270758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SERPINB5,Serpin B5,27425,119,0.81 [0.60-1.11],0.198468985213484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SERPINB6,Serpin B6,28096,122,1.21 [0.93-1.56],0.1562923626140096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SERPINB8,Serpin B8,28265,122,1.24 [0.99-1.54],0.0623067670542322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SERPINB9,Serpin B9,27738,120,1.38 [0.86-2.23],0.181634599152595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SERPINC1,Antithrombin-III,24243,100,1.97 [0.55-7.08],0.3005309991740209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SERPIND1,Heparin cofactor 2,24243,100,1.81 [0.94-3.49],0.0769972084427488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SERPINE1,Plasminogen activator inhibitor 1,28272,122,0.93 [0.74-1.17],0.5509871698093897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SERPINE2,Glia-derived nexin,24257,99,1.00 [0.75-1.33],0.9774298555665446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SERPINF1,Pigment epithelium-derived factor,23934,98,1.44 [0.70-2.94],0.3191503693649651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SERPINF2,Alpha-2-antiplasmin,23844,97,1.63 [0.41-6.48],0.4868460625730996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SERPING1,Plasma protease C1 inhibitor,24243,100,0.95 [0.35-2.59],0.9226994057809867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SERPINH1,Serpin H1,23811,95,1.11 [0.96-1.30],0.1556424934994363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SERPINI1,Neuroserpin,23663,97,1.39 [0.78-2.50],0.2681064747467127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SERPINI2,Serpin I2,24167,101,1.26 [0.93-1.70],0.1321995159656756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,27266,115,1.19 [0.93-1.52],0.1643727794622721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SETMAR,Histone-lysine N-methyltransferase SETMAR,27650,120,0.95 [0.55-1.62],0.842342911535139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SEZ6,Seizure protein 6 homolog,23584,95,1.09 [0.59-2.00],0.7859595623408966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SEZ6L,Seizure 6-like protein,27992,119,1.32 [0.73-2.39],0.360320180946224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SEZ6L2,Seizure 6-like protein 2,27803,121,1.25 [0.65-2.40],0.5075237447532206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SF3B4,Splicing factor 3B subunit 4,27803,121,0.99 [0.80-1.22],0.910417406239707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SFRP1,Secreted frizzled-related protein 1,27639,120,1.21 [0.85-1.73],0.2974343116453253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SFRP4,Secreted frizzled-related protein 4,23715,97,0.87 [0.55-1.39],0.5677535021065316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SFTPA1,Pulmonary surfactant-associated protein A1,27238,115,0.80 [0.57-1.12],0.186783433633812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SFTPA2,Pulmonary surfactant-associated protein A2,27238,115,0.72 [0.51-1.02],0.0656838207795297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SFTPD,Pulmonary surfactant-associated protein D,27929,121,0.94 [0.74-1.19],0.6163748681286606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SGSH,N-sulphoglucosamine sulphohydrolase,23876,99,0.97 [0.68-1.37],0.8619732051100869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SH2B3,SH2B adapter protein 3,27238,115,1.13 [0.96-1.34],0.1459589682289785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SH2D1A,SH2 domain-containing protein 1A,27914,119,1.15 [0.89-1.48],0.2813230870467396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,23483,97,0.97 [0.70-1.34],0.8646856925840545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SH3BP1,SH3 domain-binding protein 1,24167,101,1.02 [0.70-1.49],0.9030539941076556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SH3GL3,Endophilin-A3,23658,93,1.24 [0.99-1.56],0.0652011069837845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SH3GLB2,Endophilin-B2,24190,99,1.29 [0.98-1.70],0.0687933317467057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SHBG,Sex hormone-binding globulin,24282,100,1.27 [0.88-1.82],0.1950450488495423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SHC1,SHC-transforming protein 1,23402,100,0.95 [0.80-1.13],0.5753309888259481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SHD,SH2 domain-containing adapter protein D,23445,96,0.96 [0.76-1.23],0.7597672595845816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SHH,Sonic hedgehog protein,23569,96,1.16 [0.76-1.77],0.497048804932474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SHISA5,Protein shisa-5,24251,100,1.71 [0.86-3.40],0.1239098894758797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SHMT1,"Serine hydroxymethyltransferase, cytosolic",28007,121,1.13 [0.94-1.36],0.19511058578871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SHPK,Sedoheptulokinase,23811,95,0.81 [0.47-1.37],0.4283554476882519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SIAE,Sialate O-acetylesterase,27943,119,1.37 [0.99-1.90],0.0570096722101784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SIGLEC1,Sialoadhesin,28050,121,1.71 [1.20-2.43],0.0030101112988783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SIGLEC10,Sialic acid-binding Ig-like lectin 10,27914,119,1.25 [0.77-2.03],0.3647376993720478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SIGLEC15,Sialic acid-binding Ig-like lectin 15,27266,115,1.13 [0.94-1.35],0.1848819413913452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SIGLEC5,Sialic acid-binding Ig-like lectin 5,27919,121,1.20 [1.02-1.41],0.0258743655360389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SIGLEC6,Sialic acid-binding Ig-like lectin 6,28179,121,1.58 [1.02-2.46],0.0425007098065692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SIGLEC7,Sialic acid-binding Ig-like lectin 7,27929,121,1.23 [0.70-2.14],0.4706155130015543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SIGLEC8,Sialic acid-binding Ig-like lectin 8,23579,96,1.04 [0.69-1.58],0.8372582830448776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SIGLEC9,Sialic acid-binding Ig-like lectin 9,28142,120,1.36 [0.82-2.26],0.2314247416294595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SIL1,Nucleotide exchange factor SIL1,23579,96,1.48 [0.98-2.25],0.0627036529654575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,27992,120,1.02 [0.77-1.35],0.8971357603851451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SIRPB1,Signal-regulatory protein beta-1,27850,121,1.15 [0.81-1.64],0.4420266857036046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SIRT1,NAD-dependent protein deacetylase sirtuin-1,23569,96,1.10 [0.91-1.34],0.3300425174956162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SIRT2,NAD-dependent protein deacetylase sirtuin-2,27803,121,1.16 [0.97-1.39],0.1066246150532241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",27266,115,1.24 [0.96-1.60],0.0953667406394304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SIT1,Signaling threshold-regulating transmembrane adapter 1,27408,119,1.40 [1.05-1.86],0.0201486959510141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SKAP1,Src kinase-associated phosphoprotein 1,27689,119,1.18 [0.95-1.47],0.1339786122641972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SKAP2,Src kinase-associated phosphoprotein 2,28050,121,1.11 [0.96-1.30],0.1654475483062062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SKIV2L,Helicase SKI2W,23482,98,1.05 [0.66-1.67],0.8396838011771305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SLA2,Src-like-adapter 2,24223,100,1.11 [0.93-1.33],0.2512787373051197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SLAMF1,Signaling lymphocytic activation molecule,27408,119,1.05 [0.80-1.39],0.7296167311674271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SLAMF6,SLAM family member 6,27238,115,1.88 [1.33-2.66],0.0003983738359555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SLAMF7,SLAM family member 7,27914,119,0.95 [0.72-1.26],0.7423166018818035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SLAMF8,SLAM family member 8,27238,115,1.10 [0.80-1.52],0.561518704956444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SLC12A2,Solute carrier family 12 member 2,23482,98,1.29 [0.77-2.15],0.3340810557047809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SLC13A1,Solute carrier family 13 member 1,24145,101,1.10 [0.83-1.45],0.5022094899726858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SLC16A1,Monocarboxylate transporter 1,27266,115,1.05 [0.80-1.37],0.7435967182227365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SLC1A4,Neutral amino acid transporter A,23584,95,1.12 [0.79-1.58],0.5177257624812355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SLC27A4,Long-chain fatty acid transport protein 4,27266,115,1.08 [0.86-1.35],0.5099988412917478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SLC28A1,Sodium/nucleoside cotransporter 1,23402,100,0.96 [0.69-1.35],0.8289935080065555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SLC34A3,Sodium-dependent phosphate transport protein 2C,23402,100,0.98 [0.65-1.47],0.9103167559762444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SLC39A14,Zinc transporter ZIP14,27266,115,1.75 [1.19-2.58],0.004505706313309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SLC39A5,Zinc transporter ZIP5,27914,119,1.40 [1.15-1.70],0.0008896580073116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SLC44A4,Choline transporter-like protein 4,23584,95,1.02 [0.77-1.35],0.8805733491513504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SLC4A1,Band 3 anion transport protein,24251,100,0.84 [0.56-1.27],0.4145858856985314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SLC51B,Organic solute transporter subunit beta,23482,98,0.73 [0.54-0.99],0.0418996892098471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,23715,97,1.18 [0.95-1.48],0.1359278126547332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24167,101,1.18 [0.88-1.58],0.2739623612186148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",23402,100,1.07 [0.78-1.46],0.6703741303072865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SLIT2,Slit homolog 2 protein,27266,115,1.02 [0.75-1.40],0.8879963594836608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SLITRK1,SLIT and NTRK-like protein 1,23569,96,0.71 [0.39-1.31],0.2742465627528194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SLITRK2,SLIT and NTRK-like protein 2,28179,121,1.55 [1.04-2.33],0.0321533876599737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SLITRK6,SLIT and NTRK-like protein 6,27425,119,0.90 [0.56-1.46],0.6788267005540976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SLK,STE20-like serine/threonine-protein kinase,23811,95,0.92 [0.69-1.22],0.5592376643659687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SLMAP,Sarcolemmal membrane-associated protein,24167,101,1.27 [1.03-1.57],0.0229692185843995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SLURP1,Secreted Ly-6/uPAR-related protein 1,24074,100,0.83 [0.48-1.44],0.5034849886370886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SMAD1,Mothers against decapentaplegic homolog 1,27238,115,1.19 [0.98-1.44],0.0812459190621018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SMAD2,Mothers against decapentaplegic homolog 2,24145,101,1.33 [1.04-1.71],0.025599014547378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SMAD3,Mothers against decapentaplegic homolog 3,24145,101,1.54 [1.10-2.16],0.0114609350949329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SMAD5,Mothers against decapentaplegic homolog 5,27803,121,0.92 [0.42-1.98],0.8263648248832134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SMARCA2,Probable global transcription activator SNF2L2,27266,115,1.12 [0.91-1.40],0.2870220233365849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SMC3,Structural maintenance of chromosomes protein 3,23402,100,0.93 [0.64-1.35],0.7137783078266052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SMNDC1,Survival of motor neuron-related-splicing factor 30,24167,101,1.24 [0.99-1.57],0.0637728484785241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SMOC1,SPARC-related modular calcium-binding protein 1,28179,121,2.72 [1.76-4.19],5.808693887739668e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SMOC2,SPARC-related modular calcium-binding protein 2,28050,121,1.49 [1.01-2.19],0.0422564668962617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SMPD1,Sphingomyelin phosphodiesterase,28053,121,1.09 [0.79-1.50],0.5934141447083294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SMPD3,Sphingomyelin phosphodiesterase 3,23569,96,1.07 [0.79-1.45],0.6685791207516218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,27995,121,0.75 [0.59-0.95],0.0159418821505946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24145,101,0.94 [0.72-1.23],0.642392694342151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SMS,Spermine synthase,23483,97,1.17 [0.89-1.52],0.2600130331910483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SMTN,Smoothelin,24134,99,1.08 [0.90-1.31],0.4039585259052869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SNAP23,Synaptosomal-associated protein 23,27929,121,1.15 [0.95-1.40],0.1405779526462899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SNAP25,Synaptosomal-associated protein 25,23483,97,1.17 [0.79-1.74],0.4391257069979004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SNAP29,Synaptosomal-associated protein 29,27992,119,1.17 [0.98-1.39],0.0890219453100815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SNAPIN,SNARE-associated protein Snapin,24223,100,0.94 [0.68-1.31],0.7236405425192984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SNCA,Alpha-synuclein,23715,97,1.16 [0.98-1.37],0.0829041069313235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SNCG,Gamma-synuclein,27738,120,1.17 [0.91-1.51],0.2109166167350447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",23579,96,0.82 [0.44-1.54],0.5444305658766382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SNRPB2,U2 small nuclear ribonucleoprotein B'',24190,99,1.19 [0.86-1.65],0.286641113029328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SNU13,NHP2-like protein 1,23482,98,1.15 [0.89-1.49],0.2969358044702536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SNX15,Sorting nexin-15,23715,97,1.28 [0.91-1.80],0.1599021926597892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SNX18,Sorting nexin-18,24167,101,1.36 [0.96-1.93],0.083122948435859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SNX2,Sorting nexin-2,24145,101,1.27 [1.04-1.54],0.0180239647497451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SNX5,Sorting nexin-5,23579,96,1.16 [0.63-2.14],0.6419834493176272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SNX9,Sorting nexin-9,27929,121,1.25 [1.00-1.56],0.0483129373670431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SOD1,Superoxide dismutase [Cu-Zn],27320,114,1.13 [0.81-1.58],0.4574553004819823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SOD2,"Superoxide dismutase [Mn], mitochondrial",27919,121,0.98 [0.65-1.48],0.9301357626697552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SOD3,Extracellular superoxide dismutase,24282,100,1.24 [0.99-1.55],0.0578600396122716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SORBS1,Sorbin and SH3 domain-containing protein 1,24223,100,1.42 [0.99-2.03],0.0584665376137451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SORCS2,VPS10 domain-containing receptor SorCS2,27238,115,1.53 [0.96-2.41],0.0711712242206269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SORD,Sorbitol dehydrogenase,28052,118,0.94 [0.75-1.18],0.5933970001527378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SORT1,Sortilin,27897,121,1.30 [0.86-1.97],0.2118743919015912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SOST,Sclerostin,27897,121,1.71 [1.14-2.55],0.0092120980984713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,23584,95,0.89 [0.57-1.40],0.6263209404540092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SOX2,Transcription factor SOX-2,24184,100,0.87 [0.38-2.00],0.7399837597391694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SOX9,Transcription factor SOX-9,23584,95,1.06 [0.51-2.21],0.8776814479800715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24223,100,1.56 [1.03-2.38],0.0376004889029899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SPAG1,Sperm-associated antigen 1,24223,100,0.94 [0.67-1.31],0.7157167359582814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SPARC,SPARC,27992,119,1.07 [0.85-1.35],0.5500906606986048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SPARCL1,SPARC-like protein 1,27912,119,0.81 [0.45-1.47],0.4861110162721287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SPART,Spartin,23715,97,1.13 [0.88-1.44],0.3369999996503761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SPESP1,Sperm equatorial segment protein 1,24257,99,1.38 [0.74-2.60],0.309994404884828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SPINK1,Serine protease inhibitor Kazal-type 1,27919,121,1.87 [1.38-2.54],5.7375541815850864e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SPINK2,Serine protease inhibitor Kazal-type 2,23715,97,0.90 [0.56-1.46],0.6698019900660055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SPINK4,Serine protease inhibitor Kazal-type 4,27914,119,1.29 [1.02-1.64],0.0344295591767368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SPINK5,Serine protease inhibitor Kazal-type 5,27919,121,1.33 [0.83-2.12],0.2343044634788035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SPINK6,Serine protease inhibitor Kazal-type 6,28179,121,1.05 [0.79-1.40],0.7403431640016009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SPINK8,Serine protease inhibitor Kazal-type 8,23482,98,1.51 [1.10-2.09],0.0118274802713951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SPINT1,Kunitz-type protease inhibitor 1,27820,121,1.26 [0.69-2.32],0.4482919668617771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SPINT2,Kunitz-type protease inhibitor 2,28050,121,1.31 [0.89-1.93],0.168487220243334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SPINT3,Kunitz-type protease inhibitor 3,24167,101,0.99 [0.87-1.12],0.855722839156488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SPOCK1,Testican-1,27738,120,1.00 [0.54-1.87],0.9931005252913148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SPON1,Spondin-1,27955,121,1.40 [0.87-2.25],0.1714070122807006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SPON2,Spondin-2,27794,120,1.93 [1.22-3.04],0.0045762007550631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SPP1,Osteopontin,28219,121,1.33 [0.94-1.88],0.1032547989896808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",23569,96,1.37 [0.95-1.98],0.0884050290159657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SPRING1,SREBP regulating gene protein,23402,100,1.17 [0.88-1.54],0.27526246540097
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SPRR1B,Cornifin-B,23811,95,1.06 [0.85-1.31],0.6147925324741552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SPRR3,Small proline-rich protein 3,24190,99,1.18 [0.89-1.55],0.2474607462381993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SPRY2,Protein sprouty homolog 2,27408,119,1.15 [0.97-1.36],0.1045621040727966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",23483,97,1.46 [0.89-2.42],0.1362472878131569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SPTLC1,Serine palmitoyltransferase 1,24190,99,1.20 [0.75-1.91],0.4547419317188034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SRC,Proto-oncogene tyrosine-protein kinase Src,27948,119,1.07 [0.94-1.23],0.3149335328180243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SRP14,Signal recognition particle 14 kDa protein,27803,121,1.36 [1.07-1.72],0.0108872939070885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SRPK2,SRSF protein kinase 2,27914,119,1.17 [0.98-1.40],0.0788775432144531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SRPX,Sushi repeat-containing protein SRPX,24257,99,1.82 [1.05-3.18],0.0343169721726218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SSB,Lupus La protein,27266,115,0.93 [0.69-1.25],0.6282421965375816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",23569,96,1.28 [0.82-2.02],0.2803466646308847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,27897,121,0.98 [0.86-1.12],0.7746736722999248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,28004,119,1.32 [0.91-1.92],0.1439169817610496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SSH3,Protein phosphatase Slingshot homolog 3,23402,100,1.49 [0.87-2.53],0.1426284603903693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24167,101,1.50 [1.08-2.08],0.0145214266002087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ST13,Hsc70-interacting protein,23715,97,1.27 [0.90-1.79],0.1726330557453826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",27803,121,1.37 [1.00-1.88],0.0529282270718665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",28272,122,1.74 [1.04-2.92],0.0362997185377181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",23569,96,1.12 [0.78-1.60],0.5332710186133611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,STAB2,Stabilin-2,24251,100,0.83 [0.43-1.60],0.584183483640005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,STAM,Signal transducing adapter molecule 1,24145,101,1.26 [0.80-1.98],0.3257212655835505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,STAMBP,STAM-binding protein,27689,119,1.24 [0.97-1.59],0.08880584988305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,STAT2,Signal transducer and activator of transcription 2,23569,96,1.29 [1.01-1.63],0.0373578696602763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,STAT5B,Signal transducer and activator of transcription 5B,27803,121,1.09 [0.97-1.23],0.153055439147633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,23402,100,1.24 [0.97-1.58],0.0912898549386764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,STC1,Stanniocalcin-1,28192,122,1.30 [0.92-1.84],0.1370074388896477
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,STC2,Stanniocalcin-2,27879,119,1.34 [0.72-2.51],0.3547615739976987
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,STEAP4,Metalloreductase STEAP4,23483,97,1.20 [0.98-1.48],0.0771415945242732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,STIP1,Stress-induced-phosphoprotein 1,27870,121,1.20 [0.95-1.52],0.1279624105140557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,STK11,Serine/threonine-protein kinase STK11,27425,119,1.14 [0.91-1.41],0.2514017605025697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,STK24,Serine/threonine-protein kinase 24,27266,115,1.04 [0.80-1.36],0.7558609167971263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,STK4,Serine/threonine-protein kinase 4,27929,121,1.05 [0.88-1.26],0.5687971662819076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,STOML2,"Stomatin-like protein 2, mitochondrial",23402,100,1.04 [0.85-1.27],0.6963522349240603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,STX16,Syntaxin-16,27238,115,1.05 [0.79-1.38],0.7490236739388487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,STX1B,Syntaxin-1B,23584,95,1.22 [0.85-1.75],0.2904004901888273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,STX3,Syntaxin-3,24190,99,1.06 [0.65-1.73],0.8069710685379953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,STX4,Syntaxin-4,27803,121,1.11 [0.87-1.40],0.4000622598011349
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,STX5,Syntaxin-5,23569,96,0.96 [0.59-1.56],0.8674595461006659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,STX6,Syntaxin-6,27238,115,1.11 [0.88-1.39],0.3734946018906735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,STX7,Syntaxin-7,23569,96,1.18 [0.80-1.74],0.4083772022688826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,STX8,Syntaxin-8,27914,119,1.10 [0.81-1.51],0.5407599478284885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,STXBP1,Syntaxin-binding protein 1,24223,100,1.09 [0.85-1.39],0.4982888273354157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,STXBP3,Syntaxin-binding protein 3,27238,115,1.26 [0.90-1.75],0.175923734156246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SUGP1,SURP and G-patch domain-containing protein 1,24167,101,1.60 [1.09-2.35],0.0161576757998296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SUGT1,Protein SGT1 homolog,27238,115,1.12 [0.91-1.37],0.2968626556428255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SULT1A1,Sulfotransferase 1A1,28192,122,1.06 [0.94-1.20],0.3574348125635845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SULT2A1,Bile salt sulfotransferase,27914,119,0.84 [0.62-1.14],0.2535480265827725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SUMF1,Formylglycine-generating enzyme,23569,96,1.05 [0.81-1.36],0.719342403527569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,28192,122,1.10 [0.82-1.48],0.5318628250969377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SUOX,"Sulfite oxidase, mitochondrial",24223,100,1.21 [0.92-1.60],0.1725479323799454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SUSD1,Sushi domain-containing protein 1,27425,119,1.14 [0.81-1.60],0.447864067604323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SUSD2,Sushi domain-containing protein 2,27919,121,0.80 [0.46-1.39],0.4275721110723965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SUSD4,Sushi domain-containing protein 4,24145,101,1.32 [0.89-1.96],0.1615847667147292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SUSD5,Sushi domain-containing protein 5,23588,97,1.13 [0.64-1.98],0.6729470951481977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SV2A,Synaptic vesicle glycoprotein 2A,23584,95,1.04 [0.76-1.42],0.7908103915153324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SWAP70,Switch-associated protein 70,24167,101,1.61 [1.12-2.31],0.0095488140647502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SYAP1,Synapse-associated protein 1,23715,97,1.20 [0.87-1.66],0.2584735072980622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,23483,97,1.18 [0.87-1.58],0.2819115999707103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SYT1,Synaptotagmin-1,24190,99,1.39 [0.95-2.04],0.0929322053482332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,SYTL4,Synaptotagmin-like protein 4,24257,99,1.12 [0.87-1.44],0.3757515084543597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,23811,95,1.13 [0.94-1.36],0.1800411923588614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TACC3,Transforming acidic coiled-coil-containing protein 3,27803,121,1.07 [0.93-1.22],0.3511307528749265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TACSTD2,Tumor-associated calcium signal transducer 2,24798,108,1.68 [0.94-3.00],0.0793166771578562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TADA3,Transcriptional adapter 3,24145,101,1.66 [1.08-2.55],0.0198822498281806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TAFA5,Chemokine-like protein TAFA-5,27803,121,1.98 [1.31-2.98],0.0012091784973618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TAGLN3,Transgelin-3,23402,100,0.68 [0.50-0.93],0.0158473947961671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TALDO1,Transaldolase,24171,100,1.08 [0.71-1.62],0.7256450688115892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TANK,TRAF family member-associated NF-kappa-B activator,27408,119,1.19 [0.95-1.49],0.1203845841845096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TAP1,Antigen peptide transporter 1,23811,95,1.12 [0.84-1.49],0.4320169390278715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TARBP2,RISC-loading complex subunit TARBP2,27266,115,1.18 [0.96-1.44],0.117135277574991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",23584,95,0.92 [0.70-1.22],0.5643894548014368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24145,101,1.68 [1.08-2.64],0.0227007032726452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TAX1BP1,Tax1-binding protein 1,24190,99,1.26 [0.96-1.67],0.0977060878575428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TBC1D17,TBC1 domain family member 17,27266,115,1.25 [0.89-1.74],0.1991291236476075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TBC1D23,TBC1 domain family member 23,27803,121,1.05 [0.88-1.25],0.5862964390063976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TBC1D5,TBC1 domain family member 5,27914,119,1.14 [0.94-1.38],0.1754843194515575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TBCA,Tubulin-specific chaperone A,23715,97,1.20 [0.97-1.50],0.0931969224919719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TBCB,Tubulin-folding cofactor B,27738,120,1.09 [0.93-1.29],0.2870128472621762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TBCC,Tubulin-specific chaperone C,27738,120,1.19 [0.98-1.45],0.083904334686457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TBL1X,F-box-like/WD repeat-containing protein TBL1X,27238,115,1.21 [0.99-1.47],0.0612068262257955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TBR1,T-box brain protein 1,23584,95,0.95 [0.62-1.47],0.8260863044788602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TCL1A,T-cell leukemia/lymphoma protein 1A,27686,120,0.93 [0.79-1.09],0.3639708159985239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TCL1B,T-cell leukemia/lymphoma protein 1B,27425,119,1.00 [0.81-1.22],0.9825168085922732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TCN1,Transcobalamin-1,23800,97,0.91 [0.51-1.61],0.734321737989553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TCN2,Transcobalamin-2,28219,121,1.51 [0.91-2.50],0.1079742805220632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TCOF1,Treacle protein,24257,99,0.93 [0.49-1.73],0.8081087597100846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TCP11,T-complex protein 11 homolog,23811,95,0.88 [0.59-1.29],0.5051824479573424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TCTN3,Tectonic-3,24257,99,0.78 [0.41-1.48],0.4500422672952839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TDGF1,Teratocarcinoma-derived growth factor 1,27266,115,1.12 [1.00-1.25],0.0509024852051306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TDO2,"Tryptophan 2,3-dioxygenase",23584,95,0.77 [0.44-1.37],0.3787765246143646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TDP1,Tyrosyl-DNA phosphodiesterase 1,24145,101,1.22 [0.98-1.51],0.0776936141307227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TDRKH,Tudor and KH domain-containing protein,27266,115,1.19 [0.99-1.42],0.0610625869291219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TEF,Thyrotroph embryonic factor,23482,98,1.12 [0.73-1.73],0.5916515391572681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TEK,Angiopoietin-1 receptor,27992,119,2.00 [0.97-4.11],0.0600164651657954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TERF1,Telomeric repeat-binding factor 1,23569,96,1.69 [0.97-2.95],0.0625561365334953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TET2,Methylcytosine dioxygenase TET2,23778,95,0.99 [0.81-1.21],0.9412100407904996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TEX101,Testis-expressed protein 101,23584,95,0.71 [0.46-1.09],0.1172139328817616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TEX33,Testis-expressed protein 33,23811,95,0.69 [0.37-1.28],0.2360868356360361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TF,Serotransferrin,24294,101,0.73 [0.31-1.69],0.4612475049980178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TFAP2A,Transcription factor AP-2-alpha,23483,97,1.05 [0.76-1.44],0.7824978620662029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TFF1,Trefoil factor 1,27786,120,1.27 [1.06-1.53],0.0110434070911129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TFF2,Trefoil factor 2,28007,121,1.50 [1.18-1.92],0.0010081904368938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TFF3,Trefoil factor 3,27881,119,1.43 [1.13-1.82],0.0030305811876891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TFPI,Tissue factor pathway inhibitor,27826,119,0.91 [0.55-1.53],0.7300301429062561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TFPI2,Tissue factor pathway inhibitor 2,27897,119,1.62 [1.33-1.97],1.4705564632328524e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TFRC,Transferrin receptor protein 1,28018,118,0.70 [0.46-1.07],0.1036301423264109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TG,Thyroglobulin,24145,101,1.03 [0.87-1.22],0.7499191451118629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TGFA,Protransforming growth factor alpha,27914,119,1.65 [1.22-2.24],0.0011940065183835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TGFB1,Transforming growth factor beta-1 proprotein,28217,122,1.60 [1.09-2.35],0.016896767383093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TGFB2,Transforming growth factor beta-2 proprotein,24145,101,1.06 [0.76-1.49],0.7221986400553986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TGFBI,Transforming growth factor-beta-induced protein ig-h3,27738,119,0.74 [0.40-1.35],0.3264985113229909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TGFBR1,TGF-beta receptor type-1,23569,96,1.36 [0.65-2.86],0.4126094129226176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TGFBR2,TGF-beta receptor type-2,27992,119,1.72 [1.08-2.74],0.0225430432929147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TGFBR3,Transforming growth factor beta receptor type 3,28272,122,0.88 [0.54-1.41],0.5898288195059239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TGM2,Protein-glutamine gamma-glutamyltransferase 2,27875,120,1.18 [0.96-1.46],0.1204016542156952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TGOLN2,Trans-Golgi network integral membrane protein 2,24282,100,0.92 [0.43-1.96],0.819369267452221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23355,99,0.99 [0.79-1.23],0.909615331186144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,THBD,Thrombomodulin,27929,121,1.50 [0.84-2.65],0.1673191660925389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,THBS2,Thrombospondin-2,27919,121,1.91 [1.34-2.73],0.0003616180787944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,THBS4,Thrombospondin-4,27925,119,1.05 [0.74-1.50],0.7787426876516579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,THOP1,Thimet oligopeptidase,27811,121,1.34 [0.83-2.17],0.2312722364330738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,THPO,Thrombopoietin,27425,119,1.12 [0.74-1.70],0.5962583372771985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,THRAP3,Thyroid hormone receptor-associated protein 3,23482,98,0.96 [0.80-1.15],0.6631917833505165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,THSD1,Thrombospondin type-1 domain-containing protein 1,23393,94,1.65 [1.06-2.57],0.0277525589657152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,THTPA,Thiamine-triphosphatase,24093,101,1.24 [1.00-1.53],0.0501401799836417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,THY1,Thy-1 membrane glycoprotein,28192,122,2.12 [1.21-3.71],0.0083444375601598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TIA1,Nucleolysin TIA-1 isoform p40,27121,118,1.06 [0.93-1.21],0.3913680934581938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TIE1,Tyrosine-protein kinase receptor Tie-1,28272,122,1.02 [0.70-1.49],0.9196201501436196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",27217,114,1.50 [1.11-2.03],0.0080080370116561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,23811,95,1.08 [0.65-1.82],0.7586219047538991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,28004,119,1.21 [0.84-1.74],0.3146497452175968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24257,99,1.07 [0.67-1.70],0.7896895609912652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24190,99,1.00 [0.80-1.25],0.9986836268551994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TIMP1,Metalloproteinase inhibitor 1,27596,119,1.54 [0.89-2.65],0.1225263897889835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TIMP2,Metalloproteinase inhibitor 2,24257,99,1.58 [1.02-2.43],0.0396961144496756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TIMP3,Metalloproteinase inhibitor 3,28050,121,1.05 [0.94-1.18],0.3946962338386482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TIMP4,Metalloproteinase inhibitor 4,27919,121,1.15 [0.77-1.71],0.4891785591946966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TINAGL1,Tubulointerstitial nephritis antigen-like,27847,121,2.62 [1.34-5.13],0.0049386874728935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TJAP1,Tight junction-associated protein 1,27992,119,1.19 [0.98-1.44],0.0718657122637128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TJP3,Tight junction protein ZO-3,23483,97,1.23 [0.84-1.81],0.287560371867343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TK1,"Thymidine kinase, cytosolic",23811,95,1.19 [0.81-1.75],0.3760251087304137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TLR1,Toll-like receptor 1,23569,96,2.97 [1.78-4.94],2.939898959560448e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TLR2,Toll-like receptor 2,23811,95,1.97 [0.87-4.44],0.1041110946543096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TLR3,Toll-like receptor 3,28265,122,0.84 [0.65-1.08],0.1663536066174322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TLR4,Toll-like receptor 4,23569,96,1.87 [1.00-3.49],0.0495076025783201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,23584,95,0.86 [0.58-1.28],0.4473314216549163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TMED1,Transmembrane emp24 domain-containing protein 1,23811,95,0.77 [0.51-1.15],0.202639901043344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TMED10,Transmembrane emp24 domain-containing protein 10,23482,98,1.07 [0.75-1.53],0.7158349750034472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TMED4,Transmembrane emp24 domain-containing protein 4,23482,98,0.88 [0.60-1.30],0.5205613648295464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TMED8,Protein TMED8,24167,101,1.14 [0.95-1.37],0.1678252439902506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TMEM106A,Transmembrane protein 106A,24145,101,1.15 [0.90-1.48],0.2593851933485533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TMEM132A,Transmembrane protein 132A,23579,96,1.01 [0.74-1.36],0.9721512507015928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TMEM25,Transmembrane protein 25,24223,100,0.74 [0.46-1.18],0.1992116062781388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TMOD4,Tropomodulin-4,23402,100,0.93 [0.58-1.51],0.7779495952546175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TMPRSS11B,Transmembrane protease serine 11B,23483,97,1.15 [0.93-1.44],0.2032457493054923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TMPRSS11D,Transmembrane protease serine 11D,24136,99,1.36 [0.84-2.21],0.2145941707528847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TMPRSS15,Enteropeptidase,27803,121,1.21 [1.01-1.45],0.0378895383687947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TMPRSS5,Transmembrane protease serine 5,27594,120,0.90 [0.59-1.37],0.6212145715363375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TMSB10,Thymosin beta-10,27919,121,1.17 [0.96-1.44],0.124606652450509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNC,Tenascin,28004,119,1.15 [0.82-1.60],0.4252466770206923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNF,Tumor necrosis factor,27376,119,1.49 [1.15-1.92],0.0026428147452446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24167,101,1.32 [0.95-1.83],0.1013641595258393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,27408,119,1.45 [0.96-2.18],0.0775798118810899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,23715,97,1.22 [0.92-1.62],0.1755809985395108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,27738,120,2.19 [1.58-3.05],2.823452725930801e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,27738,120,1.34 [1.09-1.64],0.0052271529334863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,27979,120,1.31 [0.94-1.85],0.1135680493308251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,28265,122,1.81 [1.23-2.67],0.0026977217801326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,27905,121,1.74 [1.07-2.84],0.025618699379771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,27992,119,1.89 [1.24-2.87],0.0029045247666693
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,27955,121,1.55 [1.00-2.40],0.0521445562394013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,27408,119,1.41 [1.00-1.99],0.050915104207788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,27955,121,2.06 [1.27-3.36],0.0036561400487717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,23715,97,0.91 [0.55-1.50],0.7116139064683252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,28179,121,2.22 [1.45-3.39],0.0002270102136523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,27919,121,2.11 [1.26-3.55],0.0047024867045304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,27919,121,1.43 [1.03-1.99],0.0336433502779744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,28192,122,1.35 [0.75-2.41],0.3184457816256805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,28217,122,1.58 [1.06-2.35],0.0259598956599433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,27738,120,1.26 [0.96-1.65],0.0989667171881281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,28192,122,1.18 [0.83-1.67],0.3521181339368927
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,27738,120,1.94 [1.44-2.61],1.1258693200926104e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNFSF10,Tumor necrosis factor ligand superfamily member 10,28265,122,1.70 [0.93-3.10],0.0839764708101506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNFSF11,Tumor necrosis factor ligand superfamily member 11,27914,119,0.94 [0.73-1.22],0.6581102057347346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNFSF12,Tumor necrosis factor ligand superfamily member 12,28265,122,1.14 [0.67-1.95],0.6287522814610647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNFSF13,Tumor necrosis factor ligand superfamily member 13,28050,121,2.61 [1.50-4.56],0.0007111539563209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,28219,122,1.55 [0.89-2.68],0.1200591929319889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNFSF14,Tumor necrosis factor ligand superfamily member 14,27738,120,1.23 [0.94-1.61],0.136102497302389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24251,100,1.05 [0.62-1.78],0.8669277649531689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNIP1,TNFAIP3-interacting protein 1,24190,99,1.15 [0.94-1.42],0.1804944723955571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNN,Tenascin-N,24251,100,1.03 [0.67-1.58],0.9075956626667312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNNI3,"Troponin I, cardiac muscle",27425,119,1.10 [0.90-1.35],0.3636882799733678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNPO1,Transportin-1,23811,95,0.91 [0.52-1.60],0.7518985921379056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNR,Tenascin-R,27738,120,1.38 [0.95-2.02],0.0922386949036505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TNXB,Tenascin-X,27919,121,0.65 [0.36-1.18],0.1585132589871475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24257,99,1.17 [0.92-1.48],0.1953638110209965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TOP1,DNA topoisomerase 1,24167,101,1.06 [0.90-1.24],0.5159147205447792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TOP1MT,"DNA topoisomerase I, mitochondrial",23402,100,1.09 [0.76-1.56],0.6421978261464014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TOP2B,DNA topoisomerase 2-beta,23569,96,1.17 [0.93-1.48],0.1884745260616886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TOR1AIP1,Torsin-1A-interacting protein 1,23579,96,1.21 [0.88-1.65],0.2336384788388644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TP53,Cellular tumor antigen p53,27238,115,1.03 [0.70-1.51],0.8765192365570036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TP53BP1,TP53-binding protein 1,23569,96,0.90 [0.71-1.14],0.3704355471511886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TP53I3,Quinone oxidoreductase PIG3,23197,94,0.95 [0.66-1.37],0.7807983805934872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TP53INP1,Tumor protein p53-inducible nuclear protein 1,27425,119,1.10 [0.68-1.78],0.7080129154554862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TP73,Tumor protein p73,23584,95,0.58 [0.33-1.04],0.0684260775786233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TPBGL,Trophoblast glycoprotein-like,23584,95,0.92 [0.55-1.52],0.7378952906053486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TPD52L2,Tumor protein D54,23715,97,1.12 [0.93-1.34],0.218884961799675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TPK1,Thiamin pyrophosphokinase 1,24257,99,0.81 [0.41-1.59],0.5383666386869119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TPM3,Tropomyosin alpha-3 chain,23482,98,0.89 [0.56-1.41],0.619330346663613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TPMT,Thiopurine S-methyltransferase,27238,115,1.13 [0.91-1.40],0.260469316783758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TPP1,Tripeptidyl-peptidase 1,27725,121,1.11 [0.80-1.54],0.5433312297275069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TPPP2,Tubulin polymerization-promoting protein family member 2,23811,95,1.00 [0.78-1.27],0.985159716495414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TPPP3,Tubulin polymerization-promoting protein family member 3,27266,115,0.97 [0.64-1.49],0.8985402474144323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TPR,Nucleoprotein TPR,23482,98,1.37 [1.06-1.78],0.0149813827714389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TPRKB,EKC/KEOPS complex subunit TPRKB,23402,100,1.05 [0.79-1.39],0.7600608183682611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TPSAB1,Tryptase alpha/beta-1,28214,122,1.32 [0.97-1.80],0.0774972154978081
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TPSD1,Tryptase delta,24223,100,1.31 [0.85-2.00],0.2230367696964015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TPSG1,Tryptase gamma,23569,96,0.91 [0.44-1.90],0.8072856479943922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TPT1,Translationally-controlled tumor protein,27408,119,1.20 [0.99-1.46],0.0564455406138282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TRAF2,TNF receptor-associated factor 2,27914,119,1.17 [0.94-1.46],0.1517918063538747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TRAF3,"TNF receptor-associated factor 3, Isoform 2",23569,96,1.31 [0.84-2.04],0.2379078792725533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,23482,98,1.09 [0.75-1.58],0.6599734200444063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,23811,95,1.05 [0.84-1.32],0.6683314739593269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TREH,Trehalase,24251,100,0.83 [0.65-1.06],0.1336229623347003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TREM2,Triggering receptor expressed on myeloid cells 2,27905,121,1.09 [0.81-1.46],0.5689287735612971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TREML1,Trem-like transcript 1 protein,24282,100,0.85 [0.59-1.21],0.3662654558958138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TREML2,Trem-like transcript 2 protein,27919,121,1.71 [1.08-2.71],0.0230700921911166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TRIAP1,TP53-regulated inhibitor of apoptosis 1,28179,121,1.21 [0.95-1.54],0.1233339376624892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TRIM21,E3 ubiquitin-protein ligase TRIM21,27914,119,1.02 [0.82-1.26],0.8668153107945638
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TRIM24,Transcription intermediary factor 1-alpha,23760,94,1.27 [0.98-1.66],0.0736100191876608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24167,101,1.19 [1.00-1.41],0.0527760924186721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TRIM26,Tripartite motif-containing protein 26,23402,100,1.01 [0.73-1.41],0.9313690554835912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TRIM40,E3 ubiquitin ligase TRIM40,23584,95,0.95 [0.72-1.24],0.6928905480032838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TRIM5,Tripartite motif-containing protein 5,27914,119,1.12 [0.93-1.35],0.2434704877764315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TRIM58,E3 ubiquitin-protein ligase TRIM58,24145,101,1.23 [0.99-1.52],0.0605648018534087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TRPV3,Transient receptor potential cation channel subfamily V member 3,23482,98,0.94 [0.63-1.40],0.7583028597867055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TSC1,Hamartin,23569,96,1.05 [0.82-1.34],0.7097448445053329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TSC22D1,TSC22 domain family protein 1,24223,100,1.20 [0.93-1.56],0.1650906617603116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TSHB,Thyrotropin subunit beta,27929,121,1.07 [0.87-1.32],0.50842069745284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TSLP,Thymic stromal lymphopoietin,27425,119,0.90 [0.67-1.21],0.5052916684902741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TSNAX,Translin-associated protein X,23482,98,1.18 [0.74-1.89],0.4921010554205959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TSPAN1,Tetraspanin-1,27425,119,0.76 [0.48-1.21],0.2429895597325818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TSPAN15,Tetraspanin-15,23482,98,0.90 [0.60-1.36],0.6267655390180134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TSPAN7,Tetraspanin-7,23483,97,0.90 [0.71-1.14],0.3873213743223429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TSPAN8,Tetraspanin-8,24167,101,1.03 [0.85-1.24],0.787791637753639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TSPYL1,Testis-specific Y-encoded-like protein 1,23569,96,1.60 [1.07-2.38],0.0219197743088646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TST,Thiosulfate sulfurtransferase,27227,115,1.07 [0.87-1.33],0.5110533244449795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TTF2,Transcription termination factor 2,23584,95,0.97 [0.66-1.44],0.8902613840361173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TTN,Titin,23482,98,1.12 [0.87-1.45],0.3803121613003446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TTR,Transthyretin,24026,100,0.94 [0.45-1.98],0.8788962933348814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TUBB3,Tubulin beta-3 chain,23483,97,1.65 [0.91-2.99],0.1012928437158688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TWF2,Twinfilin-2,24251,100,1.14 [0.91-1.42],0.2570625310989901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TXK,Tyrosine-protein kinase TXK,23811,95,1.23 [1.00-1.52],0.0464198169335457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TXLNA,Alpha-taxilin,27738,120,1.20 [1.00-1.44],0.0469979863520474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TXN,Thioredoxin,23888,97,1.14 [0.76-1.73],0.5206661466464748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TXNDC15,Thioredoxin domain-containing protein 15,27992,119,1.32 [0.75-2.34],0.3362144877730472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TXNDC5,Thioredoxin domain-containing protein 5,28192,122,1.23 [0.99-1.53],0.066730802437569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TXNDC9,Thioredoxin domain-containing protein 9,24190,99,1.16 [0.83-1.63],0.3863804510992704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TXNL1,Thioredoxin-like protein 1,23440,97,1.08 [0.90-1.30],0.4273368598642099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",27919,121,1.24 [0.90-1.73],0.1931512167353291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TYMP,Thymidine phosphorylase,27754,121,1.17 [0.93-1.48],0.1879902204346341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TYRO3,Tyrosine-protein kinase receptor TYRO3,27929,121,1.55 [0.88-2.72],0.1298395195277374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",23569,96,1.15 [0.84-1.59],0.3853767907105232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,UBAC1,Ubiquitin-associated domain-containing protein 1,27803,121,1.30 [0.82-2.06],0.258613057122004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,UBE2B,Ubiquitin-conjugating enzyme E2 B,24145,101,2.31 [1.46-3.65],0.0003557962542695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24257,99,1.26 [0.94-1.70],0.1288494712065632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,23569,96,1.15 [0.86-1.55],0.3531508283933404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,UBQLN3,Ubiquilin-3,23482,98,1.18 [0.83-1.69],0.349873483925341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,UBXN1,UBX domain-containing protein 1,23715,97,1.19 [0.91-1.55],0.2108729912860908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24167,101,1.11 [0.97-1.27],0.1410551088006438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,UGDH,UDP-glucose 6-dehydrogenase,23482,98,0.96 [0.79-1.18],0.7220256656012669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,UHRF2,E3 ubiquitin-protein ligase UHRF2,23482,98,1.06 [0.63-1.80],0.8231794109690795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ULBP2,UL16-binding protein 2,27738,120,1.83 [1.24-2.69],0.0021205202160787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,UMOD,Uromodulin,28176,122,0.63 [0.48-0.82],0.0006628690928994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,UNC5D,Netrin receptor UNC5D,23569,96,1.00 [0.48-2.07],0.9999423627602596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,UNC79,Protein unc-79 homolog,23402,100,1.12 [0.81-1.55],0.4812895728213416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,UNG,Uracil-DNA glycosylase,24145,101,1.80 [1.29-2.50],0.0005669075326692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,UPB1,Beta-ureidopropionase,24257,99,0.89 [0.73-1.09],0.2724933682470147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,UPK3A,Uroplakin-3a,23483,97,1.40 [0.99-1.97],0.0568364423408809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,UPK3BL1,Uroplakin-3b-like protein 1,23772,95,0.98 [0.68-1.42],0.9293038648956026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,UROD,Uroporphyrinogen decarboxylase,23715,97,1.19 [0.90-1.56],0.2244317071971119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,UROS,Uroporphyrinogen-III synthase,23584,95,0.95 [0.70-1.27],0.7204740204771978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,USO1,General vesicular transport factor p115,27803,121,1.14 [0.95-1.36],0.158897600180297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24145,101,1.26 [0.98-1.63],0.0706805483936387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24190,99,1.40 [0.95-2.07],0.086692327145359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,USP47,Ubiquitin carboxyl-terminal hydrolase 47,23482,98,1.02 [0.82-1.27],0.8248659432567448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,USP8,Ubiquitin carboxyl-terminal hydrolase 8,27425,119,1.12 [0.95-1.32],0.1616852518461535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,UXS1,UDP-glucuronic acid decarboxylase 1,27238,115,0.96 [0.70-1.32],0.7925733004749216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VAMP5,Vesicle-associated membrane protein 5,27425,119,1.19 [0.91-1.56],0.2044794090364338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VAMP8,Vesicle-associated membrane protein 8,23569,96,1.18 [0.95-1.46],0.1350246497453311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VASH1,Tubulinyl-Tyr carboxypeptidase 1,27914,119,1.02 [0.84-1.24],0.845932297647492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VASN,Vasorin,27473,115,1.47 [0.81-2.65],0.205737005799196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VASP,Vasodilator-stimulated phosphoprotein,24282,100,1.18 [0.92-1.52],0.1956817034180465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,27803,121,1.09 [0.49-2.41],0.8340207945105501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VAV3,Guanine nucleotide exchange factor VAV3,23483,97,1.07 [0.88-1.30],0.4970445029367615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VCAM1,Vascular cell adhesion protein 1,27970,119,2.62 [1.52-4.50],0.0005137202930484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VCAN,Versican core protein,28192,122,1.09 [0.64-1.85],0.7437817534689675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VCPKMT,Protein-lysine methyltransferase METTL21D,23402,100,1.13 [0.94-1.36],0.1836778370454845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VEGFA,Vascular endothelial growth factor A,28171,122,1.12 [0.86-1.46],0.4065854391084744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VEGFB,Vascular endothelial growth factor B,23569,96,0.55 [0.28-1.08],0.0831233506971225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VEGFC,Vascular endothelial growth factor C,27992,119,0.94 [0.71-1.25],0.6610890047474376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VEGFD,Vascular endothelial growth factor D,28216,122,1.11 [0.71-1.73],0.6425333331676828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VGF,Neurosecretory protein VGF,24223,100,1.15 [0.61-2.15],0.670087715134613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VIM,Vimentin,27425,119,1.04 [0.90-1.20],0.5923391623658858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VIPR1,Vasoactive intestinal polypeptide receptor 1,23579,96,0.88 [0.40-1.95],0.7557726119655512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VIT,Vitrin,24257,99,1.06 [0.64-1.75],0.831244406191316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VMO1,Vitelline membrane outer layer protein 1 homolog,27803,121,1.45 [1.12-1.88],0.0051100199544088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VNN1,Pantetheinase,24282,100,0.81 [0.64-1.04],0.1032515955432337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VNN2,Vascular non-inflammatory molecule 2,27803,121,1.53 [1.06-2.19],0.0224893342174646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VPS28,Vacuolar protein sorting-associated protein 28 homolog,23811,95,1.21 [0.92-1.58],0.1645595023305248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VPS37A,Vacuolar protein sorting-associated protein 37A,27803,121,1.14 [0.94-1.39],0.1923128477112234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VPS4B,Vacuolar protein sorting-associated protein 4B,24145,101,1.14 [0.94-1.39],0.1730842358283351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VPS53,Vacuolar protein sorting-associated protein 53 homolog,27803,121,1.18 [0.97-1.44],0.1045547369775428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VSIG10,V-set and immunoglobulin domain-containing protein 10,24145,101,0.88 [0.52-1.51],0.6439423102409827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,23482,98,1.37 [0.82-2.27],0.2290484569719784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VSIG2,V-set and immunoglobulin domain-containing protein 2,24145,101,1.92 [1.48-2.49],7.237970730431221e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VSIG4,V-set and immunoglobulin domain-containing protein 4,27879,119,1.51 [1.01-2.24],0.0447296266941536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,27891,121,1.12 [0.88-1.44],0.348442331119854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VSNL1,Visinin-like protein 1,24190,99,0.98 [0.60-1.61],0.9490613882436084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VSTM1,V-set and transmembrane domain-containing protein 1,27266,115,1.43 [1.05-1.96],0.0253445169639296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VSTM2B,V-set and transmembrane domain-containing protein 2B,23811,95,0.80 [0.47-1.39],0.4312716300535378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,27425,119,1.17 [0.90-1.50],0.2355922114584915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,28192,122,1.18 [0.95-1.47],0.1297182559782468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VTCN1,V-set domain-containing T-cell activation inhibitor 1,27238,115,1.00 [0.61-1.66],0.9961381870627942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,23715,97,1.14 [0.83-1.57],0.4031499007919091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VWA1,von Willebrand factor A domain-containing protein 1,28142,121,1.18 [0.82-1.71],0.3758793059177916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VWA5A,von Willebrand factor A domain-containing protein 5A,23402,100,0.86 [0.64-1.14],0.2903777659999331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VWC2,Brorin,27641,119,1.93 [1.29-2.89],0.0015133704273811
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VWC2L,von Willebrand factor C domain-containing protein 2-like,24223,100,1.16 [0.83-1.62],0.3815225823120712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,VWF,von Willebrand factor,28272,122,1.11 [0.89-1.37],0.3552824817185649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,WARS,"Tryptophan--tRNA ligase, cytoplasmic",27919,121,1.05 [0.68-1.62],0.8145628148611092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,WAS,Wiskott-Aldrich syndrome protein,27408,119,1.12 [0.89-1.40],0.3328832013993492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,WASF1,Wiskott-Aldrich syndrome protein family member 1,27425,119,1.10 [0.93-1.30],0.2630234192623959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,WASF3,Wiskott-Aldrich syndrome protein family member 3,27266,115,1.14 [0.93-1.38],0.2003131931804143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,WASHC3,WASH complex subunit 3,24190,99,1.19 [0.95-1.50],0.1301442103414245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,WASL,Neural Wiskott-Aldrich syndrome protein,23569,96,1.08 [0.80-1.46],0.5966611115768145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,WDR46,WD repeat-containing protein 46,24145,101,1.04 [0.63-1.72],0.8660972085316813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,WFDC1,WAP four-disulfide core domain protein 1,23666,98,1.12 [0.81-1.54],0.4967304659094759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,WFDC12,WAP four-disulfide core domain protein 12,28127,121,1.12 [0.88-1.44],0.362786772838596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,WFDC2,WAP four-disulfide core domain protein 2,26480,112,2.02 [1.39-2.92],0.0002050557332911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",27650,120,0.97 [0.65-1.45],0.8925798895306364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",27955,121,0.99 [0.62-1.59],0.9703017954112888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,WIF1,Wnt inhibitory factor 1,28179,121,1.13 [0.71-1.79],0.6110194359215559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,WNT9A,Protein Wnt-9a,27408,119,1.91 [1.20-3.04],0.0065578060425332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,27738,120,1.21 [0.91-1.63],0.1937060133315724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,XCL1,Lymphotactin,28179,121,1.23 [0.96-1.59],0.1039580915323333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,XG,Glycoprotein Xg,28126,120,2.01 [1.28-3.15],0.0024851239881238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,XIAP,E3 ubiquitin-protein ligase XIAP,23569,96,1.29 [0.94-1.76],0.1156514197752882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,XPNPEP2,Xaa-Pro aminopeptidase 2,27992,119,1.02 [0.87-1.19],0.8346158808401468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,XRCC4,DNA repair protein XRCC4,27266,115,1.26 [0.83-1.91],0.284913080387123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,YAP1,Transcriptional coactivator YAP1,24190,99,2.32 [1.30-4.15],0.0042665281692358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24167,101,1.11 [0.98-1.27],0.1106001429407184
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,YES1,Tyrosine-protein kinase Yes,27803,121,1.09 [0.95-1.25],0.2238065242441939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,YJU2,Splicing factor YJU2,24145,101,1.71 [1.04-2.81],0.0352235025809527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,YOD1,Ubiquitin thioesterase OTU1,23482,98,1.09 [0.80-1.48],0.5900114753518333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,YTHDF3,YTH domain-containing family protein 3,27408,119,1.22 [1.01-1.47],0.036297436767999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,YWHAQ,14-3-3 protein theta,23715,97,1.23 [0.96-1.59],0.1050512827140816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,YY1,Transcriptional repressor protein YY1,23569,96,1.34 [0.69-2.59],0.3818959231574841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ZBP1,Z-DNA-binding protein 1,23569,96,1.42 [1.00-2.02],0.0509726914418594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ZBTB16,Zinc finger and BTB domain-containing protein 16,27238,115,1.25 [1.01-1.55],0.0416508080528314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ZBTB17,Zinc finger and BTB domain-containing protein 17,27425,119,1.37 [1.01-1.86],0.0413730574222933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ZCCHC8,Zinc finger CCHC domain-containing protein 8,23482,98,1.02 [0.74-1.39],0.9234368738169976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ZFYVE19,Abscission/NoCut checkpoint regulator,24167,101,1.15 [0.94-1.42],0.1807538484354804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ZHX2,Zinc fingers and homeoboxes protein 2,24190,99,1.15 [0.71-1.87],0.5768974446303721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ZNF174,Zinc finger protein 174,23569,96,1.22 [0.79-1.90],0.3670832939222362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ZNF75D,Zinc finger protein 75D,23811,95,0.77 [0.53-1.13],0.1812883410915488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ZNF830,Zinc finger protein 830,24145,101,0.93 [0.72-1.19],0.5602532350063363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ZNRD2,Protein ZNRD2,24167,101,1.16 [0.89-1.51],0.2606177307567673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24145,101,1.06 [0.75-1.50],0.7259747564010854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ZP3,Zona pellucida sperm-binding protein 3,23579,96,0.99 [0.92-1.07],0.8528381390255297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ZP4,Zona pellucida sperm-binding protein 4,23402,100,1.29 [0.82-2.04],0.268148196874455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,ZPR1,Zinc finger protein ZPR1,23483,97,1.02 [0.84-1.25],0.8157610720467586
